Processing 00000000.tx.1: Biliary Secretory Function in Rats Chronically Intoxicated with Aluminum Marcela A. 

Phrase: "Biliary Secretory Function in Rats Chronically"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0544458:Secretory function [Functional Concept]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "Intoxicated with Aluminum Marcela A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002367:Aluminium [Element, Ion, or Isotope]
   760   C1136146:Marcela [Plant]
   760   C2348254:ALUMINUM [Element, Ion, or Isotope]
Processing 00000000.tx.2: Gonzalez*, Marcelo G. 

Phrase: "Gonzalez"

Phrase: "*,"

Phrase: "Marcelo G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.3: Roma, Claudio A. 

Phrase: "Roma,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0445583:Roma [Intellectual Product]
  1000   C1514862:ROMA [Molecular Biology Research Technique]

Phrase: "Claudio A."
Processing 00000000.tx.4: Bernal, Maria de Lujan Alvarez and Maria C. 

Phrase: "Bernal,"

Phrase: "Maria de Lujan Alvarez"

Phrase: "and"

Phrase: "Maria C."
Processing 00000000.tx.5: Carrillo,1 * Human Physiology Area, Litoral National University, Institute of Experimental Physiology (IFISE)-CONICET, National University of Rosario, and Bromatology and Nutrition Area, Litoral National University, Argentine Received November 28, 2003; 

Phrase: "Carrillo,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "* Human Physiology Area,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]

Phrase: "Litoral National University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Institute of Experimental Physiology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "(IFISE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0011198:DE [Geographic Area]
   812   C0017480:DE [Geographic Area]
   812   C1517586:Experimental [Qualitative Concept]
   812   C3541240:DE [Idea or Concept]

Phrase: ")-"

Phrase: "CONICET,"

Phrase: "National University of Rosario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0041740:University [Manufactured Object,Organization]

Phrase: "and"

Phrase: "Bromatology"

Phrase: "and"

Phrase: "Nutrition Area,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017446:Area [Geographic Area]
   861   C0205146:Area [Spatial Concept]

Phrase: "Litoral National University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Argentine Received November 28,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1514756:Received [Qualitative Concept]
   812   C2279544:argentine [Fish]

Phrase: "2003"

Phrase: ";"
Processing 00000000.tx.6: accepted January 13, 2004  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  The effects of a chronic aluminum (Al) exposure on biliary secretory function, with special emphasis on hepatic handling of nonbile salt organic anions, was investigated. 

Phrase: "accepted January 13,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2004  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The effects of a chronic aluminum (Al) exposure"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on biliary secretory function,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0544458:Secretory function [Functional Concept]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "with special emphasis"

Phrase: "on hepatic handling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018578:Handling [Behavior]
   861   C1832073:Handling [Finding]

Phrase: "of nonbile salt organic anions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003075:Anions [Element, Ion, or Isotope]

Phrase: "was"

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.7: Male Wistar rats received, intraperitoneally, either 27 mg/kg body weight of Al, as Al hydroxide [Al (+) rats], or the vehicle saline [Al () rats] three times a week for 3 months. 

Phrase: "Male Wistar rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034716:Rats, Wistar [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700262:Wistar [Mammal]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: ","

Phrase: "intraperitoneally,"

Phrase: "either 27 mg/kg body weight of Al,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0560741:mg/kg body weight [Quantitative Concept]
   800   C1508277:kg body weight [Organism Attribute]
   770   C0005910:Body Weight [Organism Attribute]
           weight
   770   C1305866:body weight [Diagnostic Procedure]
           weight
   767   C0333746:MG body [Finding]
   744   C0043100:Weight [Quantitative Concept]
   744   C0242821:body [Human]
   744   C0460148:Body [Anatomical Structure]
   744   C1268086:Body [Anatomical Structure]
   744   C1705104:Weight [Idea or Concept]

Phrase: "as"

Phrase: "Al hydroxide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0002371:Aluminium hydroxide [Inorganic Chemical,Pharmacologic Substance]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C0220853:hydroxide [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "[Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "(+"

Phrase: ")"

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "],"

Phrase: "or"

Phrase: "the vehicle saline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036082:Saline [Substance]

Phrase: "[Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "("

Phrase: ")"

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "] three times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "a week for 3 months."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332174:/week [Temporal Concept]
   760   C0439230:week [Temporal Concept]
Processing 00000000.tx.8: Serum and hepatic Al levels were increased by the treatment (9- and 4-fold, respectively). 

Phrase: "Serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "hepatic Al levels"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   901   C0474660:aluminum levels [Laboratory or Test Result]
   884 E C0202311:Aluminium level [Laboratory Procedure]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "increased by the treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "(9-"

Phrase: "and"

Phrase: "4-fold,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.9: This was associated with enhanced malondialdehyde formation (+110%) and a reduction in GSH content (17%) and in the activity of the antioxidant enzymes catalase (84%) and GSH peroxidase (46%). 

Phrase: "This"

Phrase: "was"

Phrase: "associated with enhanced malondialdehyde formation"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0024643:Malondialdehyde [Organic Chemical]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]
   760   C2349975:Enhanced [Activity]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(+110%"

Phrase: ")"

Phrase: "and"

Phrase: "a reduction in GSH content"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "(17%"

Phrase: ")"

Phrase: "and in the activity of the antioxidant enzymes catalase"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   762   C1148564:antioxidant activity [Molecular Function]
   762   C1151515:activity catalase [Molecular Function]
   745   C0243102:enzyme activity [Molecular Function]
   742   C0003402:Antioxidant [Pharmacologic Substance]
   742   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0014442:Enzymes [Enzyme,Organic Chemical]
   742   C0014445:enzymes [Functional Concept]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1413138:CATALASE [Gene or Genome]
   742   C1515981:And [Idea or Concept]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "(84%"

Phrase: ")"

Phrase: "and"

Phrase: "GSH peroxidase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(46%"

Phrase: ")."
Processing 00000000.tx.10: Bile flow (23%) and the biliary output of bile salts (39%), cholesterol (43%), and proteins (38%) also decreased. 

Phrase: "Bile flow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "(23%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the biliary output of bile salts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709366:Output [Conceptual Entity]

Phrase: "(39%"

Phrase: ")"

Phrase: ","

Phrase: "cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "(43%"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(38%"

Phrase: ")"

Phrase: "also"

Phrase: "decreased."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.11: Compartmental analysis of the plasma decay of the model organic anion bromosulphophthalein revealed that sinusoidal uptake and canalicular excretion of the dye were significantly decreased in Al (+) rats (53 and 43%, respectively). 

Phrase: "Compartmental analysis of the plasma decay of the model organic anion bromosulphophthalein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0002778:Analysis [Laboratory Procedure]
   736   C0936012:Analysis [Research Activity]
   736   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that sinusoidal uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "canalicular excretion of the dye"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0221102:Excretion [Physiologic Function]
   760   C0504085:Excretion [Body Substance]
   760   C2699704:EXCRETION [Regulation or Law]

Phrase: "were"

Phrase: "significantly"

Phrase: "decreased in Al"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0002367:Aluminium [Element, Ion, or Isotope]
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   790   C2348254:ALUMINUM [Element, Ion, or Isotope]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "(+"

Phrase: ")"

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "(53"

Phrase: "and"

Phrase: "43%,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.12: Expression of multidrug resistanceassociated protein 2 (Mrp2), the main, multispecific transporter involved in the canalicular excretion of organic anions, was also decreased (40%), which was associated with a significant decrease in the cumulative biliary excretion of the Mrp2 substrate, dinitrophenyl-S-glutathione (50%). 

Phrase: "Expression of multidrug resistanceassociated protein 2 (Mrp2),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "the main, multispecific transporter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "involved in the canalicular excretion of organic anions,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0003075:Anions [Element, Ion, or Isotope]
   744   C0221102:Excretion [Physiologic Function]
   744   C0504085:Excretion [Body Substance]
   744   C0747055:Organic [Qualitative Concept]
   744   C1314939:Involved [Functional Concept]
   744   C2699704:EXCRETION [Regulation or Law]

Phrase: "was"

Phrase: "also"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "(40%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "was"

Phrase: "associated with a significant decrease"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0237881:significant [Quantitative Concept]
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the cumulative biliary excretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0221102:Excretion [Physiologic Function]
   827   C0504085:Excretion [Body Substance]
   827   C2699704:EXCRETION [Regulation or Law]

Phrase: "of the Mrp2 substrate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1710236:Substrate [Manufactured Object]

Phrase: "dinitrophenyl-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]

Phrase: "S-"

Phrase: "glutathione"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(50%"

Phrase: ")."
Processing 00000000.tx.13: These results show that chronic Al exposure leads to oxidative stress, cholestasis, and impairment of the hepatic handling of organic anions by decreasing both sinusoidal uptake and canalicular excretion. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that chronic Al exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]

Phrase: "leads to oxidative stress,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0038435:Stress [Finding]
   770   C0181586:leads [Medical Device]
   770   C0311404:Oxidative [Functional Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "cholestasis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008370:Cholestasis [Disease or Syndrome]

Phrase: "and"

Phrase: "impairment of the hepatic handling of organic anions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0948807:Hepatic impairment [Disease or Syndrome]
   744   C0684336:Impairment [Pathologic Function]

Phrase: "by decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "both sinusoidal uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "canalicular excretion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0221102:Excretion [Physiologic Function]
   861   C0504085:Excretion [Body Substance]
   861   C2699704:EXCRETION [Regulation or Law]
Processing 00000000.tx.14: The alteration of the latter process seems to be causally related to impairment of Mrp2 expression. 

Phrase: "The alteration of the latter process"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1515926:Alteration [Idea or Concept]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "causally"

Phrase: "related to impairment of Mrp2 expression."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   762   C1171362:expression protein [Genetic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0439849:Related [Qualitative Concept]
   742   C0445223:Related [Finding]
   742   C0684336:Impairment [Pathologic Function]
   708 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.15: We have addressed some possible mechanisms involved in these deleterious effects. 

Phrase: "We"

Phrase: "have"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "some possible mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "involved in these deleterious effects."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C1280500:effects [Qualitative Concept]
   760   C1314939:Involved [Functional Concept]
   726 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.16: Key Words: aluminum; 

Phrase: "Key Words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "aluminum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: ";"
Processing 00000000.tx.17: liver; 

Phrase: "liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: ";"
Processing 00000000.tx.18: biliary function; 

Phrase: "biliary function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.19: multidrug resistanceassociated protein 2.  

Phrase: "multidrug resistanceassociated protein 2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.20: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Aluminum (Al) is one of the most abundant metals in the earth's crust. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Aluminum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "(Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: ")"

Phrase: "is"

Phrase: "one of the most abundant metals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "in the earth's crust."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205204:Crust [Acquired Abnormality]
Processing 00000000.tx.21: Human exposure to Al has been increasing over the last decades. 

Phrase: "Human exposure to Al"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332157:Exposure to [Clinical Attribute]
           Exposure
   770   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "has"

Phrase: "been"

Phrase: "increasing over the last decades."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0442808:Increasing [Functional Concept]
   726 E C0442805:Increase [Functional Concept]
   726   C2981279:Decade [Quantitative Concept]
Processing 00000000.tx.22: This element appears mainly in food products and in drinking water derived from both natural sources and treatment methods (Yokel and McNamara, 2001). 

Phrase: "This element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013879:Element [Element, Ion, or Isotope]
  1000   C1705248:Element [Conceptual Entity]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "mainly in food products"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0681562:food products [Food]
   816 E C0016452:Food Product [Food]
           Food
   770   C1514468:Products [Entity]
   737 E C1704444:Product [Quantitative Concept]

Phrase: "and in drinking water"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0599638:Drinking Water [Substance]
           WATER
   770   C0001948:drinking [Individual Behavior]
   770   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   770   C0684271:Drinking [Organism Function]
   770   C1515981:And [Idea or Concept]
   770   C1550678:Water [Inorganic Chemical]
   737 E C0452428:Drink [Food]

Phrase: "derived from both natural sources"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0205296:Natural [Functional Concept]
   760   C0449416:sources [Finding]
   760   C1441547:Derived [Qualitative Concept]
   760   C3245521:derived [Idea or Concept]
   726 E C1705919:Source [Idea or Concept]

Phrase: "and"

Phrase: "treatment methods"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   983   C0087111:treatment method [Therapeutic or Preventive Procedure]
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "(Yokel"

Phrase: "and"

Phrase: "McNamara,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.23: The major contributors to the current human exposure are food products such as grain products, processed cheese, and salt (Nieboer et al., 1995). 

Phrase: "The major contributors to the current human exposure"

Phrase: "are"

Phrase: "food products such as grain products,"

Phrase: "processed cheese,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0452792:Processed cheese [Food]
   861   C0007968:Cheese [Food]
   861   C1522240:Processed [Phenomenon or Process]
   861   C1649604:CHEESE [Food]
   827 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "salt"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0036140:Salt [Chemical Viewed Structurally]
  1000   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
  1000   C0206136:Salt [Food,Inorganic Chemical]
   928 E C1537053:salty [Qualitative Concept]
   900 E C0678584:saltiness [Qualitative Concept]

Phrase: "(Nieboer et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.24: Also, pharmaceutical products and medical treatments can be an important way to incorporate high levels of Al, either as an active compound or as a contaminant. 

Phrase: "Also,"

Phrase: "pharmaceutical products"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0013227:Pharmaceutical Products [Pharmacologic Substance]
   983 E C1708062:Pharmaceutical Product [Pharmacologic Substance]
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "medical treatments"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0087111:Treatments [Therapeutic or Preventive Procedure]
   827 E C0039798:treatment [Functional Concept]
   827 E C1522326:Treatment [Functional Concept]
   827 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   827 E C1705169:Treatment [Conceptual Entity]
   827 E C3538994:TREATMENT [Research Activity]

Phrase: "can"

Phrase: "be"

Phrase: "an important way to"

Phrase: "incorporate"

Phrase: "high levels of Al,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   819   C0474660:aluminum levels [Laboratory or Test Result]
   802 E C0202311:Aluminium level [Laboratory Procedure]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "either as an active compound"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205177:Active [Functional Concept]
   760   C0205198:Compound [Qualitative Concept]
   760   C1706082:Compound [Chemical]

Phrase: "or as a contaminant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2827365:Contaminant [Substance]
Processing 00000000.tx.25: For example, Al hydroxide is used as an antacid and as a phosphate binder in vaccines, and antiperspirant use has been shown to contribute significantly to Al bioavailability (Yokel and McNamara, 2001). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "Al hydroxide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0002371:Aluminium hydroxide [Inorganic Chemical,Pharmacologic Substance]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C0220853:hydroxide [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "is"

Phrase: "used as an antacid"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0003138:Antacid [Pharmacologic Substance]
   770   C0003216:Antacid [Pharmacologic Substance]
   770   C1273517:used [Finding]
   770   C1383090:Antacid [Physiologic Function]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "and as a phosphate binder"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C2267031:Phosphate Binder [Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0179302:Binder [Medical Device]
   760   C1515981:And [Idea or Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   760   C1706253:Binder [Biomedical or Dental Material]

Phrase: "in vaccines,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042210:Vaccines [Immunologic Factor,Pharmacologic Substance]
   966 E C1552558:Vaccine [Intellectual Product]

Phrase: "and"

Phrase: "antiperspirant use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0042153:use [Functional Concept]
   861   C0457083:Use [Functional Concept]
   861   C1947944:Use [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contribute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "significantly to Al bioavailability"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C0005508:Bioavailability [Quantitative Concept]
   770   C1706947:BIO-AVAILABILITY [Research Activity]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "(Yokel"

Phrase: "and"

Phrase: "McNamara,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.26: Finally, bioavailability by inhalation of airborne soluble Al was shown to be about 1.5% in the industrial environment (Yokel and McNamara, 2001). 

Phrase: "Finally,"

Phrase: "bioavailability by inhalation of airborne soluble Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0005508:Bioavailability [Quantitative Concept]
   748   C1706947:BIO-AVAILABILITY [Research Activity]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "about 1.5% in the industrial environment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0557758:Industrial environment [Spatial Concept]
   748   C0014406:Environment [Spatial Concept]
   748   C0021267:Industrial [Occupational Activity]

Phrase: "(Yokel"

Phrase: "and"

Phrase: "McNamara,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.27: Al has the potential to be toxic for humans. 

Phrase: "Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "has"

Phrase: "the potential to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "be"

Phrase: "toxic for humans."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0600688:toxic [Injury or Poisoning]
   790   C1407029:Toxic [Qualitative Concept]
Processing 00000000.tx.28: Patients on dialysis (Alfrey et al., 1976) or on long-term treatment with total parenteral nutrition (Klein, 1993) have been shown to accumulate this metal in different organs. 

Phrase: "Patients on dialysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030705:Patients [Patient or Disabled Group]

Phrase: "(Alfrey et al.,"

Phrase: "1976"

Phrase: ")"

Phrase: "or on long-term treatment"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   862   C0023977:long-term treatment [Health Care Activity]
   806   C0443252:Long-term [Temporal Concept]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0205166:Long [Qualitative Concept]
   760   C1515273:Term [Temporal Concept]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C1705313:Term [Idea or Concept]
   760   C1706317:Long [Qualitative Concept]
   760   C2826302:TERM [Intellectual Product]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "with total parenteral nutrition"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0030548:Parenteral Nutrition, Total [Therapeutic or Preventive Procedure]
           parenteral nutrition
   901   C0030547:Parenteral Nutrition [Therapeutic or Preventive Procedure]
   827   C0028707:Nutrition [Biomedical Occupation or Discipline]
   827   C0392209:nutrition [Organism Attribute]
   827   C0439175:% total [Quantitative Concept]
   827   C0439810:Total [Qualitative Concept]
   827   C1442959:Nutrition [Organism Function]
   755 E C1521739:Nutritional [Qualitative Concept]
   755 E C2707262:Nutritional [Clinical Attribute]

Phrase: "(Klein,"

Phrase: "1993"

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "accumulate"

Phrase: "this metal in different organs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0025552:Metal [Inorganic Chemical]
Processing 00000000.tx.29: The human toxicological effects include encephalopathy (Alfrey et al., 1976), bone disease (Ward et al., 1978), and anemia (Short et al., 1980). 

Phrase: "The human toxicological effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "encephalopathy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085584:Encephalopathy [Disease or Syndrome]
  1000   C1963101:Encephalopathy [Finding]

Phrase: "(Alfrey et al.,"

Phrase: "1976"

Phrase: ")"

Phrase: ","

Phrase: "bone disease"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0005940:Bone disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   861   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   861   C0391978:Bone [Tissue]
   861   C1266908:Bone [Body Part, Organ, or Organ Component]
   861   C1266909:Bone [Body System]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   789 E C0443157:Bony [Functional Concept]

Phrase: "(Ward et al.,"

Phrase: "1978"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "anemia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0002871:Anaemia [Disease or Syndrome]
  1000   C1000483:Anemia [Plant]
   928 E C0857322:anaemic [Finding]

Phrase: "(Short et al.,"

Phrase: "1980"

Phrase: ")."
Processing 00000000.tx.30: Finally, Al is a possible contributing factor in Alzheimer's disease (Campbell, 2002). 

Phrase: "Finally,"

Phrase: "Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "is"

Phrase: "a possible contributing factor in Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   774   C0679238:disease factor [Functional Concept]
   774   C0960756:factor A [Organic Chemical]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]

Phrase: "(Campbell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331936:Campbell [Health Care Related Organization]

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.31: It has been demonstrated in experimental animals that Al exposure has an important impact on liver function. 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated in experimental animals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0003064:experimental animal [Animal]
   770   C0003062:Animals [Animal]
   770   C1517586:Experimental [Qualitative Concept]

Phrase: "that Al exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]

Phrase: "has"

Phrase: "an important impact on liver function."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1825598:IMPACT [Gene or Genome]
Processing 00000000.tx.32: Rats subchronically intoxicated with Al (5 mg/kg body weight/day for 114 days, iv) increased serum bile salts, which was associated with a reduction in bile flow (Klein et al., 1988) and an alteration in the glycine-to-taurine bile salt ratio (Klein et al., 1989a). 

Phrase: "Rats subchronically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "intoxicated with Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0002367:Aluminium [Element, Ion, or Isotope]
   790   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "(5 mg/kg body weight/day for 114 days,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   784   C0439400:mg/kg/day [Quantitative Concept]
   762   C0439418:kg/day [Quantitative Concept]
   762   C0439422:day mg [Quantitative Concept]
   762   C0439423:mg/day [Quantitative Concept]
   742   C0332173:/day [Temporal Concept]
   742   C0439228:day [Temporal Concept]
   742   C0439505:/day [Temporal Concept]

Phrase: "iv) increased serum bile salts,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   840   C0005404:Bile Salts [Biologically Active Substance,Steroid]
   840   C0523530:Bile Salts [Laboratory Procedure]
   804   C0005388:Bile [Body Substance]
   804   C0036140:Salts [Chemical Viewed Structurally]
   771 E C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   771 E C0206136:Salt [Food,Inorganic Chemical]
   721 E C1537053:salty [Qualitative Concept]

Phrase: "which"

Phrase: "was"

Phrase: "associated with a reduction"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in bile flow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "(Klein et al.,"

Phrase: "1988"

Phrase: ")"

Phrase: "and"

Phrase: "an alteration in the glycine-to-taurine bile salt ratio"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1515926:Alteration [Idea or Concept]

Phrase: "(Klein et al.,"

Phrase: "1989a"

Phrase: ")."
Processing 00000000.tx.33: A reduction in cytochrome P450 levels in microsomes has also been described (Jeffery et al., 1987). 

Phrase: "A reduction in cytochrome P450 levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in microsomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026029:Microsomes [Cell Component]
   916 E C1979928:Microsomal [Qualitative Concept]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Jeffery et al.,"

Phrase: "1987"

Phrase: ")."
Processing 00000000.tx.34: Alterations of bile secretory function due to chronic Al exposure have not been studied yet. 

Phrase: "Alterations of bile secretory function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1515926:Alteration [Idea or Concept]

Phrase: "due to chronic Al exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "yet."
Processing 00000000.tx.35: They could be considerably different from those occurring under short-term exposure, since exacerbation of the deleterious effect, due to hepatic accumulation of Al or other potentially toxic biliary constituents, or, conversely, compensatory mechanisms may occur. 

Phrase: "They"

Phrase: "could"

Phrase: "be"

Phrase: "considerably different from those occurring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "under short-term exposure,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]
   734   C0443303:Short-term [Temporal Concept]

Phrase: "since"

Phrase: "exacerbation of the deleterious effect,"

Phrase: "due to hepatic accumulation"

Phrase: "of Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "or"

Phrase: "other potentially toxic biliary constituents,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0729650:Constituents [Substance]

Phrase: "or"

Phrase: ","

Phrase: "conversely,"

Phrase: "compensatory mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "may"

Phrase: "occur."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.36: Therefore, using a rat model, we have studied the interaction between chronic exposure to Al and bile secretory function, with special emphasis on organic anion biliary transport. 

Phrase: "Therefore,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a rat model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "we"

Phrase: "have"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the interaction between chronic exposure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "to Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "bile secretory function,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0544458:Secretory function [Functional Concept]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "with special emphasis"

Phrase: "on organic anion biliary transport."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1159606:organic anion transport [Cell Function]
   875   C1159585:anion transport [Cell Function]
   812   C0005528:Transport, NOS [Cell Function]
   812   C1317949:Transport [Manufactured Object]
   812   C3495449:transport [Medical Device]
Processing 00000000.tx.37: Bile formation and biliary excretion of cholephilic xenobiotics are determined by the ability of the hepatocyte to transport solutes. 

Phrase: "Bile formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0232750:Bile formation [Organ or Tissue Function]
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "biliary excretion of cholephilic xenobiotics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0221102:Excretion [Physiologic Function]
   760   C0504085:Excretion [Body Substance]
   760   C2699704:EXCRETION [Regulation or Law]

Phrase: "are"

Phrase: "determined by the ability of the hepatocyte to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0085732:Ability [Organism Attribute]
   744   C0227525:Hepatocyte [Cell]
   744   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005528:Transport, NOS [Cell Function]
  1000   C1317949:Transport [Manufactured Object]
  1000   C3495449:transport [Medical Device]

Phrase: "solutes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597488:solutes [Chemical Viewed Structurally]
Processing 00000000.tx.38: Several transport systems have been identified both in the sinusoidal and in the canalicular membranes, and most of them have been functionally characterized by molecular cloning (Jansen, 2000). 

Phrase: "Several transport systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "both in the sinusoidal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0238767:Both [Spatial Concept]
   770   C0442041:Sinusoidal [Spatial Concept]
   770   C1706086:Both [Qualitative Concept]

Phrase: "and in the canalicular membranes,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0025255:Membranes [Tissue]
   760   C1515981:And [Idea or Concept]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "and"

Phrase: "most of them"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205393:Most [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "functionally"

Phrase: "characterized by molecular cloning"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0009015:Cloning [Research Activity]
   770   C1521991:Molecular [Qualitative Concept]
   770   C1880022:Characterized [Activity]

Phrase: "(Jansen,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.39: The multidrug resistanceassociated protein 2 (Mrp2), located in the canalicular membrane, mediates the rate-limiting step in the biliary secretion of different organic anions, including glutathione (GSH)-S-conjugates of leukotriene-C4 or bromosulphophthalein (BSP), glucuronide conjugates of bilirubin, estrogens, and bile salts, and both reduced and oxidized GSH (Konig et al., 1999; Paulusma et al., 1999). 

Phrase: "The multidrug resistanceassociated protein 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Mrp2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "located in the canalicular membrane,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025255:Membrane [Tissue]
   760   C0596901:Membrane [Cell Component]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the rate-limiting step in"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1261552:Step [Conceptual Entity]
   812   C1704379:Step [Functional Concept]
   812   C1705117:Step [Quantitative Concept]
   812   C2825408:Step [Manufactured Object]

Phrase: "the biliary secretion of different organic anions,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "glutathione"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(GSH)-S-conjugates of leukotriene-C4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0301869:conjugates [Immunologic Factor]

Phrase: "or"

Phrase: "bromosulphophthalein (BSP),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038753:Bromosulfophthalein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "glucuronide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0812407:Glucuronide [Carbohydrate]

Phrase: "conjugates of bilirubin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C0236556:conjugate bilirubin [Biologically Active Substance,Organic Chemical]
   858   C0697273:conjugate bilirubin [Laboratory Procedure]
   790   C0005437:Bilirubin [Biologically Active Substance,Organic Chemical]
   790   C0301869:Conjugate [Immunologic Factor]

Phrase: "estrogens,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   966 E C2936882:Estrogen [Pharmacologic Substance]
   916 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "bile salts,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0005404:Bile Salts [Biologically Active Substance,Steroid]
  1000   C0523530:Bile Salts [Laboratory Procedure]
   861   C0005388:Bile [Body Substance]
   861   C0036140:Salts [Chemical Viewed Structurally]
   827 E C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827 E C0206136:Salt [Food,Inorganic Chemical]
   777 E C1537053:salty [Qualitative Concept]
   755 E C0678584:saltiness [Qualitative Concept]

Phrase: "and"

Phrase: "both"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "and"

Phrase: "oxidized GSH (Konig et al.,"

Phrase: "1999"

Phrase: "; Paulusma et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.40: Excretion of the last two compounds has been shown to be a driving force in the so-called "bile saltindependent fraction of the bile flow" (Ballatori and Truong, 1992). 

Phrase: "Excretion of the last two compounds"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0221102:Excretion [Physiologic Function]
   753   C0504085:Excretion [Body Substance]
   753   C2699704:EXCRETION [Regulation or Law]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a driving force in the so-called ""bile saltindependent fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0441722:Force [Phenomenon or Process]
   739   C0563538:Force [Phenomenon or Process]

Phrase: "of the bile flow"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "(Ballatori"

Phrase: "and"

Phrase: "Truong,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.41: Therefore, our second aim was to investigate the functional status of Mrp2, due to its dual, key role both in the generation of bile flow and in the biliary transport of organic anions.  

Phrase: "Therefore,"

Phrase: "our second aim"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1947946:Aim [Idea or Concept]
   861   C2948600:Aim [Pharmacologic Substance]
   861   C3540471:AIM [Gene or Genome]
   861   C3540472:AIM [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the functional status of Mrp2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0598463:Functional Status [Finding]
   744   C0449438:Status [Qualitative Concept]

Phrase: "due to its dual, key role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035820:Role [Social Behavior]
   827   C1705810:Role [Conceptual Entity]

Phrase: "both in the generation of bile flow"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0005388:Bile [Body Substance]
   748   C0079411:Generation [Temporal Concept]
   748   C0238767:Both [Spatial Concept]
   748   C0806140:Flow [Natural Phenomenon or Process]
   748   C1706086:Both [Qualitative Concept]
   748   C3146294:Generation [Activity]

Phrase: "and in the biliary transport of organic anions."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   782   C1159606:organic anion transport [Cell Function]
   750   C1159585:anion transport [Cell Function]
   744   C0003075:Anions [Element, Ion, or Isotope]
   744   C0005528:Transport, NOS [Cell Function]
   744   C0521378:Biliary [Functional Concept]
   744   C0747055:Organic [Qualitative Concept]
   744   C1317949:Transport [Manufactured Object]
   744   C1515981:And [Idea or Concept]
   744   C3495449:transport [Medical Device]
Processing 00000000.tx.42: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Animals and treatments. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "and"

Phrase: "treatments."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0087111:Treatments [Therapeutic or Preventive Procedure]
   966 E C0039798:treatment [Functional Concept]
   966 E C1522326:Treatment [Functional Concept]
   966 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   966 E C1705169:Treatment [Conceptual Entity]
   966 E C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.43: Male Wistar rats (300360 g) were used throughout. 

Phrase: "Male Wistar rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034716:Rats, Wistar [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700262:Wistar [Mammal]

Phrase: "(300360 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "throughout."
Processing 00000000.tx.44: All the experimental protocols were performed according to the Guide for Care and Use of Laboratory Animals (National Institutes of Health publication 25-28, revised 1996). 

Phrase: "All"

Phrase: "the experimental protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]

Phrase: "were"

Phrase: "performed according to the Guide"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0181090:Guide [Professional or Occupational Group]
   760   C0302614:Guide [Medical Device]
   760   C0680240:according [Social Behavior]
   760   C0884358:Performed [Functional Concept]
   760   C1706050:Guide [Manufactured Object]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "for Care"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947933:Care [Activity]

Phrase: "and"

Phrase: "Use of Laboratory Animals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1524063:Use of [Functional Concept]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "(National Institutes of Health publication 25-28,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   877   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   795   C0018684:Health [Idea or Concept]
   795   C0021622:Institutes [Organization]
   795   C0034036:Publication [Intellectual Product,Manufactured Object]
   795   C0034037:Publication [Occupational Activity]
   795   C1704324:Publication [Intellectual Product]
   795   C3245503:national [Intellectual Product]
   762 E C1272753:Institute [Idea or Concept]

Phrase: "revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.45: Rats were housed with a 12 h light/dark cycle and controlled temperature (2125C), and they were fed ad libitum with a standard rodent diet and water. 

Phrase: "Rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "housed with a 12 h light/dark cycle"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   800   C2718082:Light-Dark Cycle [Temporal Concept]
           Light Cycle
   744   C0020056:Housed [Manufactured Object]
   744   C0023693:Light [Natural Phenomenon or Process]
   744   C0033727:H+ [Element, Ion, or Isotope]
   744   C0332582:Dark [Qualitative Concept]
   744   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441932:H+ [Classification]
   744   C0564385:/h [Quantitative Concept]
   744   C1306462:Light [Functional Concept]
   744   C1511572:Cycle [Temporal Concept]
   744   C1881376:Light [Qualitative Concept]
   711 E C0442519:house [Conceptual Entity]
   711 E C2003847:House [Manufactured Object]

Phrase: "and"

Phrase: "controlled temperature"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449862:Controlled temperature [Phenomenon or Process]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]

Phrase: "(2125C"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "they"

Phrase: "were"

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "ad libitum with a standard rodent diet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   778   C1879743:ad libitum [Qualitative Concept]

Phrase: "and"

Phrase: "water."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]
Processing 00000000.tx.46: After 710 days of acclimatization, rats were assigned randomly to two different groups of similar mean body weight. 

Phrase: "After 710 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "of acclimatization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000934:Acclimatisation [Organism Function]

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "assigned"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516050:Assigned [Functional Concept]
  1000   C1552601:assigned [Intellectual Product]

Phrase: "randomly to two different groups of similar mean body weight."
Meta Candidates (Total=22; Excluded=0; Pruned=0; Remaining=22)
   760   C0005910:Body Weight [Organism Attribute]
           weight
   760   C1305866:body weight [Diagnostic Procedure]
           weight
   739   C0043100:Weight [Quantitative Concept]
   739   C0205448:Two [Quantitative Concept]
   739   C0242821:body [Human]
   739   C0441833:Group [Idea or Concept]
   739   C0444504:Mean [Quantitative Concept]
   739   C0460148:Body [Anatomical Structure]
   739   C0687744:group [Population Group]
   739   C1257890:Group [Population Group]
   739   C1268086:Body [Anatomical Structure]
   739   C1552516:Group [Health Care Related Organization]
   739   C1552839:groups [Idea or Concept]
   739   C1705104:Weight [Idea or Concept]
   739   C1705242:Different [Qualitative Concept]
   739   C1705428:Group [Conceptual Entity]
   739   C1705429:Group [Population Group]
   739   C2347634:Mean [Quantitative Concept]
   739   C2348143:Mean [Quantitative Concept]
   739   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.47: One group received Al (as Al hydroxide) at the dose of 27 mg/kg body weight, ip, in 0.5 ml of saline, three times a week for 90 consecutive days [Al (+) rats]. 

Phrase: "One group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "("

Phrase: "as Al hydroxide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0002371:Aluminium hydroxide [Inorganic Chemical,Pharmacologic Substance]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C0220853:hydroxide [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: ")"

Phrase: "at the dose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178602:Dose [Quantitative Concept]
  1000   C0869039:Dose [Quantitative Concept]
  1000   C1114758:Dose # [Clinical Attribute]

Phrase: "of 27 mg/kg body weight,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   937   C0560741:mg/kg body weight [Quantitative Concept]
   884   C1508277:kg body weight [Organism Attribute]
   853   C0333746:MG body [Finding]
   840   C0005910:Body Weight [Organism Attribute]
           weight
   840   C1305866:body weight [Diagnostic Procedure]
           weight
   804   C0043100:Weight [Quantitative Concept]
   804   C0242821:body [Human]
   804   C0460148:Body [Anatomical Structure]
   804   C1268086:Body [Anatomical Structure]
   804   C1705104:Weight [Idea or Concept]
   721 E C1995017:Bodies [Cell Component]

Phrase: "ip,"

Phrase: "in 0.5 ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439526:/mL [Quantitative Concept]
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "of saline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036082:Saline [Substance]

Phrase: "three times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "a week for 90 consecutive days"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   783   C0677547:days week [Temporal Concept]
   767 E C0585023:day week [Temporal Concept]
   753   C0332174:/week [Temporal Concept]
   753   C0439230:week [Temporal Concept]

Phrase: "[Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "(+"

Phrase: ")"

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "]."
Processing 00000000.tx.48: A second group received the vehicle alone with an identical administration schedule [Al () rats]. 

Phrase: "A second group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   964   C0680398:secondary group [Population Group]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "the vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: "alone with an identical administration schedule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205171:Alone [Quantitative Concept]
   753   C0439044:alone [Finding]
   753   C0679994:alone [Group Attribute]

Phrase: "[Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "("

Phrase: ")"

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "]."
Processing 00000000.tx.49: This protocol was designed according to the experimental model of Al intoxication developed in the Department of Pathological Anatomy, School of Odontology, University of Buenos Aires (Degiorgis et al., 1987). 

Phrase: "This protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442711:Protocol [Intellectual Product]
  1000   C1507394:Protocol [Intellectual Product]
  1000   C1522729:Protocol [Intellectual Product]
  1000   C2348563:Protocol [Intellectual Product]

Phrase: "was"

Phrase: "designed according to the experimental model of Al intoxication"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   764   C0086272:Experimental Model [Intellectual Product]
   764   C0473223:Aluminium intoxication [Disease or Syndrome]
   745   C0015320:Experimental Design [Research Activity]
   745   C0035171:Experimental Design [Research Activity]
   745   C0920594:model design [Intellectual Product]
   742   C0002367:Aluminium [Element, Ion, or Isotope]
   742   C0680240:according [Social Behavior]
   742   C0728899:Intoxication [Finding]
   742   C1517586:Experimental [Qualitative Concept]
   742   C2348254:ALUMINUM [Element, Ion, or Isotope]
   742   C3161035:Model [Intellectual Product]
   708   C1707689:Design [Activity]
   708   C2983265:DESIGN [Intellectual Product]

Phrase: "developed in the Department of Pathological Anatomy,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0002808:Anatomy [Biomedical Occupation or Discipline]
   748   C0030664:Pathological [Biomedical Occupation or Discipline]
   748   C0700276:anatomy [Anatomical Structure]
   748   C1384516:anatomy [Qualitative Concept]
   748   C1521733:Pathological [Functional Concept]
   748   C1704729:Department [Organization]
   738   C0587487:Pathology department [Health Care Related Organization]
   702   C1555812:Anatomic Pathology [Intellectual Product]

Phrase: "School of Odontology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0036375:School [Manufactured Object,Organization]

Phrase: "University of Buenos Aires"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0041740:University [Manufactured Object,Organization]

Phrase: "(Degiorgis et al.,"

Phrase: "1987"

Phrase: ")."
Processing 00000000.tx.50: Al hydroxide was used for Al supply because it is one of the main Al-containing components of drinking water (Fulton et al., 1989) and is a major ingredient in antacid and vaccine formulations (Lione, 1985). 

Phrase: "Al hydroxide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0002371:Aluminium hydroxide [Inorganic Chemical,Pharmacologic Substance]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C0220853:hydroxide [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "was"

Phrase: "used for Al supply"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C0243163:supply [Idea or Concept]
   770   C0699914:supply [Quantitative Concept]
   770   C1273517:used [Finding]
   770   C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   770   C1561604:supply [Functional Concept]
   770   C1875802:SUPPLY [Medical Device]
   770   C1999230:Supply [Activity]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "because"

Phrase: "it"

Phrase: "is"

Phrase: "one of the main Al-containing components of drinking water"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205447:One [Quantitative Concept]

Phrase: "(Fulton et al.,"

Phrase: "1989"

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "a major ingredient in antacid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1550600:Ingredient [Chemical Viewed Functionally]

Phrase: "and"

Phrase: "vaccine formulations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0524527:Formulation [Research Activity]

Phrase: "(Lione,"

Phrase: "1985"

Phrase: ")."
Processing 00000000.tx.51: After treatment, rats from control and treated groups were sacrificed by exsanguination, and samples of liver were obtained to determine lipid peroxidation; 

Phrase: "After treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "rats from control"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034693:rats [Mammal]
   790   C0034721:Rats [Mammal]

Phrase: "and"

Phrase: "treated groups"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   861   C0332293:treated [Therapeutic or Preventive Procedure]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1522326:Treated [Functional Concept]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   827 E C1292734:TREAT [Functional Concept]

Phrase: "were"

Phrase: "sacrificed by exsanguination,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0232100:Exsanguination [Pathologic Function]
   756   C0681205:Sacrifice [Idea or Concept]

Phrase: "and"

Phrase: "samples of liver"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0370003:Sample [Substance]
   756   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "lipid peroxidation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023775:Lipid Peroxidation [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0178796:peroxidation [Phenomenon or Process]

Phrase: ";"
Processing 00000000.tx.52: hepatic GSH content; 

Phrase: "hepatic GSH content"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
   827   C1260386:GSH [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.53: glutathione-S-transferase (GST), catalase (CAT), and glutathione peroxidase (GSH-Px) activities; 

Phrase: "glutathione-S-transferase (GST),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "catalase (CAT),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]

Phrase: "and"

Phrase: "glutathione peroxidase (GSH-Px) activities"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C1151528:glutathione peroxidase activity [Molecular Function]
   884   C1151518:peroxidase activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]
   734   C0017822:GLUTATHIONE PEROXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1415275:GLUTATHIONE PEROXIDASE [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.54: and Mrp2 protein levels. 

Phrase: "and"

Phrase: "Mrp2 protein levels."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   841   C0428479:Protein level [Laboratory or Test Result]
   799   C0441889:Levels [Qualitative Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.55: Another set of animals from both experimental groups was used to perform pharmacokinetic studies. 

Phrase: "Another"

Phrase: "set of animals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0003062:Animals [Animal]
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]

Phrase: "from both experimental groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1517586:Experimental [Qualitative Concept]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "pharmacokinetic studies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0201734:pharmacokinetic studies [Research Activity]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
Processing 00000000.tx.56: Finally, a different group of rats was used to study the transport activity of Mrp2. 

Phrase: "Finally,"

Phrase: "a different group of rats"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0441835:Group A [Classification]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the transport activity of Mrp2."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C1537044:protein activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]
   731   C0005529:Active Transport [Physiologic Function]
Processing 00000000.tx.57: Al content in plasma and liver was determined by electrothermical atomic absorption spectroscopy (graphite oven and Perkin-Elmer Spectrometer 5000, Boston, MA, USA). 

Phrase: "Al content in plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0423896:Content [Mental Process]
   770   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "was"

Phrase: "determined by electrothermical atomic absorption spectroscopy"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0037806:Atomic Absorption Spectroscopy [Laboratory Procedure]
   753   C0000854:Absorption [Natural Phenomenon or Process]
   753   C0037812:spectroscopy [Laboratory Procedure]
   753   C0220777:absorption [Functional Concept]
   753   C2347023:Absorption [Phenomenon or Process]
   753   C2347080:Absorption [Phenomenon or Process]
   753   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   753   C2713504:Spectroscopy [Occupation or Discipline]
   753   C2825050:Absorption [Phenomenon or Process]
   753   C2984732:SPECTROSCOPY [Functional Concept]

Phrase: "(graphite oven"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0336755:Oven [Manufactured Object]
   861   C1706357:Oven [Medical Device]

Phrase: "and"

Phrase: "Perkin-Elmer Spectrometer 5000,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0183395:Spectrometer [Medical Device]
   812   C1710143:Spectrometer [Manufactured Object]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.58: Oxidative stress measurement. 

Phrase: "Oxidative stress measurement."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0242485:Measurement [Functional Concept]
   734   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
Processing 00000000.tx.59: The amount of aldehydic products generated by lipid peroxidation in liver tissue was quantified by the thiobarbituric acidreactive substances (TBARS) colorimetric method of Ohkawa et al. 

Phrase: "The amount of aldehydic products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "generated by lipid peroxidation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0023775:Lipid Peroxidation [Molecular Function]
   770   C0023779:Lipid [Lipid]
   770   C0178796:peroxidation [Phenomenon or Process]
   770   C3146294:Generated [Activity]

Phrase: "in liver tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0736268:Liver tissue [Body Part, Organ, or Organ Component]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "quantified by the thiobarbituric acidreactive substances (TBARS) colorimetric method of Ohkawa et al."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   736   C0025663:Method [Intellectual Product]
   736   C0439861:Substances [Substance]
   736   C0449851:Method [Functional Concept]
   736   C0871511:METHOD [Intellectual Product]
   703   C1709793:Quantify [Quantitative Concept]
Processing 00000000.tx.60: (1979). 

Phrase: "(1979"

Phrase: ")."
Processing 00000000.tx.61: The colored products resulting from the reaction between TBA and the hydrolyzed, peroxidized lipids were extracted with n-butanol, and the color was measured at 532 nm. 

Phrase: "The colored products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "resulting from the reaction"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0443286:Reaction [Functional Concept]
   770   C0678226:resulting [Functional Concept]
   770   C1114821:Reaction [Clinical Attribute]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "between TBA"

Phrase: "and"

Phrase: "the hydrolyzed, peroxidized lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023779:Lipids [Lipid]

Phrase: "were"

Phrase: "extracted with n-butanol,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   819   C0089147:BUTANOL N [Lipid]
           butanol
   770   C0001977:Butanol [Lipid]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "the color"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0009393:Color [Natural Phenomenon or Process]
  1000   C1550604:color [Indicator, Reagent, or Diagnostic Aid]
  1000   C1705245:Color [Pharmacologic Substance]
   928 E C0522507:colored [Qualitative Concept]

Phrase: "was"

Phrase: "measured at 532 nm."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0312860:NM [Cell Function]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.62: TBARS were expressed in terms of malondialdehyde (MDA) levels (nmoles/g liver weight) by using a standard curve of 1,1,3,3-tetramethoxypropane, which is converted mole for mole into MDA. 

Phrase: "TBARS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439861:Substances [Substance]

Phrase: "were"

Phrase: "expressed in terms of malondialdehyde (MDA) levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0024643:Malondialdehyde [Organic Chemical]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719   C1515273:Term [Temporal Concept]
   719 E C1547707:Level [Geographic Area]
   719   C1705313:Term [Idea or Concept]
   719   C2826302:TERM [Intellectual Product]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "(nmoles/g liver weight"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0005910:weight [Organism Attribute]
   812   C0043100:Weight [Quantitative Concept]
   812   C1305866:weight [Diagnostic Procedure]
   812   C1705104:Weight [Idea or Concept]

Phrase: ")"

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a standard curve of 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205134:Curve [Spatial Concept]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "3-tetramethoxypropane,"

Phrase: "which"

Phrase: "is"

Phrase: "converted"

Phrase: "mole for mole"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   858   C2347289:Mole/Mole [Quantitative Concept]

Phrase: "into MDA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024643:Malondialdehyde [Organic Chemical]
Processing 00000000.tx.63: Liver homogenates in 5% TCA were used to measure total GSH levels as the main nonprotein sulphidryl compounds, as described previously (Ellman, 1959). 

Phrase: "Liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "homogenates in 5% TCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0041405:TCA [Geographic Area]
   770   C0085758:TCA [Congenital Abnormality]
   770   C1415587:TCA [Gene or Genome]
   770   C3536819:TCA [Pharmacologic Substance]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "total GSH levels as the main nonprotein sulphidryl compounds,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   742   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0441889:Levels [Qualitative Concept]
   742   C1260386:GSH [Disease or Syndrome]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Ellman,"

Phrase: "1959"

Phrase: ")."
Processing 00000000.tx.64: GST, CAT, and GSH-Px activities were assessed in liver cytosolic fractions. 

Phrase: "GST,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "CAT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]

Phrase: "and"

Phrase: "GSH-Px activities"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C1151528:glutathione peroxidase activity [Molecular Function]
   884   C1151518:peroxidase activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]
   734   C0017822:GLUTATHIONE PEROXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1415275:GLUTATHIONE PEROXIDASE [Gene or Genome]

Phrase: "were"

Phrase: "assessed in liver cytosolic fractions."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   781   C0982262:LIVER FRACTION [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   C0023884:Liver [Body Part, Organ, or Organ Component]
   760   C0736268:LIVER [Body Part, Organ, or Organ Component]
   760   C1264633:Fractions [Quantitative Concept]
   760   C1278929:Liver [Body Part, Organ, or Organ Component]
   760   C1383501:Cytosolic [Cell Component]
   760   C1516048:Assessed [Activity]
   760   C2346688:LIVER [Food]
   726 E C1554103:Fraction [Idea or Concept]
   704 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.65: The cytosol fraction was obtained by ultracentrifugation (100,000 x g) of liver homogenates (20%, w/v) prepared in 1 mM EDTA, 30 mM Na2HPO4, and 250 mM sucrose buffer, pH 7.4. 

Phrase: "The cytosol fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "obtained by ultracentrifugation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0041609:Ultracentrifugation [Laboratory Procedure]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(100,000 x g) of liver homogenates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439267:g% [Quantitative Concept]

Phrase: "(20%,"

Phrase: "w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "prepared in 1 mM EDTA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1418486:MM-1 [Gene or Genome]
   760   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   726   C1521827:Prepare [Functional Concept]

Phrase: "30 mM Na2HPO4,"

Phrase: "and"

Phrase: "250 mM sucrose buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "pH 7.4."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.66: GST activity was assayed using 1-chloro-2,4-dinitrobenzene (CDNB) as substrate (Goldstein and Combes, 1966) and expressed as nmol/min/mg protein. 

Phrase: "GST activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1152039:glutathione S-transferase activity [Molecular Function]
           glutathione transferase activity
   861   C1151895:transferase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase

Phrase: "was"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "1-chloro-2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0580272:1/2 [Intellectual Product]
   913   C1519043:1-2 [Research Activity]
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: "4-dinitrobenzene (CDNB) as substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0012459:Dinitrobenzene [Organic Chemical]

Phrase: "(Goldstein"

Phrase: "and"

Phrase: "Combes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331946:combes [Health Care Related Organization]

Phrase: "1966"

Phrase: ")"

Phrase: "and"

Phrase: "expressed as nmol/min/mg protein."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   820   C1881965:nmol/mg{protein} [Quantitative Concept]
   790   C2827910:nmol/min [Quantitative Concept]
   783   C0439291:nmol/mg [Quantitative Concept]
   783   C0439420:mg/min [Quantitative Concept]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439191:NMOLE [Quantitative Concept]
   753   C0439269:mg% [Quantitative Concept]
   753   C0702093:/min [Temporal Concept]
   753   C1960952:mg % [Quantitative Concept]
   753   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.67: CAT and GSH-Px activities were assessed by the methods of Beers and Sizer (1952) and Paglia and Valentine (1967), respectively. 

Phrase: "CAT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]

Phrase: "and"

Phrase: "GSH-Px activities"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C1151528:glutathione peroxidase activity [Molecular Function]
   884   C1151518:peroxidase activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]
   734   C0017822:GLUTATHIONE PEROXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1415275:GLUTATHIONE PEROXIDASE [Gene or Genome]

Phrase: "were"

Phrase: "assessed by the methods of Beers"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0004922:Beers [Food]
   753   C0025663:Methods [Intellectual Product]
   753   C0025664:methods [Intellectual Product]
   753   C0449851:Methods [Functional Concept]
   753   C1516048:Assessed [Activity]
   719 E C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "Sizer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221872:sizer [Medical Device]

Phrase: "(1952"

Phrase: ")"

Phrase: "and"

Phrase: "Paglia"

Phrase: "and"

Phrase: "Valentine"

Phrase: "(1967"

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.68: Protein levels in each fraction were determined as previously described (Lowry et al., 1951). 

Phrase: "Protein levels in each fraction"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C0428479:Protein level [Laboratory or Test Result]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "determined as previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Lowry et al.,"

Phrase: "1951"

Phrase: ")."
Processing 00000000.tx.69: Basal bile flow and pharmacokinetic studies. 

Phrase: "Basal bile flow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "pharmacokinetic studies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0201734:pharmacokinetic studies [Research Activity]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
Processing 00000000.tx.70: At 90 days of treatment, rats were anesthetized with acepromazine (1 mg/kg body weight, ip) and ketamine (100 mg/kg body weight, ip). 

Phrase: "At 90 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "of treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "anesthetized with acepromazine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0000959:Acepromazine [Organic Chemical,Pharmacologic Substance]
   790   C1720436:Anesthetized [Finding]

Phrase: "(1 mg/kg body weight,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   937   C0560741:mg/kg body weight [Quantitative Concept]
   884   C1508277:kg body weight [Organism Attribute]
   853   C0333746:MG body [Finding]
   840   C0005910:Body Weight [Organism Attribute]
           weight
   840   C1305866:body weight [Diagnostic Procedure]
           weight
   804   C0043100:Weight [Quantitative Concept]
   804   C0242821:body [Human]
   804   C0460148:Body [Anatomical Structure]
   804   C1268086:Body [Anatomical Structure]
   804   C1705104:Weight [Idea or Concept]
   721 E C1995017:Bodies [Cell Component]

Phrase: "ip)"

Phrase: "and"

Phrase: "ketamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022614:Ketamine [Organic Chemical,Pharmacologic Substance]

Phrase: "(100 mg/kg body weight,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   937   C0560741:mg/kg body weight [Quantitative Concept]
   884   C1508277:kg body weight [Organism Attribute]
   853   C0333746:MG body [Finding]
   840   C0005910:Body Weight [Organism Attribute]
           weight
   840   C1305866:body weight [Diagnostic Procedure]
           weight
   804   C0043100:Weight [Quantitative Concept]
   804   C0242821:body [Human]
   804   C0460148:Body [Anatomical Structure]
   804   C1268086:Body [Anatomical Structure]
   804   C1705104:Weight [Idea or Concept]
   721 E C1995017:Bodies [Cell Component]

Phrase: "ip"

Phrase: ")."
Processing 00000000.tx.71: The bile duct and the right femoral vein were cannulated with polyethylene tubing PE 10 and PE 50, respectively. 

Phrase: "The bile duct"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0005400:Bile duct [Body Part, Organ, or Organ Component]
  1000   C1280889:Bile duct [Body Part, Organ, or Organ Component]
  1000   C1711174:DUCT, BILE [Tissue]
   861   C0005388:Bile [Body Substance]
   861   C0687028:Duct [Body Part, Organ, or Organ Component]
   861   C1267211:Duct [Body Part, Organ, or Organ Component]
   861   C1550227:duct [Body Part, Organ, or Organ Component]
   861   C1705650:Duct [Medical Device]
   789 E C1512083:Ductal [Qualitative Concept]

Phrase: "and"

Phrase: "the right femoral vein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0739300:Right femoral vein [Body Part, Organ, or Organ Component]
   901   C0015809:Femoral vein [Body Part, Organ, or Organ Component]
   827   C0015811:Femoral [Body Part, Organ, or Organ Component]
   827   C0042449:Vein [Body Part, Organ, or Organ Component]
   827   C1278960:Vein [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "cannulated with polyethylene tubing PE 10"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0032487:polyethylene [Biomedical or Dental Material,Organic Chemical]
   753   C0137914:Polyethylene [Biomedical or Dental Material,Organic Chemical]
   753   C0184165:tubing [Medical Device]
   753   C0752345:Polyethylene [Biomedical or Dental Material,Organic Chemical]

Phrase: "and"

Phrase: "PE 50,"

Phrase: "respectively."
Processing 00000000.tx.72: Body temperature was maintained throughout at 37  0.5C with a heating lamp to avoid hypothermic variations of bile secretory function. 

Phrase: "Body temperature"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0005903:Body Temperature [Organism Attribute]
           temperature
   861   C0039476:*Temperature [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   777 E C1995017:Bodies [Cell Component]

Phrase: "was"

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "throughout at 37  0.5C"

Phrase: "with a heating lamp to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0181514:heat lamp [Medical Device]
   827   C0392223:Lamp [Manufactured Object]
   827   C1705111:Lamp [Medical Device]
   827   C3539922:LAMP [Laboratory Procedure]

Phrase: "avoid"

Phrase: "hypothermic variations of bile secretory function."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:variations [Qualitative Concept]
Processing 00000000.tx.73: After 20 min of stabilization, spontaneously secreted bile was collected for 15 min in preweighed vials and on ice. 

Phrase: "After 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "of stabilization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1293130:Stabilisation [Therapeutic or Preventive Procedure]

Phrase: "spontaneously secreted bile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005388:Bile [Body Substance]

Phrase: "was"

Phrase: "collected for 15 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0702093:/min [Temporal Concept]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]

Phrase: "in preweighed vials"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0184301:vials [Medical Device]
   861   C1533199:Vials [Quantitative Concept]
   827 E C1706497:VIAL [Medical Device]

Phrase: "and on ice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   790   C1515981:And [Idea or Concept]
Processing 00000000.tx.74: Bile flow was determined gravimetrically, by assuming a bile density of 1 g/ml, and expressed as l/min/100 g body weight. 

Phrase: "Bile flow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "determined"

Phrase: "gravimetrically,"

Phrase: "by assuming"

Phrase: "a bile density of 1 g/ml,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0178587:density [Quantitative Concept]

Phrase: "and"

Phrase: "expressed as l/min/100 g body weight."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   789   C2827897:g*min/L [Quantitative Concept]
   770   C0005910:Body Weight [Organism Attribute]
           weight
   770   C1305866:body weight [Diagnostic Procedure]
           weight
   767   C0439294:g l [Quantitative Concept]
   767   C0560021:g/min [Quantitative Concept]
   744   C0043100:Weight [Quantitative Concept]
   744   C0242821:body [Human]
   744   C0439267:g% [Quantitative Concept]
   744   C0460148:Body [Anatomical Structure]
   744   C0702093:/min [Temporal Concept]
   744   C1268086:Body [Anatomical Structure]
   744   C1705104:Weight [Idea or Concept]
Processing 00000000.tx.75: Biliary excretion outputs were calculated as the product of bile flow and solute concentration values. 

Phrase: "Biliary excretion outputs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1709366:Output [Conceptual Entity]

Phrase: "were"

Phrase: "calculated as the product of bile flow"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0005388:Bile [Body Substance]
   748   C0444686:Calculated [Functional Concept]
   748   C0806140:Flow [Natural Phenomenon or Process]
   748   C1441506:Calculated [Activity]
   748   C1443182:Calculated [Laboratory Procedure]
   748   C1514468:product [Entity]
   748   C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "solute concentration values."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.76: After these basal studies, pharmacokinetic studies were carried out to characterize the functional status of the nonbile salt organic anion transport systems by using the Mrp2 substrate BSP; 

Phrase: "After these basal studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "pharmacokinetic studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0201734:pharmacokinetic studies [Research Activity]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439787:Out [Spatial Concept]
   861   C0849355:Out [Qualitative Concept]

Phrase: "characterize"

Phrase: "the functional status of the nonbile salt organic anion transport systems"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0598463:Functional Status [Finding]
   738   C0449438:Status [Qualitative Concept]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Mrp2 substrate BSP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0038753:Bromosulfophthalein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.77: for this purpose, rats of both groups received a BSP injection (6 mg/100 g body weight, iv). 

Phrase: "for this purpose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285529:Purpose [Functional Concept]

Phrase: "rats of both groups"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "a BSP injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "(6 mg/100 g body weight,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   858   C0333746:MG body [Finding]
   827   C0005910:Body Weight [Organism Attribute]
           weight
   827   C1305866:body weight [Diagnostic Procedure]
           weight
   799   C0043100:Weight [Quantitative Concept]
   799   C0242821:body [Human]
   799   C0460148:Body [Anatomical Structure]
   799   C1268086:Body [Anatomical Structure]
   799   C1705104:Weight [Idea or Concept]
   716 E C1995017:Bodies [Cell Component]

Phrase: "iv"

Phrase: ")."
Processing 00000000.tx.78: Blood samples were collected every 2 min over a 30-min time period, and bile samples were collected every 10 min over a 60-min time period. 

Phrase: "Blood samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178913:blood samples [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "every 2 min over a 30-min time period,"

Phrase: "and"

Phrase: "bile samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0444119:Bile sample [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "every 10 min over a 60-min time period."
Processing 00000000.tx.79: Plasma and bile BSP concentrations were determined spectrophotometrically at 580 nm, after the addition of 0.5 M NaOH. 

Phrase: "Plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "and"

Phrase: "bile BSP concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "determined"

Phrase: "spectrophotometrically at 580 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0312860:NM [Cell Function]

Phrase: "after"

Phrase: "the addition of 0.5 M NaOH."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1883712:Addition [Functional Concept]
Processing 00000000.tx.80: The percentage of biliary BSP recovery was estimated by the percentage ratio between the dye excreted in bile samples throughout the experimental period and the amount of BSP injected. 

Phrase: "The percentage of biliary BSP recovery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439165:Percentage [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: "was"

Phrase: "estimated by the percentage ratio"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0439165:Percentage [Quantitative Concept]
   760   C0456603:Ratio [Quantitative Concept]
   760   C0750572:Estimated [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "between the dye"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]

Phrase: "excreted in bile samples"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   816   C0444119:Bile sample [Body Substance]
   770   C0005388:Bile [Body Substance]
   770   C1688651:% excreted [Quantitative Concept]
   737 E C0221102:excrete [Physiologic Function]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "throughout the experimental period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "and"

Phrase: "the amount of BSP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "injected."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]
Processing 00000000.tx.81: In vivo pharmacokinetic studies of BSP plasma decay were carried out to assess the fractional transfer rates for the transport of the dye from plasma to liver (hepatic uptake, r12), liver to plasma (sinusoidal efflux, r21), and liver to bile (canalicular excretion, r3), and other pharmacokinetic parameters. 

Phrase: "In vivo pharmacokinetic studies of BSP plasma decay"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   776   C0681829:in vivo study [Research Activity]
           studies vivo
   770   C0201734:pharmacokinetic studies [Research Activity]
   744   C0947630:studies [Laboratory Procedure]
   711 E C0557651:Study [Manufactured Object]
   711 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439787:Out [Spatial Concept]
   861   C0849355:Out [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the fractional transfer rates for the transport of the dye"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0040671:Transfer [Mental Process]
   739   C1705822:Transfer [Activity]
   706   C0871208:Rate [Activity]
   706   C1521828:Rate [Quantitative Concept]

Phrase: "from plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "to liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "(hepatic uptake,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205054:Hepatic [Body Location or Region]
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "r12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1333731:R12 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1704993:R12 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "liver to plasma"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0023884:Liver [Body Part, Organ, or Organ Component]
   790   C0736268:LIVER [Body Part, Organ, or Organ Component]
   790   C1278929:Liver [Body Part, Organ, or Organ Component]
   790   C2346688:LIVER [Food]
   734 E C0205054:Hepatic [Body Location or Region]

Phrase: "(sinusoidal efflux,"

Phrase: "r21"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1549845:R21 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "liver to bile"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0023884:Liver [Body Part, Organ, or Organ Component]
   790   C0736268:LIVER [Body Part, Organ, or Organ Component]
   790   C1278929:Liver [Body Part, Organ, or Organ Component]
   790   C2346688:LIVER [Food]
   734 E C0205054:Hepatic [Body Location or Region]

Phrase: "(canalicular excretion,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0221102:Excretion [Physiologic Function]
   861   C0504085:Excretion [Body Substance]
   861   C2699704:EXCRETION [Regulation or Law]

Phrase: "r3"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "other pharmacokinetic parameters."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1705911:Pharmacokinetic Parameters [Idea or Concept]
   861   C0449381:Parameters [Finding]
   827 E C0549193:Parameter [Spatial Concept]
   827 E C1704769:Parameter [Conceptual Entity]
   827 E C2350001:Parameter [Quantitative Concept]
Processing 00000000.tx.82: For this purpose, the plasma dye concentration data (Cp), plotted against time (t), were fitted by a least-squares curve-fitting technique to the following biexponential equation: Preliminary triexponential fits failed to show any improvement in the goodness of fit, as judged by the Akaike's criterion. 

Phrase: "For this purpose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285529:Purpose [Functional Concept]

Phrase: "the plasma dye concentration data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1511726:Data [Idea or Concept]
   812   C3245479:data [Medical Device]
   708   C0683150:plasma concentration [Quantitative Concept]

Phrase: "(Cp"

Phrase: ")"

Phrase: ","

Phrase: "plotted against time (t),"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0040223:Time [Temporal Concept]
   790   C3541383:Time [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "were"

Phrase: "fitted by a least-squares curve-fitting technique"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0023189:Least Squares [Quantitative Concept]
   744   C0036572:Fit [Sign or Symptom]
           Fitting
   744   C0205134:Curve [Spatial Concept]
   744   C0424576:Fit [Finding]
   744   C0441548:Fitting [Health Care Activity]
   744   C0449851:Technique [Functional Concept]
   744   C2349186:Fit [Activity]
   711   C0205120:Square [Spatial Concept]
   711   C1552595:Square [Intellectual Product]

Phrase: "to the following biexponential equation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0552449:Equation [Conceptual Entity]

Phrase: ":"

Phrase: "Preliminary triexponential fits"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0036572:Fits NOS [Sign or Symptom]
   793 E C0424576:Fit [Finding]
   793 E C2349186:Fit [Activity]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "any improvement in the goodness of fit,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2986411:Improvement [Conceptual Entity]

Phrase: "as"

Phrase: "judged by the Akaike's criterion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243161:Criterion [Intellectual Product]
   726   C0221191:Judge [Professional or Occupational Group]
Processing 00000000.tx.83: Therefore, a two-compartmental model with an open-ended biliary outflow was considered physiologically realistic for compartmental analysis. 

Phrase: "Therefore,"

Phrase: "a two-compartmental model with an open-ended biliary outflow"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C2986731:Compartmental Model [Intellectual Product]
   739   C3161035:Model [Intellectual Product]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "physiologically realistic for compartmental analysis."
Processing 00000000.tx.84: Volume of distribution of the dye is given by the following equation: where D is the dose of BSP administered. 

Phrase: "Volume of distribution of the dye"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0683148:Volume of distribution [Quantitative Concept]
           Distribution Volume
   753   C0449468:*Volume [Quantitative Concept]
   753   C1690016:% volume [Qualitative Concept]
   753   C1705102:Volume [Intellectual Product]
   753   C2700258:Volume [Laboratory Procedure]

Phrase: "is"

Phrase: "given by the following equation"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0552449:Equation [Conceptual Entity]
   760   C1442162:GIVEN [Conceptual Entity]
   760   C1550718:given [Idea or Concept]
   760   C3244317:given [Intellectual Product]
   726   C0332283:follow [Temporal Concept]
   726   C1719822:Follow [Intellectual Product]
   726 E C1947971:Give [Functional Concept]

Phrase: ":"

Phrase: "where D"

Phrase: "is"

Phrase: "the dose of BSP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0178602:Dose [Quantitative Concept]
   770   C0869039:Dose [Quantitative Concept]
   770   C1114758:Dose # [Clinical Attribute]

Phrase: "administered."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521801:Administered [Functional Concept]
   966 E C1621583:Administer [Functional Concept]
Processing 00000000.tx.85: Plasma clearance (Clp) was calculated using the following equation: where AUC is the area under the curve and can be calculated using the following equation: Half-times for the rapid (t1/2 ) and the slow (t1/2 ) phases of BSP plasma decay were calculated as follows: The fractional transfer rates were calculated as previously described (Richards et al., 1959) using the following equations: Free and GSH-conjugated BSP (GSH-BSP) were separated from each other by reverse-phase high-performance thin-layer chromatography (RP-HPTLC), by adapting the method for HPLC of Snel et al. 

Phrase: "Plasma clearance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0032105:Plasma [Body Substance]
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "(Clp)"

Phrase: "was"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following equation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0552449:Equation [Conceptual Entity]

Phrase: ":"

Phrase: "where AUC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0376690:AUC [Quantitative Concept]

Phrase: "is"

Phrase: "the area under the curve"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C0376690:Area under the curve [Quantitative Concept]
           Area Under Curve
   760   C0017446:Area [Geographic Area]
   760   C0205146:Area [Spatial Concept]

Phrase: "and"

Phrase: "can"

Phrase: "be"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following equation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0552449:Equation [Conceptual Entity]

Phrase: ":"

Phrase: "Half-times for the rapid"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   760   C2825407:Half [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "(t1/2 )"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413227:T1 [Gene or Genome]

Phrase: "and"

Phrase: "the slow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439834:Slow [Qualitative Concept]

Phrase: "(t1/2 ) phases of BSP plasma decay"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   757   C0439560:Phase 2 [Temporal Concept]
   748   C0585064:Phases [Temporal Concept]
   748   C1067936:Phasis [Eukaryote]
   714 E C0205390:Phase [Temporal Concept]

Phrase: "were"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "The fractional transfer rates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0040671:Transfer [Mental Process]
   827   C1705822:Transfer [Activity]
   793   C0871208:Rate [Activity]
   793   C1521828:Rate [Quantitative Concept]

Phrase: "were"

Phrase: "calculated as previously"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0444686:Calculated [Functional Concept]
   790   C1441506:Calculated [Activity]
   790   C1443182:Calculated [Laboratory Procedure]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Richards et al.,"

Phrase: "1959"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following equations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0552449:equations [Conceptual Entity]

Phrase: ":"

Phrase: "Free"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332296:free [Functional Concept]
  1000   C1880497:Free [Qualitative Concept]
  1000   C1996904:Free [Qualitative Concept]

Phrase: "and"

Phrase: "GSH-conjugated BSP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0038753:Bromosulfophthalein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "(GSH-BSP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038753:Bromosulfophthalein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "were"

Phrase: "separated from each other"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]

Phrase: "by reverse-phase high-performance thin-layer chromatography (RP-HPTLC),"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   900   C0597410:Chromatography, Reverse-Phase [Laboratory Procedure]
   845   C0008569:Thin Layer Chromatography [Laboratory Procedure]
   795   C0008550:Chromatography [Laboratory Procedure]
   795   C0205168:Thin [Qualitative Concept]
   795   C0205250:High [Qualitative Concept]
   795   C0597198:Performance [Individual Behavior]
   795   C0934502:Layer [Body Part, Organ, or Organ Component]
   795   C1299351:High [Qualitative Concept]
   795   C1522408:Layer [Qualitative Concept]
   795   C1561599:Layer [Intellectual Product]
   795   C1882330:Performance [Activity]
   795   C2700149:HIGH [Intellectual Product]
   724 E C0039870:Thinness [Finding]

Phrase: "by adapting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2937289:adapting [Organic Chemical]

Phrase: "the method for HPLC of Snel et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0025663:Method [Intellectual Product]
   744   C0449851:Method [Functional Concept]
   744   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.86: (1993). 

Phrase: "(1993"

Phrase: ")."
Processing 00000000.tx.87: Briefly, samples and standards (BSP and GSH-BSP) (< 1 l) were spotted on RP-HPTLC plates (Sigma-Aldrich Corp., St. Louis, MO). 

Phrase: "Briefly,"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "standards"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0038137:standards [Intellectual Product]
  1000   C0175675:Standards [Qualitative Concept]
   966 E C1442989:Standard [Qualitative Concept]
   966 E C2828392:Standard [Intellectual Product]

Phrase: "(BSP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038753:Bromosulfophthalein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "GSH-BSP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038753:Bromosulfophthalein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "("

Phrase: "< 1 l)"

Phrase: "were"

Phrase: "spotted on RP-HPTLC plates"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   782   C0008569:Thin Layer Chromatography [Laboratory Procedure]
   777   C0597410:Chromatography, Reverse-Phase [Laboratory Procedure]
   739   C0008550:Chromatography [Laboratory Procedure]
   739   C0205168:Thin [Qualitative Concept]
   739   C0205250:High [Qualitative Concept]
   739   C0205390:Phase [Temporal Concept]
   739   C0597198:Performance [Individual Behavior]
   739   C0934502:Layer [Body Part, Organ, or Organ Component]
   739   C1139930:plates [Medical Device]
   739   C1299351:High [Qualitative Concept]
   739   C1522408:Layer [Qualitative Concept]
   739   C1555029:Reverse [Idea or Concept]
   739   C1561599:Layer [Intellectual Product]
   739   C1882330:Performance [Activity]
   739   C2700149:HIGH [Intellectual Product]
   706 E C0005971:Plate [Medical Device]
   706   C0329155:Spot [Fish]
   706   C1427618:SPOT [Gene or Genome]
   706   C1705203:Spot [Conceptual Entity]
   706 E C3537155:Plate [Manufactured Object]

Phrase: "(Sigma-Aldrich Corp.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0683758:Corp. [Organization]

Phrase: "St. Louis,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.88: The mobile phase consisted of 10 mM sodium phosphate buffer, pH 6: acetonitrile (80:30, v:v). 

Phrase: "The mobile phase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3469601:Mobile Phase [Indicator, Reagent, or Diagnostic Aid]
   861   C0205390:Phase [Temporal Concept]

Phrase: "consisted of 10 mM sodium phosphate buffer,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   778   C0074757:sodium phosphate [Inorganic Chemical,Pharmacologic Substance]
   778   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   714   C0332529:CONSIST [Qualitative Concept]

Phrase: "pH 6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: ":"

Phrase: "acetonitrile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050456:acetonitrile [Organic Chemical]

Phrase: "(80"

Phrase: ":"

Phrase: "30,"

Phrase: "v:v)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0560268:%V/V [Quantitative Concept]
  1000   C2349105:V(V) [Element, Ion, or Isotope]
Processing 00000000.tx.89: Chromatography was performed with an Eastman Chromagram chamber plate set (Distillation Products Industries, Rochester, NY). 

Phrase: "Chromatography"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0008550:Chromatography [Laboratory Procedure]
   900 E C0302647:chromatograph [Medical Device]

Phrase: "was"

Phrase: "performed with an Eastman Chromagram chamber plate set (Distillation Products Industries,"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   738   C0005971:Plate [Medical Device]
   738   C0021267:Industries [Occupational Activity]
   738   C0036849:Set [Mental Process]
   738   C0884358:Performed [Functional Concept]
   738   C0935616:Chamber [Body Part, Organ, or Organ Component]
   738   C1139930:plate [Medical Device]
   738   C1442518:Set [Functional Concept]
   738   C1514468:Products [Entity]
   738   C1705195:Set [Conceptual Entity]
   738   C2718007:Distillation [Laboratory Procedure]
   738   C3537155:Plate [Manufactured Object]
   712   C0303743:INDUSTRIAL PRODUCTS [Chemical Viewed Structurally]
   704 E C1704444:Product [Quantitative Concept]
   704 E C2947996:Perform [Pharmacologic Substance]

Phrase: "Rochester,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.90: After 1 h, bands were visualized under NH3 atmosphere and immediately digitized. 

Phrase: "After 1 h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "visualized under NH3 atmosphere"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004178:Atmosphere [Natural Phenomenon or Process]
   770   C0201879:NH3 [Laboratory Procedure]
   770   C0234621:Visualized [Functional Concept]
   770   C0678214:atmosphere [Quantitative Concept]

Phrase: "and"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "digitized."
Processing 00000000.tx.91: Densitometry of resulting bands was performed by image analysis using GelPro Analyzer 3.0 software (Cybernetics, Silver Spring, MA, USA). 

Phrase: "Densitometry of resulting bands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0011321:Densitometry [Laboratory Procedure]

Phrase: "was"

Phrase: "performed by image analysis"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0200765:Image analysis [Laboratory Procedure]
   833   C1550369:Performed By [Qualitative Concept]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0884358:Performed [Functional Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C1704254:Image [Intellectual Product]
   770   C1704922:Image [Entity]
   770   C3542466:Image [Intellectual Product]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GelPro Analyzer 3.0 software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Cybernetics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010521:Cybernetics [Occupational Activity]

Phrase: "Silver Spring,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0037125:Silver [Element, Ion, or Isotope]
   861   C0241232:Spring [Temporal Concept]
   861   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   861   C1305285:Silver [Qualitative Concept]
   861   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   861   C1705204:Spring [Manufactured Object]
   777 E C0079853:Moon [Geographic Area]
   768 E C0003782:Argyria [Injury or Poisoning]
   768 E C3463959:Argyria [Eukaryote]

Phrase: "MA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.92: Mrp2 protein levels. 

Phrase: "Mrp2 protein levels."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   841   C0428479:Protein level [Laboratory or Test Result]
   799   C0441889:Levels [Qualitative Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.93: Expression of Mrp2 was assessed by Western blotting. 

Phrase: "Expression of Mrp2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "assessed by Western blotting."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1516048:Assessed [Activity]
   770   C1705493:Western [Spatial Concept]
Processing 00000000.tx.94: Samples of liver tissue were taken from multiple liver lobes immediately after perfusion with ice-cold saline, snap-frozen in liquid nitrogen, and stored at 70C until assay. 

Phrase: "Samples of liver tissue"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   870   C0586688:Liver tissue sample [Tissue]
   802   C1292533:Tissue Sample [Tissue]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "taken from multiple liver lobes immediately"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   790   C0447541:liver lobes [Body Part, Organ, or Organ Component]
   753   C0023884:Liver [Body Part, Organ, or Organ Component]
   753   C0205548:Immediately [Temporal Concept]
   753   C0439064:Multiple [Quantitative Concept]
   753   C0736268:LIVER [Body Part, Organ, or Organ Component]
   753   C0796494:lobes [Body Part, Organ, or Organ Component]
   753   C1278929:Liver [Body Part, Organ, or Organ Component]
   753   C1883727:Taken [Conceptual Entity]
   753   C2346688:LIVER [Food]
   719 E C1428707:Lobe [Gene or Genome]
   719 E C1515187:Take [Health Care Activity]
   719 E C3539671:Lobe [Gene or Genome]

Phrase: "after"

Phrase: "perfusion with ice-cold saline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0031001:Perfusion [Therapeutic or Preventive Procedure]

Phrase: "snap-"

Phrase: "frozen in liquid nitrogen,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0260055:Liquid nitrogen [Element, Ion, or Isotope]
   833   C1550121:Liquid nitrogen [Intellectual Product]
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0028158:Nitrogen [Element, Ion, or Isotope]
   770   C0302908:Liquid [Substance]
   770   C0677542:Frozen [Functional Concept]
   770   C1304698:Liquid [Finding]
   770   C1546699:Liquid NOS [Intellectual Product]
   770   C1550581:nitrogen [Human-caused Phenomenon or Process]
   770   C1561501:Liquid NOS [Substance]

Phrase: "and"

Phrase: "stored at 70C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]

Phrase: "until assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.95: Immunoblotting of Mrp2 was carried out on mixed membrane fractions obtained as described previously (Meier et al., 1984). 

Phrase: "Immunoblotting of Mrp2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out on mixed membrane fractions"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0025255:Membrane [Tissue]
   760   C0205430:Mixed [Functional Concept]
   760   C0439787:Out [Spatial Concept]
   760   C0596901:Membrane [Cell Component]
   760   C0849355:Out [Qualitative Concept]
   760   C1264633:Fractions [Quantitative Concept]
   760   C1706182:Membrane [Manufactured Object]
   760   C3160715:Mixed [Finding]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Meier et al.,"

Phrase: "1984"

Phrase: ")."
Processing 00000000.tx.96: Preparations were loaded onto 10% SDS-polyacrylamide gels and subjected to electrophoresis. 

Phrase: "Preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0455052:Preparation [Health Care Activity]
   966   C1521827:Preparation [Functional Concept]

Phrase: "were"

Phrase: "loaded onto 10% SDS-polyacrylamide gels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   753   C0017243:Gels [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C1708715:Loaded [Activity]
   719 E C1382104:Gel [Substance]
   719 E C1550025:Load [Idea or Concept]
   719 E C1704782:Load [Manufactured Object]

Phrase: "and"

Phrase: "subjected to electrophoresis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]
Processing 00000000.tx.97: After electrotransfer, nitrocellulose membranes were probed with a monoclonal, mouse anti-Mrp2 (MC-206; Kamiya Biomedical Co., Seattle, WA) at 1:2000 dilution for 1 h. 

Phrase: "After electrotransfer,"

Phrase: "nitrocellulose membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "probed with a monoclonal, mouse anti-Mrp2"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   757   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   757   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0443737:Monoclonal protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0700271:monoclonal protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C1317659:Protein.monoclonal [Laboratory or Test Result]
   757   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0025914:Mouse [Mammal]
   739   C0025929:mouse [Mammal]
   739   C0026809:Mouse [Mammal]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0746619:monoclonal [Finding]
   706   C0182400:Probe [Medical Device]
   706   C1704681:Probe [Gene or Genome]
   706   C2347609:Probe [Chemical Viewed Functionally]
   706   C3536729:Probe [Manufactured Object]

Phrase: "(MC-206"

Phrase: "; Kamiya Biomedical Co.,"

Phrase: "Seattle,"

Phrase: "WA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043038:WA [Geographic Area]

Phrase: ")"

Phrase: "at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: ":"

Phrase: "2000 dilution for 1 h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079240:Dilution [Laboratory Procedure]
   760   C1948037:Dilution [Functional Concept]
Processing 00000000.tx.98: The immune complex was detected by incubation with HRP-linked secondary antibodies (Amersham Pharmacia Biotech, Piscataway, NJ) at a 1:2000 dilution for 1 h. 

Phrase: "The immune complex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003313:Immune complex [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439662:Immune [Functional Concept]
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "was"

Phrase: "detected by incubation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "with HRP-linked secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Amersham Pharmacia Biotech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "Piscataway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551491:Piscataway [Population Group]

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")"

Phrase: "at a 1"

Phrase: ":"

Phrase: "2000 dilution for 1 h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079240:Dilution [Laboratory Procedure]
   760   C1948037:Dilution [Functional Concept]
Processing 00000000.tx.99: Immunoreactive bands were detected using a chemiluminescence kit (ECL+Plus, Amersham Pharmacia Biotech) exposed to Bio-Max MR-2 films (Sigma-Aldrich Corp.) for 5 min and quantified by densitometry (Shimadzu CS-9000, Shimadzu Corp., Kyoto, Japan). 

Phrase: "Immunoreactive bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a chemiluminescence kit (ECL+Plus, Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "exposed to Bio-Max MR-2 films"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   778   C0332157:Exposed to [Clinical Attribute]
           Exposed
   748   C0086296:Films [Manufactured Object]
   748   C2347167:Mr. [Conceptual Entity]
   714 E C1561571:film [Biomedical or Dental Material]
   714 E C1561572:film [Substance]

Phrase: "(Sigma-Aldrich Corp.) for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0683758:Corp. [Organization]

Phrase: "and"

Phrase: "quantified by densitometry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011321:Densitometry [Laboratory Procedure]
   756   C1709793:Quantify [Quantitative Concept]

Phrase: "(Shimadzu CS-9000,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3540510:cs [Quantitative Concept]

Phrase: "Shimadzu Corp.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corp. [Organization]

Phrase: "Kyoto,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")."
Processing 00000000.tx.100: Transport activity of Mrp2. 

Phrase: "Transport activity of Mrp2."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C1537044:protein activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
   738   C0005529:Active Transport [Physiologic Function]
Processing 00000000.tx.101: Mrp2 transport activity was evaluated by administering CDNB (10 mol/kg body weight, iv, in saline). 

Phrase: "Mrp2 transport activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   858   C1537044:protein activity [Molecular Function]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]
   709   C1154702:multidrug transport [Cell Function]

Phrase: "was"

Phrase: "evaluated by administering CDNB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0220825:Evaluated [Functional Concept]
   726   C1621583:Administer [Functional Concept]

Phrase: "CDNB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012459:Dinitrobenzene [Organic Chemical]

Phrase: "(10 mol/kg body weight,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   884   C1508277:kg body weight [Organism Attribute]
   840   C0005910:Body Weight [Organism Attribute]
           weight
   840   C1305866:body weight [Diagnostic Procedure]
           weight
   804   C0043100:Weight [Quantitative Concept]
   804   C0242821:body [Human]
   804   C0460148:Body [Anatomical Structure]
   804   C1268086:Body [Anatomical Structure]
   804   C1705104:Weight [Idea or Concept]
   721 E C1995017:Bodies [Cell Component]

Phrase: "iv,"

Phrase: "in saline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036082:Saline [Substance]

Phrase: ")."
Processing 00000000.tx.102: CDNB permeates the sinusoidal membrane freely and is further conjugated with GSH by the GST system, so that its GSH derivate, dinitrophenyl-S-GSH (DNP-SG), is selectively excreted into bile by Mrp2. 

Phrase: "CDNB"

Phrase: "CDNB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012459:Dinitrobenzene [Organic Chemical]

Phrase: "permeates"

Phrase: "the sinusoidal membrane freely"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "conjugated with GSH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0522529:Conjugated [Spatial Concept]
   790   C1260386:GSH [Disease or Syndrome]
   756 E C0301869:Conjugate [Immunologic Factor]

Phrase: "by the GST system,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   756   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   741 E C0205373:Systemic [Functional Concept]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that"

Phrase: "its GSH derivate,"

Phrase: "dinitrophenyl-S-GSH (DNP-SG),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "selectively"

Phrase: "excreted into bile"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0005388:Bile [Body Substance]
   790   C1688651:% excreted [Quantitative Concept]
   756 E C0221102:excrete [Physiologic Function]

Phrase: "by Mrp2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.103: After CDNB administration, bile samples were collected at 10-min intervals for 60 min, and the biliary excretion rate of DNP-SG was calculated as the product of bile flow and the DNP-SG biliary concentration, as measured spectrophotometrically at 335 nm. 

Phrase: "After CDNB"

Phrase: "CDNB administration,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001554:Administration [Occupational Activity]
   827   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "bile samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0444119:Bile sample [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "collected at 10-min intervals"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0456692:/10 min [Temporal Concept]
   760   C0702093:/min [Temporal Concept]
   760   C1272706:intervals [Temporal Concept]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]
   726 E C1552654:Interval [Idea or Concept]
   726 E C1552713:Interval [Intellectual Product]

Phrase: "for 60 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "the biliary excretion rate of DNP-SG"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C2827741:Excretion Rate [Quantitative Concept]
   744   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0221102:Excretion [Physiologic Function]
   744   C0504085:Excretion [Body Substance]
   744   C0521378:Biliary [Functional Concept]
   744   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]
   744   C0871208:Rate [Activity]
   744   C1260386:GSH [Disease or Syndrome]
   744   C1521828:Rate [Quantitative Concept]
   744   C2699704:EXCRETION [Regulation or Law]

Phrase: "was"

Phrase: "calculated as the product of bile flow"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0005388:Bile [Body Substance]
   748   C0444686:Calculated [Functional Concept]
   748   C0806140:Flow [Natural Phenomenon or Process]
   748   C1441506:Calculated [Activity]
   748   C1443182:Calculated [Laboratory Procedure]
   748   C1514468:product [Entity]
   748   C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "the DNP-SG biliary concentration,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   799   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0086045:Concentration [Mental Process]
   799   C0521378:Biliary [Functional Concept]
   799   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]
   799   C1260386:GSH [Disease or Syndrome]
   799   C1446561:Concentration [Quantitative Concept]
   727 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "as"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "spectrophotometrically at 335 nm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0312860:NM [Cell Function]
Processing 00000000.tx.104: Statistical analysis. 

Phrase: "Statistical analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.105: All the values were expressed as mean  SE. 

Phrase: "All"

Phrase: "the values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "expressed as mean  SE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444504:Mean [Quantitative Concept]
   770   C2347634:Mean [Quantitative Concept]
   770   C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.106: Variables were statistically compared by the Student's t-test. 

Phrase: "Variables"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439828:variables [Qualitative Concept]

Phrase: "were"

Phrase: "statistically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038215:Statistically [Occupation or Discipline]

Phrase: "compared by the Student's t-test."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0429928:time test [Temporal Concept]
   753   C0022885:Test [Laboratory Procedure]
   753   C0038492:student [Professional or Occupational Group]
   753   C0039593:Test [Functional Concept]
   753   C0040223:Time [Temporal Concept]
   753   C0392366:test [Intellectual Product]
   753   C1551041:student [Idea or Concept]
   753   C1552573:student [Intellectual Product]
   753   C1707455:Compared [Activity]
   753   C3541383:Time [Temporal Concept]
Processing 00000000.tx.107: A value of p < 0.05 was considered significantly different.  

Phrase: "A value of p < 0.05"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1522609:Value [Quantitative Concept]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "significantly different."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1705242:Different [Qualitative Concept]
   789 E C1705241:*Difference [Quantitative Concept]
   761 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.108: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  After 90 days of Al treatment, no animal deaths occurred and no evident toxic symptoms were observed in either Al (+) or Al () rats. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES  After 90 days of Al treatment,"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   748   C0002367:Aluminium [Element, Ion, or Isotope]
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C0439083:>90 [Quantitative Concept]
   748   C0439087:<90 [Quantitative Concept]
   748   C0439228:days [Temporal Concept]
   748   C1514811:Reference [Idea or Concept]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C1706462:Reference [Conceptual Entity]
   748   C2348254:ALUMINUM [Element, Ion, or Isotope]
   748   C3538994:TREATMENT [Research Activity]
   714 E C0332173:/day [Temporal Concept]
   714 E C0439505:/day [Temporal Concept]

Phrase: "no animal deaths"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011065:deaths [Organism Function]
   861   C1306577:DEATHS [Finding]

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "no evident toxic symptoms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0858786:toxic symptom [Sign or Symptom]
   827   C0683368:symptoms [Functional Concept]
   827   C1457887:Symptoms [Sign or Symptom]

Phrase: "were"

Phrase: "observed in either Al"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1441672:Observed [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "(+"

Phrase: ")"

Phrase: "or"

Phrase: "Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "("

Phrase: ")"

Phrase: "rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]
Processing 00000000.tx.109: At the end of the treatment, the mean body weight of Al (+) rats was not statistically different from that of Al () rats [337  4 g vs. 335  10 g, respectively; p > 0.05]. 

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "the mean body weight of Al"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0005910:Body Weight [Organism Attribute]
           weight
   790   C1305866:body weight [Diagnostic Procedure]
           weight
   753   C0043100:Weight [Quantitative Concept]
   753   C0242821:body [Human]
   753   C0444504:Mean [Quantitative Concept]
   753   C0460148:Body [Anatomical Structure]
   753   C1268086:Body [Anatomical Structure]
   753   C1705104:Weight [Idea or Concept]
   753   C2347634:Mean [Quantitative Concept]
   753   C2348143:Mean [Quantitative Concept]

Phrase: "(+"

Phrase: ")"

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "was"

Phrase: "not statistically different from that of Al"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705242:Different [Qualitative Concept]

Phrase: "("

Phrase: ")"

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "[337  4 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "vs. 335  10 g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "respectively"

Phrase: "; p > 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "]."
Processing 00000000.tx.110: Increases in the Al levels of plasma and liver were observed after the 90 days of Al administration. 

Phrase: "Increases in the Al levels of plasma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "were"

Phrase: "observed after the 90 days of Al administration."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   744   C0001554:Administration [Occupational Activity]
   744   C0002367:Aluminium [Element, Ion, or Isotope]
   744   C0439083:>90 [Quantitative Concept]
   744   C0439087:<90 [Quantitative Concept]
   744   C0439228:days [Temporal Concept]
   744   C1441672:Observed [Functional Concept]
   744   C1533734:Administration [Therapeutic or Preventive Procedure]
   744   C2348254:ALUMINUM [Element, Ion, or Isotope]
   711 E C0332173:/day [Temporal Concept]
   711 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.111: Plasma Al concentrations increased from 9  4 g/l (control rats) to 750  50 g/l, and the hepatic Al content increased from 26  9 g/g liver weight (control rats) to 122  12 g/g liver weight. 

Phrase: "Plasma Al concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   896   C0683150:plasma concentration [Quantitative Concept]
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "increased from 9  4 g/l (control rats"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0439294:g l [Quantitative Concept]
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0205217:Increased [Quantitative Concept]
   744   C0243148:control [Qualitative Concept]
   744   C0439267:g% [Quantitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "to 750  50 g/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439294:g l [Quantitative Concept]

Phrase: "and"

Phrase: "the hepatic Al content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]

Phrase: "increased from 26  9 g/g liver weight"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   770   C1319635:g/g [Quantitative Concept]
   767   C0043094:Increased weight [Finding]
   744   C0005910:weight [Organism Attribute]
   744   C0023884:Liver [Body Part, Organ, or Organ Component]
   744   C0043100:Weight [Quantitative Concept]
   744   C0205217:Increased [Quantitative Concept]
   744   C0439267:g% [Quantitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C0736268:LIVER [Body Part, Organ, or Organ Component]
   744   C1278929:Liver [Body Part, Organ, or Organ Component]
   744   C1305866:weight [Diagnostic Procedure]
   744   C1705104:Weight [Idea or Concept]
   744   C2346688:LIVER [Food]
   731 E C0231246:gaining weight [Sign or Symptom]
   731 E C2911647:Weight gain [Finding]

Phrase: "(control rats"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "to 122  12 g/g liver weight."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0005910:weight [Organism Attribute]
   799   C0043100:Weight [Quantitative Concept]
   799   C1305866:weight [Diagnostic Procedure]
   799   C1705104:Weight [Idea or Concept]
Processing 00000000.tx.112: The levels of lipid peroxidation in liver tissue and the status of hepatic antioxidant defenses following Al treatment are given in Table 1. 

Phrase: "The levels of lipid peroxidation"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   797   C0428460:levels lipid [Laboratory or Test Result]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in liver tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0736268:Liver tissue [Body Part, Organ, or Organ Component]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "the status of hepatic antioxidant defenses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0449925:Hepatic status [Qualitative Concept]
   753   C0449438:Status [Qualitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "Al treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "are"

Phrase: "given in Table 1."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0039224:Table [Manufactured Object]
   770   C1442162:GIVEN [Conceptual Entity]
   770   C1550718:given [Idea or Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   770   C3244317:given [Intellectual Product]
   737 E C1947971:Give [Functional Concept]
Processing 00000000.tx.113: Lipid peroxidation, as measured in terms of TBARS, was significantly increased in Al (+) rats. 

Phrase: "Lipid peroxidation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023775:Lipid Peroxidation [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0178796:peroxidation [Phenomenon or Process]

Phrase: "as"

Phrase: "measured in terms of TBARS,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   757   C0449840:Substance measured [Clinical Attribute]
   748   C0439861:Substances [Substance]
   748   C0444706:Measured [Qualitative Concept]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
   714   C1515273:Term [Temporal Concept]
   714   C1705313:Term [Idea or Concept]
   714   C2826302:TERM [Intellectual Product]

Phrase: "was"

Phrase: "significantly"

Phrase: "increased in Al"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0002367:Aluminium [Element, Ion, or Isotope]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C2348254:ALUMINUM [Element, Ion, or Isotope]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(+"

Phrase: ")"

Phrase: "rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]
Processing 00000000.tx.114: Conversely, the total GSH content and the activities of the antioxidant enzymes GST, GSH-Px, and CAT were significantly reduced in Al (+) rats. 

Phrase: "Conversely,"

Phrase: "the total GSH content"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
   827   C1260386:GSH [Disease or Syndrome]

Phrase: "and"

Phrase: "the activities of the antioxidant enzymes GST,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   801   C1152039:glutathione S-transferase activity [Molecular Function]
           glutathione transferase activity
   745   C1148564:antioxidant activity [Molecular Function]
   745   C1151895:transferase activity [Molecular Function]
   742   C0441655:Activities [Activity]
   728   C0243102:enzyme activity [Molecular Function]
   708 E C0205177:Activity [Functional Concept]
   708 E C0439167:% activity [Quantitative Concept]
   708 E C1561536:*Activity [Idea or Concept]

Phrase: "GSH-Px,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0017822:GLUTATHIONE PEROXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415275:GLUTATHIONE PEROXIDASE [Gene or Genome]
   861   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "CAT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]

Phrase: "were"

Phrase: "significantly"

Phrase: "reduced in Al"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002367:Aluminium [Element, Ion, or Isotope]
   790   C0392756:Reduced [Qualitative Concept]
   790   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "(+"

Phrase: ")"

Phrase: "rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]
Processing 00000000.tx.115: View this table: [in this window] [in a new window]  TABLE 1 Effect of A1 Treatment on Hepatic TBARS Content and the Status of Hepatic Antioxidant Defenses  Table 2 gives the basal bile flow and the basal excretion rate of different bile constituents after 90 days of Al treatment. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1 Effect of A1 Treatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1518681:Treatment Effect [Finding]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on Hepatic TBARS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439861:Substances [Substance]

Phrase: "Content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "the Status of Hepatic Antioxidant Defenses  Table 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0449925:Hepatic status [Qualitative Concept]
   744   C0449438:Status [Qualitative Concept]

Phrase: "gives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "the basal bile flow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "the basal excretion rate of different bile constituents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C2827741:Excretion Rate [Quantitative Concept]
   767   C1648294:Basal rate [Clinical Attribute]
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]

Phrase: "after 90 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "of Al treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.116: Bile flow was decreased by 23% in Al (+) rats. 

Phrase: "Bile flow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "decreased by 23%"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   790   C0450348:23 [Quantitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "in Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "(+"

Phrase: ")"

Phrase: "rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]
Processing 00000000.tx.117: Similarly, the biliary outputs of proteins, cholesterol, and bile salts were significantly lower in Al (+) rats compared with Al () rats. 

Phrase: "Similarly,"

Phrase: "the biliary outputs of proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1709366:Output [Conceptual Entity]

Phrase: "cholesterol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "and"

Phrase: "bile salts"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0005404:Bile Salts [Biologically Active Substance,Steroid]
  1000   C0523530:Bile Salts [Laboratory Procedure]
   861   C0005388:Bile [Body Substance]
   861   C0036140:Salts [Chemical Viewed Structurally]
   827 E C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827 E C0206136:Salt [Food,Inorganic Chemical]
   777 E C1537053:salty [Qualitative Concept]
   755 E C0678584:saltiness [Qualitative Concept]

Phrase: "were"

Phrase: "significantly lower in Al"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "(+"

Phrase: ")"

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "compared with Al"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002367:Aluminium [Element, Ion, or Isotope]
   790   C1707455:Compared [Activity]
   790   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "("

Phrase: ")"

Phrase: "rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]
Processing 00000000.tx.118: View this table: [in this window] [in a new window]  TABLE 2 Effect of A1 Treatment on Bile Flow and Biliary Output of Several Biliary Solutes  The efficiency of the different steps involved in the hepatic handling of the nonbile acid organic anion model, BSP, was assessed by pharmacokinetic analysis. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 2 Effect of A1 Treatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1518681:Treatment Effect [Finding]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on Bile Flow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "Biliary Output of Several Biliary Solutes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709366:Output [Conceptual Entity]

Phrase: "The efficiency of the different steps"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0013682:Efficiency [Quantitative Concept]

Phrase: "involved in the hepatic handling of the nonbile acid organic anion model,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   751   C0369760:Organic acid [Organic Chemical]
   736   C0001128:Acid [Chemical]
   736   C0003075:Anion [Element, Ion, or Isotope]
   736   C0018578:Handling [Behavior]
   736   C0202406:Acid [Laboratory Procedure]
   736   C0205054:Hepatic [Body Location or Region]
   736   C0747055:Organic [Qualitative Concept]
   736   C1314939:Involved [Functional Concept]
   736   C1832073:Handling [Finding]
   736   C3161035:Model [Intellectual Product]

Phrase: "BSP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038753:Bromosulfophthalein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "assessed by pharmacokinetic analysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0201734:PHARMACOKINETIC [Research Activity]
   770   C0936012:Analysis [Research Activity]
   770   C1516048:Assessed [Activity]
   770   C1524024:analysis [Functional Concept]
Processing 00000000.tx.119: Plasma decay of BSP was slower in Al (+) rats, as shown by the increase in the half-times for the rapid and slow phases of plasma decay (Table 3). 

Phrase: "Plasma decay of BSP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1265875:Decay [Acquired Abnormality]
   770   C2700592:Decay [Phenomenon or Process]

Phrase: "was"

Phrase: "slower in Al"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0439834:Slow [Qualitative Concept]

Phrase: "(+"

Phrase: ")"

Phrase: "rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "as"

Phrase: "shown by the increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442805:Increase [Functional Concept]
   737   C1547282:Show [Intellectual Product]

Phrase: "in the half-times"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   861   C2825407:Half [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "for the rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "slow phases of plasma decay"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0585064:Phases [Temporal Concept]
   760   C1067936:Phasis [Eukaryote]
   726 E C0205390:Phase [Temporal Concept]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.120: Al treatment reduced significantly the plasma clearance of BSP (59%), which was accompanied by a significant reduction in the fractional rate of hepatic BSP uptake (r12, 53%) and in the fractional rate of the biliary excretion of the dye (r3, 43%). 

Phrase: "Al treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "significantly"

Phrase: "the plasma clearance of BSP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0032105:Plasma [Body Substance]
   760   C0449297:Clearance [Qualitative Concept]
   760   C1382187:Clearance [Clinical Attribute]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "(59%"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "was"

Phrase: "accompanied by a significant reduction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0237881:significant [Quantitative Concept]
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]

Phrase: "in the fractional rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "of hepatic BSP uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]

Phrase: "(r12,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1333731:R12 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1704993:R12 [Gene or Genome]

Phrase: "53%"

Phrase: ")"

Phrase: "and in the fractional rate of the biliary excretion of the dye"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   751   C2827741:Excretion Rate [Quantitative Concept]
   736   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   736   C0221102:Excretion [Physiologic Function]
   736   C0504085:Excretion [Body Substance]
   736   C0521378:Biliary [Functional Concept]
   736   C0871208:Rate [Activity]
   736   C1515981:And [Idea or Concept]
   736   C1521828:Rate [Quantitative Concept]
   736   C2699704:EXCRETION [Regulation or Law]
   715   C1264633:Fraction of [Quantitative Concept]

Phrase: "(r3,"

Phrase: "43%"

Phrase: ")."
Processing 00000000.tx.121: A clear tendency existed for the fractional rate of hepatic BSP reflux to be lower, but, due to high interindividual variability, the difference did not achieve statistical significance (Table 3). 

Phrase: "A clear tendency"

Phrase: "existed for the fractional rate of hepatic BSP reflux to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   739   C0017168:reflux [Disease or Syndrome]
   739   C0038753:Bromosulfophthalein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   739   C0205054:Hepatic [Body Location or Region]
   739   C0232483:Reflux [Pathologic Function]
   739   C0871208:Rate [Activity]
   739   C1521828:Rate [Quantitative Concept]
   739   C1882919:REFLUX [Phenomenon or Process]
   722   C1264633:Fraction of [Quantitative Concept]
   706   C2987476:Exist [Conceptual Entity]

Phrase: "be"

Phrase: "lower,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "but"

Phrase: ","

Phrase: "due to high interindividual variability,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C2827666:Variability [Conceptual Entity]
   755 E C0439828:Variable [Qualitative Concept]

Phrase: "the difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "achieve"

Phrase: "statistical significance"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.122: View this table: [in this window] [in a new window]  TABLE 3 Effect of A1 Treatment on Pharmacokinetic Parameters Derived from the Bicompartmental Analysis of Plasma Decay of BSP  The model organic anion BSP was selectively cleared by the liver, conjugated with GSH within the hepatocytes in a process catalyzed by a GST isoenzyme, and subsequently excreted into bile. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 3 Effect of A1 Treatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1518681:Treatment Effect [Finding]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on Pharmacokinetic Parameters"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1705911:Pharmacokinetic Parameters [Idea or Concept]
   861   C0449381:Parameters [Finding]
   827 E C0549193:Parameter [Spatial Concept]
   827 E C1704769:Parameter [Conceptual Entity]
   827 E C2350001:Parameter [Quantitative Concept]

Phrase: "Derived from the Bicompartmental Analysis of Plasma Decay of BSP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0032105:Plasma [Body Substance]
   739   C0038753:Bromosulfophthalein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   739   C0936012:Analysis [Research Activity]
   739   C1265875:Decay [Acquired Abnormality]
   739   C1441547:Derived [Qualitative Concept]
   739   C1524024:analysis [Functional Concept]
   739   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   739   C2700592:Decay [Phenomenon or Process]
   739   C3245521:derived [Idea or Concept]

Phrase: "The model organic anion BSP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038753:Bromosulfophthalein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "selectively"

Phrase: "cleared by the liver,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0521097:Cleared by [Functional Concept]
           cleared
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   737 E C2963144:Clear [Qualitative Concept]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "conjugated with GSH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0522529:Conjugated [Spatial Concept]
   790   C1260386:GSH [Disease or Syndrome]
   756 E C0301869:Conjugate [Immunologic Factor]

Phrase: "within the hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0227525:Hepatocytes [Cell]
   966 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in a process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "catalyzed by a GST isoenzyme,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   748   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0022173:Isoenzyme [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1442929:Isoenzyme, NOS [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "subsequently"

Phrase: "excreted into bile."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0005388:Bile [Body Substance]
   790   C1688651:% excreted [Quantitative Concept]
   756 E C0221102:excrete [Physiologic Function]
Processing 00000000.tx.123: Upon analyzing the biliary excretion of total, free, and conjugated BSP, a decrease in the total excretion of the dye, without any change in the conjugated-to-total BSP ratio, was observed in Al (+) rats (Table 4). 

Phrase: "Upon analyzing"

Phrase: "the biliary excretion of total,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0221102:Excretion [Physiologic Function]
   760   C0504085:Excretion [Body Substance]
   760   C2699704:EXCRETION [Regulation or Law]

Phrase: "free,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332296:free [Functional Concept]
  1000   C1880497:Free [Qualitative Concept]
  1000   C1996904:Free [Qualitative Concept]

Phrase: "and"

Phrase: "conjugated BSP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038753:Bromosulfophthalein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "a decrease in the total excretion of the dye,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0392756:Decrease [Qualitative Concept]
   742   C0547047:Decrease [Quantitative Concept]

Phrase: "without any change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "in the conjugated-to-total BSP ratio,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0456603:Ratio [Quantitative Concept]
   804   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "observed in Al"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002367:Aluminium [Element, Ion, or Isotope]
   790   C1441672:Observed [Functional Concept]
   790   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "(+"

Phrase: ")"

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "(Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.124: View this table: [in this window] [in a new window]  TABLE 4 Effect of A1 Treatment on BSP Biliary Excretion  Since the canalicular transfer of BSP, the rate-limiting step in its overall transfer from plasma to bile, was significantly impaired by Al treatment, we assessed both expression and function of Mrp2, the main canalicular carrier involved in this process. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 4 Effect of A1 Treatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1518681:Treatment Effect [Finding]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on BSP Biliary Excretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0221102:Excretion [Physiologic Function]
   827   C0504085:Excretion [Body Substance]
   827   C2699704:EXCRETION [Regulation or Law]

Phrase: "Since"

Phrase: "the canalicular transfer of BSP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040671:Transfer [Mental Process]
   760   C1705822:Transfer [Activity]

Phrase: "the rate-limiting step in"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1261552:Step [Conceptual Entity]
   812   C1704379:Step [Functional Concept]
   812   C1705117:Step [Quantitative Concept]
   812   C2825408:Step [Manufactured Object]

Phrase: "its overall transfer from plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040671:Transfer [Mental Process]
   760   C1705822:Transfer [Activity]

Phrase: "to bile,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005388:Bile [Body Substance]

Phrase: "was"

Phrase: "significantly"

Phrase: "impaired by Al treatment,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0221099:Impaired [Functional Concept]
   770   C0684336:Impaired [Pathologic Function]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "we"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "both expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "function of Mrp2,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0815043:function protein [Amino Acid, Peptide, or Protein]
   783   C1527118:Protein Function [Molecular Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "the main canalicular carrier"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0007294:Carrier [Finding]
   827   C0560175:Carrier [Finding]
   827   C1706209:Carrier [Medical Device]
   827   C3273162:Carrier [Intellectual Product]

Phrase: "involved in this process."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1184743:Process [Body Part, Organ, or Organ Component]
   770   C1314939:Involved [Functional Concept]
   770   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.125: Al induced a decrease in the Mrp2 levels (40%), as quantified by densitometric analysis of the Western blotting bands (Fig. 1). 

Phrase: "Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a decrease in the Mrp2 levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0392756:Decrease [Qualitative Concept]
   742   C0547047:Decrease [Quantitative Concept]

Phrase: "(40%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "quantified by densitometric analysis of the Western blotting bands"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   773   C0949466:Western blot analysis [Laboratory Procedure]
       E   Western Blot
   764   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0175723:Bands [Medical Device]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]
   742   C1705493:Western [Spatial Concept]
   708 E C0439645:Band [Spatial Concept]
   708 E C1521913:band [Cell Component]
   708   C1709793:Quantify [Quantitative Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.126: Transport activity of this protein was further evaluated in vivo by analyzing the time course of the biliary excretion of the Mrp2 substrate DNP-SG. 

Phrase: "Transport activity of this protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C1537044:protein activity [Molecular Function]
   762   C0005529:Active Transport [Physiologic Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "in vivo by analyzing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "the time course of the biliary excretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0449247:Time course [Temporal Concept]
   748   C0040223:Time [Temporal Concept]
   748   C0750729:Course [Temporal Concept]
   748   C3541383:Time [Temporal Concept]

Phrase: "of the Mrp2 substrate DNP-SG."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   835   C0072393:Protein S [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   835   C1418948:PROTEIN S [Gene or Genome]
   790   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332285:Of [Spatial Concept]
   790   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]
   790   C1260386:GSH [Disease or Syndrome]
   790   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.127: DNP-SG is produced intracellularly by GST-mediated conjugation of CDNB, which freely permeates the sinusoidal membrane, with GSH; 

Phrase: "DNP-SG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "produced"

Phrase: "intracellularly by GST-mediated conjugation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   748   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C1160466:conjugation [Cell Function]

Phrase: "of CDNB"

Phrase: "CDNB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012459:Dinitrobenzene [Organic Chemical]

Phrase: "which freely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879743:Freely [Qualitative Concept]

Phrase: "permeates"

Phrase: "the sinusoidal membrane,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "with GSH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1260386:GSH [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.128: this avoids the influence of changes in basolateral transporter activity on its secretory process, so that DNP-SG's biliary excretion reflects either or both GST-conjugating activity or Mrp2 transport efficiency. 

Phrase: "this"

Phrase: "avoids"

Phrase: "the influence of changes"

Phrase: "in basolateral transporter activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1152949:transporter activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "on its secretory process,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1159342:Secretory Process [Cell Function]
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that DNP-SG's biliary excretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0221102:Excretion [Physiologic Function]
   812   C0504085:Excretion [Body Substance]
   812   C2699704:EXCRETION [Regulation or Law]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "either"

Phrase: "or"

Phrase: "both GST-conjugating activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   933   C1152039:glutathione S-transferase activity [Molecular Function]
           glutathione transferase activity
   853   C1151895:transferase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   717   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "Mrp2 transport efficiency."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0013682:Efficiency [Quantitative Concept]
   727 E C0442799:Efficient [Qualitative Concept]
   709   C1154702:multidrug transport [Cell Function]
Processing 00000000.tx.129: Figure 2 shows that Al treatment both reduced and delayed the biliary secretion of DNP-SG. 

Phrase: "Figure 2"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that Al treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "both reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "and"

Phrase: "delayed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205421:Delayed [Temporal Concept]
  1000   C3272602:Delayed [Qualitative Concept]

Phrase: "the biliary secretion of DNP-SG."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C0521378:Biliary [Functional Concept]
   748   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]
   748   C1260386:GSH [Disease or Syndrome]
Processing 00000000.tx.130: As a consequence, both the peak of DNP-SG biliary excretion and cumulative DNP-SG biliary secretion (throughout the experimental period) were decreased by 50% compared with Al () groups. 

Phrase: "As a consequence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686907:Consequence [Functional Concept]

Phrase: "both"

Phrase: "the peak of DNP-SG biliary excretion"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0221102:Excretion [Physiologic Function]
   744   C0444505:Peak [Quantitative Concept]
   744   C0504085:Excretion [Body Substance]
   744   C0521378:Biliary [Functional Concept]
   744   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]
   744   C1260386:GSH [Disease or Syndrome]
   744   C2699704:EXCRETION [Regulation or Law]

Phrase: "and"

Phrase: "cumulative DNP-SG biliary secretion"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]
   799   C0521378:Biliary [Functional Concept]
   799   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]
   799   C1260386:GSH [Disease or Syndrome]
   799   C1511559:Cumulative [Qualitative Concept]

Phrase: "("

Phrase: "throughout the experimental period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: ")"

Phrase: "were"

Phrase: "decreased by 50%"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "compared with Al"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002367:Aluminium [Element, Ion, or Isotope]
   790   C1707455:Compared [Activity]
   790   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "("

Phrase: ")"

Phrase: "groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.131: Since GST-conjugating activity towards CDNB was only decreased by 35% (Table 1), changes in CDNB conjugation cannot fully account for the decrease in DNP-SG output, with the remaining drop due to impaired transport activity. 

Phrase: "Since"

Phrase: "GST-conjugating activity towards CDNB"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   822   C1152039:glutathione S-transferase activity [Molecular Function]
           glutathione transferase activity
   767   C1151895:transferase activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "CDNB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012459:Dinitrobenzene [Organic Chemical]

Phrase: "was"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "decreased by 35%"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "changes in CDNB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "CDNB conjugation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1160466:conjugation [Cell Function]
   755 E C0522529:Conjugated [Spatial Concept]

Phrase: "cannot"

Phrase: "fully"

Phrase: "account for the decrease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   770   C1551359:account [Idea or Concept]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]

Phrase: "in DNP-SG output,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   853   C0560033:in/s [Quantitative Concept]
   804   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0150312:In [Quantitative Concept]
   804   C0332285:In [Spatial Concept]
   804   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]
   804   C1260386:GSH [Disease or Syndrome]
   804   C1709366:Output [Conceptual Entity]

Phrase: "with the remaining drop"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1321095:Drop [Quantitative Concept]
   861   C1705648:Drop [Activity]
   861   C2347093:Drop [Quantitative Concept]
   861   C2348338:Drop [Quantitative Concept]

Phrase: "due to impaired transport activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.132: View larger version (29K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.133: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.134: Upper panel: Western blotting of Mrp2 protein content in total plasma membrane of Al () and Al (+) rats (bands of two representative animals from each group). 

Phrase: "Upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ":"

Phrase: "Western blotting of Mrp2 protein content"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   764   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
           protein blotting
   748 E C0949466:Western Blot [Laboratory Procedure]
   742   C1705493:Western [Spatial Concept]

Phrase: "in total plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0007603:Plasma membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0032105:Plasma [Body Substance]
   827   C0596901:Membrane [Cell Component]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "of Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "("

Phrase: ")"

Phrase: "and"

Phrase: "Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "(+"

Phrase: ")"

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "(bands of two representative animals"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0175723:Bands [Medical Device]
   726 E C0439645:Band [Spatial Concept]
   726 E C1521913:band [Cell Component]

Phrase: "from each group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: ")."
Processing 00000000.tx.135: Lower panel: Densitometric analysis of Mrp2 immunoreactive bands in Al () rats (open bar) and in Al (+) rats (solid bar) is also shown. 

Phrase: "Lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ":"

Phrase: "Densitometric analysis of Mrp2 immunoreactive bands"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C1514534:Protein Analysis [Molecular Biology Research Technique]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "in Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "("

Phrase: ")"

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "(open bar)"

Phrase: "and in Al"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002367:Aluminium [Element, Ion, or Isotope]
   790   C1515981:And [Idea or Concept]
   790   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "(+"

Phrase: ")"

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "(solid bar)"

Phrase: "is"

Phrase: "also"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.136: *p < 0.05.  

Phrase: "*p < 0.05."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.137: View larger version (21K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.138: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.139: Effects of Al on the time course of biliary excretion rate of DNP-SG. 

Phrase: "Effects of Al"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "on the time course"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0449247:Time course [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C0750729:Course [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "of biliary excretion rate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C2827741:Excretion Rate [Quantitative Concept]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "of DNP-SG."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332285:Of [Spatial Concept]
   812   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]
   812   C1260386:GSH [Disease or Syndrome]
Processing 00000000.tx.140: Inset shows cumulative DNP-SG biliary excretion throughout the experimental period in Al () rats (open bar) and in Al (+) rats (solid bar).   

Phrase: "Inset"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "cumulative DNP-SG biliary excretion"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   799   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0221102:Excretion [Physiologic Function]
   799   C0504085:Excretion [Body Substance]
   799   C0521378:Biliary [Functional Concept]
   799   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]
   799   C1260386:GSH [Disease or Syndrome]
   799   C1511559:Cumulative [Qualitative Concept]
   799   C2699704:EXCRETION [Regulation or Law]

Phrase: "throughout the experimental period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "in Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "("

Phrase: ")"

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "(open bar)"

Phrase: "and in Al"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002367:Aluminium [Element, Ion, or Isotope]
   790   C1515981:And [Idea or Concept]
   790   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "(+"

Phrase: ")"

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "(solid bar"

Phrase: ")."
Processing 00000000.tx.141: DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  The present study was conducted to elucidate the mechanisms involved in the impairment of bile secretory function induced by chronic administration of Al to rats. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "elucidate"

Phrase: "the mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "involved in the impairment of bile secretory function"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0544458:Secretory function [Functional Concept]
   744   C0005388:Bile [Body Substance]
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C0684336:Impairment [Pathologic Function]
   744   C0700205:FUNCTION [Classification]
   744   C1314939:Involved [Functional Concept]
   744   C1327616:Secretory [Cell Function]
   744   C1705273:Function [Intellectual Product]

Phrase: "induced by chronic administration of Al"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0001554:Administration [Occupational Activity]
   753   C0002367:Aluminium [Element, Ion, or Isotope]
   753   C0205191:chronic [Temporal Concept]
   753   C0205263:Induced [Functional Concept]
   753   C1533734:Administration [Therapeutic or Preventive Procedure]
   753   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "to rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]
Processing 00000000.tx.142: Exposure to Al for 3 months induced a significant (4-fold) increase in hepatic Al content, similar to previous studies where Al was administered parenterally (Bertholf et al., 1989; El-Maraghy et al., 2001). 

Phrase: "Exposure to Al"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332157:Exposure to [Clinical Attribute]
           Exposure
   790   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "for 3 months"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442461:3 Months [Temporal Concept]
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]

Phrase: "(4-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "increase in hepatic Al content,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0002367:Aluminium [Element, Ion, or Isotope]
   760   C0205054:Hepatic [Body Location or Region]
   760   C0423896:Content [Mental Process]
   760   C0442805:Increase [Functional Concept]
   760   C0456205:Content [Conceptual Entity]
   760   C2348254:ALUMINUM [Element, Ion, or Isotope]
   704 E C1517378:Gain [Quantitative Concept]

Phrase: "similar to previous studies where Al"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "was"

Phrase: "administered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521801:Administered [Functional Concept]
   966 E C1621583:Administer [Functional Concept]

Phrase: "parenterally"

Phrase: "(Bertholf et al.,"

Phrase: "1989"

Phrase: "; El-Maraghy et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.143: This finding was attributed to the presence of Al in hepatic giant cells (Bertholf et al., 1989). 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "was"

Phrase: "attributed to the presence of Al"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0002367:Aluminium [Element, Ion, or Isotope]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C2348254:ALUMINUM [Element, Ion, or Isotope]
   719   C0449234:Attribute [Idea or Concept]
   719   C1704772:Attribute [Conceptual Entity]
   719   C1882133:Attribute [Qualitative Concept]

Phrase: "in hepatic giant cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   913   C0227525:Hepatic Cells [Cell]
   901   C0017526:Giant Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0017547:Giant [Disease or Syndrome]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Bertholf et al.,"

Phrase: "1989"

Phrase: ")."
Processing 00000000.tx.144: The hepatic Al accumulation was accompanied by a decrease in bile flow and in bile salt secretion, a primary driving force for bile formation, suggesting that, at least in part, bile flow decrease was due to a reduction in its bile saltdependent fraction. 

Phrase: "The hepatic Al accumulation"

Phrase: "was"

Phrase: "accompanied by a decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "in bile flow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "and in bile salt secretion,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0005404:Bile salt [Biologically Active Substance,Steroid]
   806   C0523530:Bile Salt [Laboratory Procedure]
   797   C0232754:Bile secretion [Organ or Tissue Function]
   760   C0005388:Bile [Body Substance]
   760   C0036140:Salt [Chemical Viewed Structurally]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C0206136:Salt [Food,Inorganic Chemical]
   760   C1515981:And [Idea or Concept]

Phrase: "a primary driving force for bile formation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441722:Force [Phenomenon or Process]
   748   C0563538:Force [Phenomenon or Process]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that,"

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "bile flow decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392756:Decrease [Qualitative Concept]
   827   C0547047:Decrease [Quantitative Concept]

Phrase: "was due to a reduction"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
   760   C1421478:WAS [Gene or Genome]
   760   C3146286:Due [Idea or Concept]

Phrase: "in its bile saltdependent fraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.145: A similar result was observed when Al was administered subchronically (i.e., over 14 days; Klein et al., 1988), but not when Al was given enterally, a fact attributed to the lack of Al accumulation in liver when using this way of administration (Klein et al., 1989b). 

Phrase: "A similar result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1274040:Result [Functional Concept]
   861   C1546471:Result [Idea or Concept]
   861   C2825142:Result [Finding]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "was"

Phrase: "administered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521801:Administered [Functional Concept]
   966 E C1621583:Administer [Functional Concept]

Phrase: "subchronically"

Phrase: "(i.e., over 14 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0439228:days [Temporal Concept]
   771 E C0332173:/day [Temporal Concept]
   771 E C0439505:/day [Temporal Concept]

Phrase: "; Klein et al.,"

Phrase: "1988"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "when"

Phrase: "Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "was"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "enterally,"

Phrase: "a fact"

Phrase: "attributed to the lack of Al accumulation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0002367:Aluminium [Element, Ion, or Isotope]
   748   C0332268:lack [Qualitative Concept]
   748   C2348254:ALUMINUM [Element, Ion, or Isotope]
   714   C0449234:Attribute [Idea or Concept]
   714   C1704772:Attribute [Conceptual Entity]
   714   C1882133:Attribute [Qualitative Concept]

Phrase: "in liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "when"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this way of administration"

Phrase: "(Klein et al.,"

Phrase: "1989b"

Phrase: ")."
Processing 00000000.tx.146: Our finding that bile secretory function was similarly affected 90 days after Al administration as it was with a shorter administration period (14 days) indicates that no further compensatory mechanism takes place to counteract the alterations in the bile secretory mechanisms occurring early after Al exposure. 

Phrase: "Our"

Phrase: "finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that bile secretory function"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0544458:Secretory function [Functional Concept]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "was"

Phrase: "similarly"

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "90 days after Al administration"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0439228:days [Temporal Concept]
   726 E C0332173:/day [Temporal Concept]
   726 E C0439505:/day [Temporal Concept]

Phrase: "as"

Phrase: "it"

Phrase: "was with a shorter administration period"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   767   C0425946:short period [Finding]
   753   C0001554:Administration [Occupational Activity]
   753   C0043194:WAS [Disease or Syndrome]
   753   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439531:/period [Temporal Concept]
   753   C1421478:WAS [Gene or Genome]
   753   C1533734:Administration [Therapeutic or Preventive Procedure]
   753   C1948053:Period [Temporal Concept]
   719   C1282927:short [Qualitative Concept]
   719   C1806781:Short [Quantitative Concept]
   719   C2350002:Short [Quantitative Concept]

Phrase: "(14 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: ")"

Phrase: "indicates"

Phrase: "that"

Phrase: "no further compensatory mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "takes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "place"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442504:Place [Spatial Concept]
  1000   C1704765:Place [Functional Concept]
  1000   C1882509:Place [Activity]
  1000   C3496241:place [Disease or Syndrome]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "counteract"

Phrase: "the alterations in the bile secretory mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1515926:Alteration [Idea or Concept]

Phrase: "occurring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1709305:Occur [Activity]
   966   C2745955:OCCUR [Temporal Concept]

Phrase: "early after Al exposure."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C0274281:Exposure, NOS [Injury or Poisoning]
   770   C0332157:Exposure [Clinical Attribute]
   770   C1279919:Early [Temporal Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
Processing 00000000.tx.147: Whereas the alterations in the bile salt secretory function induced by Al intoxication had been evaluated previously (Klein et al., 1988), no reported data are available on the changes induced by Al on the hepatic handling of nonbile salt organic anions. 

Phrase: "Whereas"

Phrase: "the alterations in the bile salt secretory function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1515926:Alteration [Idea or Concept]

Phrase: "induced by Al intoxication"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0473223:Aluminium intoxication [Disease or Syndrome]
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C0205263:Induced [Functional Concept]
   770   C0728899:Intoxication [Finding]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "had"

Phrase: "been"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "previously"

Phrase: "(Klein et al.,"

Phrase: "1988"

Phrase: ")"

Phrase: ","

Phrase: "no reported data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0011000:report data [Research Activity]
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "available on the changes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0470187:Available [Functional Concept]

Phrase: "induced by Al"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002367:Aluminium [Element, Ion, or Isotope]
   790   C0205263:Induced [Functional Concept]
   790   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "on the hepatic handling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018578:Handling [Behavior]
   861   C1832073:Handling [Finding]

Phrase: "of nonbile salt organic anions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003075:Anions [Element, Ion, or Isotope]
Processing 00000000.tx.148: This information is highly relevant, though, since these transport systems are involved in the biliary elimination of potentially toxic endo- and xenobiotics, including bilirubin, glucuronidated and sulfated bile salts, leukotriene C4, medicaments, and numerous dietary constituents (Klaassen, 2002; Takikawa, 2002). 

Phrase: "This information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1533716:Information [Idea or Concept]
   928 E C3242430:informational [Idea or Concept]

Phrase: "is"

Phrase: "highly relevant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347946:Relevant [Qualitative Concept]

Phrase: "though"

Phrase: ","

Phrase: "since"

Phrase: "these transport systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "are"

Phrase: "involved in the biliary elimination of potentially toxic endo-"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0014175:Endo [Disease or Syndrome]
   742   C0221102:Elimination [Physiologic Function]
   742   C0521378:Biliary [Functional Concept]
   742   C0600688:toxic [Injury or Poisoning]
   742   C1314939:Involved [Functional Concept]
   742   C1407029:Toxic [Qualitative Concept]
   742   C1427293:ENDO [Gene or Genome]

Phrase: "and"

Phrase: "xenobiotics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043335:Xenobiotics [Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "bilirubin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005437:Bilirubin [Biologically Active Substance,Organic Chemical]

Phrase: "glucuronidated"

Phrase: "and"

Phrase: "sulfated bile salts,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   901   C0005404:Bile Salts [Biologically Active Substance,Steroid]
   901   C0523530:Bile Salts [Laboratory Procedure]
   880   C0302965:Sulfate salt [Inorganic Chemical]
   827   C0005388:Bile [Body Substance]
   827   C0036140:Salts [Chemical Viewed Structurally]
   793 E C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   793 E C0206136:Salt [Food,Inorganic Chemical]
   743 E C1537053:salty [Qualitative Concept]
   721 E C0678584:saltiness [Qualitative Concept]

Phrase: "leukotriene C4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023542:Leukotriene C4 [Biologically Active Substance,Eicosanoid]
   861   C0023545:Leukotriene [Biologically Active Substance,Eicosanoid]

Phrase: "medicaments,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0456386:Medicaments [Pharmacologic Substance]
   900 E C0013227:Drug [Pharmacologic Substance]
   900 E C1254351:Drug [Pharmacologic Substance]
   888 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   888 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "numerous dietary constituents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0596442:dietary constituent [Substance]
   827   C0729650:Constituents [Substance]

Phrase: "(Klaassen,"

Phrase: "2002"

Phrase: "; Takikawa,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.149: To determine possible alterations in these transport systems induced by Al administration, we evaluated the hepatic handling of the model organic anion BSP, a relatively nontoxic organic anion that is widely used as an indicator of liver function. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "possible alterations in these transport systems"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1515926:Alteration [Idea or Concept]

Phrase: "induced by Al administration,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0001554:Administration [Occupational Activity]
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C0205263:Induced [Functional Concept]
   770   C1533734:Administration [Therapeutic or Preventive Procedure]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the hepatic handling of the model organic anion BSP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0018578:Handling [Behavior]
   742   C1832073:Handling [Finding]

Phrase: "a relatively nontoxic organic anion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003075:Anion [Element, Ion, or Isotope]

Phrase: "that"

Phrase: "is"

Phrase: "widely"

Phrase: "used as an indicator of liver function."
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   778   C0232741:Liver function [Organ or Tissue Function]
   774   C1708102:Function Indicator [Manufactured Object]
   757   C1524063:Use of [Functional Concept]
   748   C0021212:indicator [Indicator, Reagent, or Diagnostic Aid]
   748   C0023884:Liver [Body Part, Organ, or Organ Component]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C0736268:LIVER [Body Part, Organ, or Organ Component]
   748   C1235732:Indicator [Bird]
   748   C1273517:used [Finding]
   748   C1278929:Liver [Body Part, Organ, or Organ Component]
   748   C1522602:Indicator [Functional Concept]
   748   C1705273:Function [Intellectual Product]
   748   C2346688:LIVER [Food]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.150: For this purpose, kinetics analysis of the plasma disappearance of dye, which provides a quantitative estimation of the efficiency by which transport events are functioning in the hepatocyte in vivo, was carried out. 

Phrase: "For this purpose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285529:Purpose [Functional Concept]

Phrase: "kinetics analysis of the plasma disappearance of dye,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "which"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a quantitative estimation of the efficiency"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0680844:estimation [Mental Process]
   753   C0681916:Estimation [Quantitative Concept]
   753   C0750572:Estimation [Quantitative Concept]

Phrase: "by which"

Phrase: "transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005528:Transport, NOS [Cell Function]
  1000   C1317949:Transport [Manufactured Object]
  1000   C3495449:transport [Medical Device]

Phrase: "events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441471:Events [Event]
  1000   C3541888:Events [Classification]

Phrase: "are"

Phrase: "functioning in the hepatocyte"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0227525:Hepatocyte [Cell]
   770   C0542341:functioning [Functional Concept]
   770   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   737 E C0031843:function [Physiologic Function]
   737 E C0700205:FUNCTION [Classification]
   737 E C1705273:Function [Intellectual Product]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.151: BSP is selectively taken up by the liver through an Na+-independent transport mechanism (mediated by the organic anion transporting polypeptide [OATP] families), conjugated with GSH within the hepatocytes by GST, and subsequently excreted into bile by the multispecific, ATP-dependent canalicular transporter Mrp2 (Takikawa, 2002). 

Phrase: "BSP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038753:Bromosulfophthalein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "selectively"

Phrase: "taken up"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1883727:Taken [Conceptual Entity]
   799 E C1515187:Take [Health Care Activity]

Phrase: "by the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "through an Na+-independent transport mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0441712:Mechanism [Functional Concept]
   812   C1706376:Mechanism [Manufactured Object]

Phrase: "("

Phrase: "mediated by the organic anion transporting polypeptide [OATP] families"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   789   C1159606:organic anion transport [Cell Function]
   754   C1159585:anion transport [Cell Function]
   744   C0003075:Anion [Element, Ion, or Isotope]
   744   C0015576:Families [Family Group]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0747055:Organic [Qualitative Concept]
   744   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]
   744   C1704727:Family [Conceptual Entity]
   711   C0005528:Transport, NOS [Cell Function]
   711   C1317949:Transport [Manufactured Object]
   711   C3495449:transport [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "conjugated with GSH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0522529:Conjugated [Spatial Concept]
   790   C1260386:GSH [Disease or Syndrome]
   756 E C0301869:Conjugate [Immunologic Factor]

Phrase: "within the hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0227525:Hepatocytes [Cell]
   966 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "by GST,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "subsequently"

Phrase: "excreted into bile"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0005388:Bile [Body Substance]
   790   C1688651:% excreted [Quantitative Concept]
   756 E C0221102:excrete [Physiologic Function]

Phrase: "by the multispecific, ATP-dependent canalicular transporter Mrp2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   829   C0007292:Transporter Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0851827:Dependent [Qualitative Concept]
   791   C1701901:Dependent [Qualitative Concept]
   791   C3244310:dependent [Functional Concept]

Phrase: "(Takikawa,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.152: The pharmacokinetic analysis indicated that both sinusoidal uptake and canalicular excretion of the dye were impaired by Al administration, as assessed by the decrease in the fractional transfer rates for the transport of the dye from plasma to liver (r12) and from liver to bile (r3), respectively (Table 3). 

Phrase: "The pharmacokinetic analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "both sinusoidal uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "canalicular excretion of the dye"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0221102:Excretion [Physiologic Function]
   760   C0504085:Excretion [Body Substance]
   760   C2699704:EXCRETION [Regulation or Law]

Phrase: "were"

Phrase: "impaired by Al administration,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0001554:Administration [Occupational Activity]
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C0221099:Impaired [Functional Concept]
   770   C0684336:Impaired [Pathologic Function]
   770   C1533734:Administration [Therapeutic or Preventive Procedure]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "as"

Phrase: "assessed by the decrease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   770   C1516048:Assessed [Activity]

Phrase: "in the fractional transfer rates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0040671:Transfer [Mental Process]
   827   C1705822:Transfer [Activity]
   793   C0871208:Rate [Activity]
   793   C1521828:Rate [Quantitative Concept]

Phrase: "for the transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005528:Transport, NOS [Cell Function]
  1000   C1317949:Transport [Manufactured Object]
  1000   C3495449:transport [Medical Device]

Phrase: "of the dye"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]

Phrase: "from plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "to liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "(r12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1333731:R12 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1704993:R12 [Gene or Genome]

Phrase: ")"

Phrase: "and from liver"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0023884:Liver [Body Part, Organ, or Organ Component]
   790   C0736268:LIVER [Body Part, Organ, or Organ Component]
   790   C1278929:Liver [Body Part, Organ, or Organ Component]
   790   C1515981:And [Idea or Concept]
   790   C2346688:LIVER [Food]
   734 E C0205054:Hepatic [Body Location or Region]

Phrase: "to bile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005388:Bile [Body Substance]

Phrase: "(r3"

Phrase: ")"

Phrase: ","

Phrase: "respectively"

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.153: The alteration in these transport steps, particularly the impairment of the canalicular transfer of the dye (which is the rate-limiting step in the overall transfer of BSP from blood to bile), explains the decrease in the total excretion of the dye (Table 4). 

Phrase: "The alteration in these transport steps,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1515926:Alteration [Idea or Concept]

Phrase: "particularly"

Phrase: "the impairment of the canalicular transfer of the dye"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0684336:Impairment [Pathologic Function]

Phrase: "("

Phrase: "which"

Phrase: "is"

Phrase: "the rate-limiting step in"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1261552:Step [Conceptual Entity]
   812   C1704379:Step [Functional Concept]
   812   C1705117:Step [Quantitative Concept]
   812   C2825408:Step [Manufactured Object]

Phrase: "the overall transfer of BSP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040671:Transfer [Mental Process]
   760   C1705822:Transfer [Activity]

Phrase: "from blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "to bile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005388:Bile [Body Substance]

Phrase: ")"

Phrase: ","

Phrase: "explains"

Phrase: "the decrease in the total excretion of the dye"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0392756:Decrease [Qualitative Concept]
   742   C0547047:Decrease [Quantitative Concept]

Phrase: "(Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.154: Changes in BSP intrahepatic conjugation, a metabolic step that facilitates its canalicular transfer (Barnhart and Combes, 1976), seem not to account for the alteration of the transport step, as no change in the conjugated-to-total BSP ratio was observed in bile (Table 4). 

Phrase: "Changes in BSP intrahepatic conjugation,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "a metabolic step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: "that"

Phrase: "facilitates"

Phrase: "its canalicular transfer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040671:Transfer [Mental Process]
   861   C1705822:Transfer [Activity]

Phrase: "(Barnhart"

Phrase: "and"

Phrase: "Combes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331946:combes [Health Care Related Organization]

Phrase: "1976"

Phrase: ")"

Phrase: ","

Phrase: "seem"

Phrase: "not to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "account for the alteration of the transport step,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0005528:Transport, NOS [Cell Function]
   744   C1261552:Step [Conceptual Entity]
   744   C1317949:Transport [Manufactured Object]
   744   C1515926:Alteration [Idea or Concept]
   744   C1551359:account [Idea or Concept]
   744   C1704379:Step [Functional Concept]
   744   C1705117:Step [Quantitative Concept]
   744   C2741673:Account # [Clinical Attribute]
   744   C2825408:Step [Manufactured Object]
   744   C2981730:Account [Classification]
   744   C3495449:transport [Medical Device]

Phrase: "as"

Phrase: "no change in the conjugated-to-total BSP ratio"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0442739:No change [Finding]
   764   C1548568:No change [Intellectual Product]
   742   C0392747:Change [Functional Concept]
   742   C0443172:change [Quantitative Concept]
   742   C1705241:Change [Quantitative Concept]

Phrase: "was"

Phrase: "observed in bile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0005388:Bile [Body Substance]
   790   C1441672:Observed [Functional Concept]

Phrase: "(Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.155: Although conjugating activity of GST, the enzyme involved in GSH-S conjugation of the dye, was impaired by Al (Table 1), increased transit time throughout the hepatocyte due to defective excretion, which increase chances for dye conjugation, may have compensated for the decrease in the conjugating activity. 

Phrase: "Although"

Phrase: "conjugating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301869:Conjugate [Immunologic Factor]

Phrase: "activity of GST,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   900   C1152039:glutathione S-transferase activity [Molecular Function]
           glutathione transferase activity
   797   C1151895:transferase activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "involved in GSH-S conjugation of the dye,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   744   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1160466:conjugation [Cell Function]
   744   C1260386:GSH [Disease or Syndrome]
   744   C1314939:Involved [Functional Concept]

Phrase: "was"

Phrase: "impaired by Al"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0002367:Aluminium [Element, Ion, or Isotope]
   790   C0221099:Impaired [Functional Concept]
   790   C0684336:Impaired [Pathologic Function]
   790   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "increased transit time throughout the hepatocyte"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0040223:Time [Temporal Concept]
   753   C1301827:transit [Functional Concept]
   753   C3541383:Time [Temporal Concept]

Phrase: "due to defective excretion,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0221102:Excretion [Physiologic Function]
   861   C0504085:Excretion [Body Substance]
   861   C2699704:EXCRETION [Regulation or Law]

Phrase: "which"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "chances for dye conjugation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0237506:Chance [Qualitative Concept]

Phrase: "may"

Phrase: "have"

Phrase: "compensated for the decrease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205432:Compensated [Qualitative Concept]
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "in the conjugating activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.156: However, a differential effect of Al on transport efficiency of free and conjugated BSP cannot be ruled out. 

Phrase: "However,"

Phrase: "a differential effect of Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on transport efficiency"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013682:Efficiency [Quantitative Concept]
   789 E C0442799:Efficient [Qualitative Concept]

Phrase: "of free"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332296:free [Functional Concept]
  1000   C1880497:Free [Qualitative Concept]
  1000   C1996904:Free [Qualitative Concept]

Phrase: "and"

Phrase: "conjugated BSP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038753:Bromosulfophthalein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "cannot"

Phrase: "be"

Phrase: "ruled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1446409:ruled [Qualitative Concept]
   966 E C0805874:Rule [Idea or Concept]
   966 E C0870077:Rule [Intellectual Product]

Phrase: "out."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.157: For example, an impairment of bile salt output, like that occurring in Al-treated rats, may selectively decrease free BSP biliary output (Gregus et al., 1980), thus explaining the lack of change in BSP output under conditions of impaired BSP conjugation. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "an impairment of bile salt output,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0684336:Impairment [Pathologic Function]

Phrase: "like that"

Phrase: "occurring in Al-treated rats,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0002367:Aluminium [Element, Ion, or Isotope]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0332293:treated [Therapeutic or Preventive Procedure]
   760   C1522326:Treated [Functional Concept]
   760   C2348254:ALUMINUM [Element, Ion, or Isotope]
   726 E C1292734:TREAT [Functional Concept]
   726   C1709305:Occur [Activity]
   726   C2745955:OCCUR [Temporal Concept]

Phrase: "may"

Phrase: "selectively"

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "free BSP biliary output"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1709366:Output [Conceptual Entity]

Phrase: "(Gregus et al.,"

Phrase: "1980"

Phrase: ")"

Phrase: ","

Phrase: "thus"

Phrase: "explaining"

Phrase: "the lack of change"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "in BSP output"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709366:Output [Conceptual Entity]

Phrase: "under conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "of impaired BSP conjugation."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1160466:conjugation [Cell Function]
   755 E C0522529:Conjugated [Spatial Concept]
Processing 00000000.tx.158: Therefore, the alteration in the canalicular transfer of the dye is more likely accounted for by an alteration in the activity/content of its canalicular transporter Mrp2. 

Phrase: "Therefore,"

Phrase: "the alteration in the canalicular transfer of the dye"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1515926:Alteration [Idea or Concept]

Phrase: "is"

Phrase: "more likely"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205172:More [Functional Concept]
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "accounted for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1551359:account [Idea or Concept]
   799   C2741673:Account # [Clinical Attribute]
   799   C2981730:Account [Classification]

Phrase: "by an alteration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515926:Alteration [Idea or Concept]

Phrase: "in the activity/content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "of its canalicular transporter Mrp2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0007292:Transporter Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.159: Western blot analysis and the further assessment of functional activity of Mrp2 confirmed this assertion. 

Phrase: "Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "the further assessment of functional activity of Mrp2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C0278372:Functional assessment [Diagnostic Procedure]
   738   C1261322:Assessment [Health Care Activity]
   738   C1516048:Assessment [Activity]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "this assertion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1301625:Assertion [Qualitative Concept]
Processing 00000000.tx.160: Indeed, the hepatic level of Mrp2 was decreased in Al (+) rats, which was accompanied by a decreased excretion of the specific Mrp2 substrate DNP-SG. 

Phrase: "Indeed,"

Phrase: "the hepatic level of Mrp2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0428479:Protein level [Laboratory or Test Result]
   767   C0456948:Level 2 [Intellectual Product]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "decreased in Al"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0002367:Aluminium [Element, Ion, or Isotope]
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   790   C2348254:ALUMINUM [Element, Ion, or Isotope]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "(+"

Phrase: ")"

Phrase: "rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "which"

Phrase: "was"

Phrase: "accompanied by a decreased excretion"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0205216:Decreased [Quantitative Concept]
   760   C0221102:Excretion [Physiologic Function]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C0504085:Excretion [Body Substance]
   760   C2699704:EXCRETION [Regulation or Law]
   726 E C0547047:Decrease [Quantitative Concept]

Phrase: "of the specific Mrp2 substrate DNP-SG."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   830   C0072393:Protein S [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   830   C1418948:PROTEIN S [Gene or Genome]
   788   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   788   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   788   C0205369:Specific [Qualitative Concept]
   788   C0332285:Of [Spatial Concept]
   788   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]
   788   C1260386:GSH [Disease or Syndrome]
   788   C1552740:specific [Intellectual Product]
   788   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.161: The underlying mechanisms by which Al affects bile production in general and organic anion transport status in particular are far from being completely understood and cannot be addressed using our results. 

Phrase: "The underlying mechanisms by which Al"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441712:Mechanisms [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "bile production in general"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "organic anion transport status in particular"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449438:Status [Qualitative Concept]

Phrase: "are"

Phrase: "far from"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0205108:far [Spatial Concept]

Phrase: "being"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "understood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]

Phrase: "and"

Phrase: "cannot"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "our results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]
Processing 00000000.tx.162: However, our data point to the possible involvement of oxidative stress in Al-induced hepatotoxicity (Table 1), as indicated by an increase in TBARS, a finding causally linked to enhanced liver lipid peroxidation, and a decrease in the levels of antioxidant defenses, including GSH and the antioxidant enzymes CAT (Abubakar et al., 2003) and GSH-Px (El-Maraghy et al., 2001). 

Phrase: "However,"

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "point to the possible involvement of oxidative stress"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   744   C0038435:Stress [Finding]
   744   C0311404:Oxidative [Functional Concept]
   744   C0332149:Possible [Qualitative Concept]
   744   C1314939:Involvement [Functional Concept]
   744   C1552961:Point [Quantitative Concept]
   744   C1705910:Possible [Qualitative Concept]
   744   C2347617:point [Quantitative Concept]
   744   C2362652:Possible [Qualitative Concept]

Phrase: "in Al-induced hepatotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0235378:Hepatotoxicity [Injury or Poisoning]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "indicated by an increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442805:Increase [Functional Concept]
   770   C1444656:Indicated [Finding]

Phrase: "in TBARS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439861:Substances [Substance]

Phrase: "a finding causally"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037088:Finding [Sign or Symptom]
   861   C0243095:Finding [Finding]
   861   C2825141:Finding [Finding]

Phrase: "linked to enhanced liver lipid peroxidation,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0023775:Lipid Peroxidation [Molecular Function]
   753   C0023779:Lipid [Lipid]
   753   C0023884:Liver [Body Part, Organ, or Organ Component]
   753   C0178796:peroxidation [Phenomenon or Process]
   753   C0736268:LIVER [Body Part, Organ, or Organ Component]
   753   C1278929:Liver [Body Part, Organ, or Organ Component]
   753   C2346688:LIVER [Food]
   753   C2349975:Enhanced [Activity]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "a decrease in the levels of antioxidant defenses,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "GSH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1260386:GSH [Disease or Syndrome]

Phrase: "and"

Phrase: "the antioxidant enzymes CAT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1413138:CATALASE [Gene or Genome]

Phrase: "(Abubakar et al.,"

Phrase: "2003"

Phrase: ")"

Phrase: "and"

Phrase: "GSH-Px"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0017822:GLUTATHIONE PEROXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415275:GLUTATHIONE PEROXIDASE [Gene or Genome]
   861   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(El-Maraghy et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.163: These results are in keeping with other studies showing that even lower (ip) Al doses and shorter administration periods induce a significant increase in hepatic reactive oxygen species (Abubakar et al., 2003). 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are in keeping"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1551058:Are [Quantitative Concept]
   756   C0333118:Keep [Functional Concept]

Phrase: "with other studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that even lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441994:Lower [Spatial Concept]
   861   C1548802:Lower [Body Location or Region]
   861   C2003888:Lower [Activity]

Phrase: "(ip) Al doses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0178602:Doses [Quantitative Concept]
   793 E C0869039:Dose [Quantitative Concept]
   793 E C1114758:Dose # [Clinical Attribute]
   793 E C1428722:DOS [Gene or Genome]

Phrase: "and"

Phrase: "shorter administration periods"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   896   C0425946:Short periods [Finding]
   793   C0439531:/period [Temporal Concept]
   793   C1948053:Period [Temporal Concept]
   743 E C0332182:Periodic [Temporal Concept]
   743 E C1706381:PERIODIC [Intellectual Product]
   721 E C0031084:Periodicities [Temporal Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a significant increase in hepatic reactive oxygen species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "(Abubakar et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.164: The effect is associated with decreased levels of hepatic antioxidant defenses including GSH (Abubakar et al., 2003; El-Maraghy et al., 2001 ), CAT (Abubakar et al., 2003.), and GSH-Px (El-Maraghy et al., 2001). 

Phrase: "The effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "associated with decreased levels of hepatic antioxidant defenses"
Meta Candidates (Total=15; Excluded=6; Pruned=0; Remaining=9)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0003402:Antioxidant [Pharmacologic Substance]
   744   C0205054:Hepatic [Body Location or Region]
   744   C0205216:Decreased [Quantitative Concept]
   744   C0392756:Decreased [Qualitative Concept]
   744   C0441889:Levels [Qualitative Concept]
   744   C0442797:decreased [Qualitative Concept]
   744   C1880266:Defense [Conceptual Entity]
   711 E C0456079:Level [Classification]
   711 E C0547047:Decrease [Quantitative Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1547707:Level [Geographic Area]
   711 E C1706221:Associate [Professional or Occupational Group]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "GSH (Abubakar et al.,"

Phrase: "2003"

Phrase: "; El-Maraghy et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: ","

Phrase: "CAT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]

Phrase: "(Abubakar et al.,"

Phrase: "2003."

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "GSH-Px"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0017822:GLUTATHIONE PEROXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415275:GLUTATHIONE PEROXIDASE [Gene or Genome]
   861   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(El-Maraghy et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.165: Furthermore, the decrease in GST activity we have reported could be a contributing factor since this enzyme has GSH-Px activity and is instrumental in detoxifying lipid hydroperoxides (Mari and Cederbaum, 2001). 

Phrase: "Furthermore,"

Phrase: "the decrease in GST activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "we"

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "could"

Phrase: "be"

Phrase: "a contributing factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "since"

Phrase: "this enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "has"

Phrase: "GSH-Px activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1151528:glutathione peroxidase activity [Molecular Function]
   901   C1151518:peroxidase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0017822:GLUTATHIONE PEROXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1415275:GLUTATHIONE PEROXIDASE [Gene or Genome]

Phrase: "and"

Phrase: "is"

Phrase: "instrumental in detoxifying lipid hydroperoxides"

Phrase: "(Mari"

Phrase: "and"

Phrase: "Cederbaum,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.166: Oxidative stress alters the expression of canalicular transporters at a post-transcriptional level, serving as a potential mechanism of alteration of biliary secretory function. 

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the expression of canalicular transporters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "at a post-transcriptional level,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "serving as a potential mechanism of alteration of biliary secretory function."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   756   C0544458:Secretory function [Functional Concept]
   738   C0031843:function [Physiologic Function]
   738   C0441712:Mechanism [Functional Concept]
   738   C0521378:Biliary [Functional Concept]
   738   C0542341:Function [Functional Concept]
   738   C0700205:FUNCTION [Classification]
   738   C1327616:Secretory [Cell Function]
   738   C1515926:Alteration [Idea or Concept]
   738   C1519269:Serving [Quantitative Concept]
   738   C1705273:Function [Intellectual Product]
   738   C1706376:Mechanism [Manufactured Object]
   738   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.167: Indeed, incorporation of oxidizing agents into the perfusate of the isolated, perfused rat liver leads to cholestasis accompanied by a loss of immunoreactive Mrp2 from the canalicular membrane due, in turn, to internalization of the transporter in subapical vesicles (Schmitt et al., 2000). 

Phrase: "Indeed,"

Phrase: "incorporation of oxidizing agents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0243126:incorporation [Functional Concept]

Phrase: "into the perfusate"

Phrase: "of the isolated, perfused rat liver"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   812   C0023884:Liver [Body Part, Organ, or Organ Component]
   812   C0034693:Rat, NOS [Mammal]
   812   C0034721:Rat [Mammal]
   812   C0736268:LIVER [Body Part, Organ, or Organ Component]
   812   C1278929:Liver [Body Part, Organ, or Organ Component]
   812   C2346688:LIVER [Food]
   756 E C0205054:Hepatic [Body Location or Region]

Phrase: "leads to cholestasis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0008370:Cholestasis [Disease or Syndrome]
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0181586:leads [Medical Device]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "accompanied by a loss of immunoreactive Mrp2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1517945:Loss [Quantitative Concept]

Phrase: "from the canalicular membrane due, in turn,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   804   C0025255:Membrane [Tissue]
   804   C0541749:turn [Finding]
   804   C0596901:Membrane [Cell Component]
   804   C0678226:due [Functional Concept]
   804   C1706182:Membrane [Manufactured Object]
   804   C1709743:Turn [Spatial Concept]
   804   C3146286:Due [Idea or Concept]
   733 E C0205287:Membranous [Qualitative Concept]

Phrase: "to internalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871786:internalization [Mental Process]

Phrase: "of the transporter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in subapical vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "(Schmitt et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.168: Sustained internalization as a consequence of long-lasting oxidative stress, likely to occur in our Al (+) rats, may lead to delivery of Mrp2 to the lysosomal compartment followed by degradation, as was shown to occur late in lipopolysaccharide-induced cholestasis (Kubitz et al., 1999; Trauner et al., 1997). 

Phrase: "Sustained internalization as a consequence of long-lasting oxidative stress,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0871786:internalization [Mental Process]

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "occur in our Al"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1709305:Occur [Activity]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "(+"

Phrase: ")"

Phrase: "rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "may"

Phrase: "lead to delivery of Mrp2"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   767   C2346661:Lead 2+ [Element, Ion, or Isotope]
   744   C0011209:Delivery [Therapeutic or Preventive Procedure]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0559563:delivery [Finding]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C1705822:Delivery [Activity]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to the lysosomal compartment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185625:Compartment [Body Space or Junction]
   861   C2986730:Compartment [Spatial Concept]

Phrase: "followed by degradation,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "as"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "late in lipopolysaccharide-induced cholestasis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205087:Late [Temporal Concept]

Phrase: "(Kubitz et al.,"

Phrase: "1999"

Phrase: "; Trauner et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.169: This may explain our results showing a decreased expression of Mrp2 in Al (+) rats. 

Phrase: "This"

Phrase: "may"

Phrase: "explain"

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a decreased expression of Mrp2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "(+"

Phrase: ")"

Phrase: "rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]
Processing 00000000.tx.170: A balance between exocytic insertion and endocytic internalization of canalicular transporters exists, and this balance may be disrupted either by inhibiting vesicle-mediated insertion of newly synthesized transporters or by stimulating their internalization, or both. 

Phrase: "A balance between exocytic insertion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0014653:Balance [Organism Function]
   760   C0205415:Balance [Functional Concept]
   760   C0560184:Balance [Finding]

Phrase: "and"

Phrase: "endocytic internalization of canalicular transporters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0871786:internalization [Mental Process]

Phrase: "exists"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: ","

Phrase: "and"

Phrase: "this balance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014653:Balance [Organism Function]
  1000   C0205415:Balance [Functional Concept]
  1000   C0560184:Balance [Finding]

Phrase: "may"

Phrase: "be"

Phrase: "disrupted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:Disrupted [Qualitative Concept]

Phrase: "either by inhibiting vesicle-mediated insertion of newly synthesized transporters"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   739   C0021107:Insertion [Therapeutic or Preventive Procedure]
   739   C0086597:mediated [Social Behavior]
   739   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   739   C0333262:Vesicle [Acquired Abnormality]
   739   C0441587:Insertion [Health Care Activity]
   739   C0596902:transporters [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0750546:newly [Idea or Concept]
   739   C1512796:Insertion [Genetic Function]
   739   C1622418:vesicle [Cell Component]
   739   C1883254:Synthesized [Activity]
   739   C1883719:Insertion [Functional Concept]
   739   C3463820:Inhibiting [Activity]

Phrase: "or by stimulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1948023:Stimulating [Natural Phenomenon or Process]

Phrase: "their internalization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871786:internalization [Mental Process]

Phrase: "or"

Phrase: "both."
Processing 00000000.tx.171: Our results showing that Al (+) rats have an inhibited biliary excretion of protein and cholesterol, two compounds thought to reach bile mainly via a microtubule-dependent, vesicular mechanism (LaRusso, 1984; Marzolo et al., 1990), make the first possibility likely. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "(+"

Phrase: ")"

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "have"

Phrase: "an inhibited biliary excretion of protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0221102:Excretion [Physiologic Function]
   753   C0504085:Excretion [Body Substance]
   753   C2699704:EXCRETION [Regulation or Law]

Phrase: "and"

Phrase: "cholesterol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "two compounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205198:Compound [Qualitative Concept]
   827   C1706082:Compound [Chemical]

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "bile mainly via a microtubule-dependent, vesicular mechanism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0005388:Bile [Body Substance]

Phrase: "(LaRusso,"

Phrase: "1984"

Phrase: "; Marzolo et al.,"

Phrase: "1990"

Phrase: ")"

Phrase: ","

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "the first possibility likely."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   755   C0332149:Possible [Qualitative Concept]
   755   C1705910:Possible [Qualitative Concept]
   755   C2362652:Possible [Qualitative Concept]
Processing 00000000.tx.172: However, a more direct action of Al in decreasing Mrp2 synthesis and/or in increasing Mrp2 degradation can not be excluded. 

Phrase: "However,"

Phrase: "a more direct action of Al"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439851:Direct [Qualitative Concept]
   753   C0441472:Action [Functional Concept]
   753   C1947931:Direct [Qualitative Concept]
   753   C3266814:Action [Activity]

Phrase: "in decreasing Mrp2 synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C0597295:Protein Synthesis [Molecular Function]
   799   C0220781:synthesis [Biologic Function]
   799   C1883254:Synthesis [Activity]

Phrase: "and/or in increasing Mrp2 degradation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C1706528:And/Or [Conceptual Entity]
   762   C0597297:Protein Degradation [Molecular Function]
   762   C0597304:Protein Degradation [Molecular Function]
   762   C1623036:Protein Degradation [Molecular Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0243125:degradation [Functional Concept]
   742   C0442808:Increasing [Functional Concept]
   742   C0699900:Degradation [Organism Function]
   742   C1515981:And [Idea or Concept]

Phrase: "can"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "excluded."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.173: Berlyne et al. 

Phrase: "Berlyne et al."
Processing 00000000.tx.174: (1972) proposed that Al exerts its hepatotoxic effect by affecting protein synthesis, an assertion confirmed by others showing that the hepatic levels of numerous phase Idetoxifying enzyme proteins decreased after Al exposure (Fulton and Jeffery, 1994; Jeffery et al., 1987). 

Phrase: "(1972"

Phrase: ")"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "its hepatotoxic effect by affecting protein synthesis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0235378:Hepatotoxic effect [Injury or Poisoning]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "an assertion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1301625:Assertion [Qualitative Concept]

Phrase: "confirmed by others"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0750484:Confirmed [Idea or Concept]
   790   C1955473:Others [Finding]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the hepatic levels of numerous phase Idetoxifying enzyme proteins"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   762   C0014440:enzyme levels [Laboratory Procedure]
   762   C1287349:enzyme levels [Laboratory or Test Result]
   742   C0441889:Levels [Qualitative Concept]
   728   C0428479:Protein level [Laboratory or Test Result]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "decreased after Al exposure"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0274281:Exposure, NOS [Injury or Poisoning]
   770   C0332157:Exposure [Clinical Attribute]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "(Fulton"

Phrase: "and"

Phrase: "Jeffery,"

Phrase: "1994"

Phrase: "; Jeffery et al.,"

Phrase: "1987"

Phrase: ")."
Processing 00000000.tx.175: The reduction in the hepatic levels of several enzymes reported in this study (Table 1) confirms and extends this concept to phase IIdetoxifying enzymes (GST) and other antioxidant enzymes (CAT and GSH-Px). 

Phrase: "The reduction in the hepatic levels of several enzymes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0301630:Reduction [Natural Phenomenon or Process]
   742   C0392756:Reduction [Qualitative Concept]
   742   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "reported in this study"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   802   C1317750:Study report [Intellectual Product]
   802   C1831145:Study report [Clinical Attribute]
   770   C0557651:Study [Manufactured Object]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C2603343:Study [Research Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "and"

Phrase: "extends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "this concept to phase IIdetoxifying enzymes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0178566:concept [Idea or Concept]

Phrase: "(GST"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "and"

Phrase: "other antioxidant enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "(CAT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]

Phrase: "and"

Phrase: "GSH-Px"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0017822:GLUTATHIONE PEROXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415275:GLUTATHIONE PEROXIDASE [Gene or Genome]
   861   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: ")."
Processing 00000000.tx.176: The second possibility, the activation of lysosomal degradation of proteins by Al, seems more unlikely, since this metal was shown to inhibit rather than to activate the lysosomal proton pump (Zatta et al., 2000). 

Phrase: "The second possibility,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "the activation of lysosomal degradation of proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0599177:protein activation [Genetic Function]
   748   C1879547:Activation [Activity]

Phrase: "by Al,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "seems"

Phrase: "more unlikely,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "since"

Phrase: "this metal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0025552:Metal [Inorganic Chemical]
   928 E C2986473:Metallic [Qualitative Concept]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "rather than"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the lysosomal proton pump"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   964   C1527253:Lysosome Proton Pump [Cell Component]
           Lysosome Proton
   901   C0018440:Proton Pump [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1621561:proton pump [Molecular Function]
   827   C0033727:Proton [Element, Ion, or Isotope]
   827   C0182537:Pump [Medical Device]
   827   C1706421:Pump [Manufactured Object]

Phrase: "(Zatta et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.177: Regardless of the mechanism involved, the Al-induced impairment of the expression/function of Mrp2 and, presumably, other transport proteins involved in transhepatocellular transport of cholephilic compound may explain, at least in part, the cholestatic effect of this metal. 

Phrase: "Regardless of the mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: ","

Phrase: "the Al-induced impairment of the expression/function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0684336:Impairment [Pathologic Function]

Phrase: "of Mrp2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: ","

Phrase: "presumably,"

Phrase: "other transport proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007292:Transport Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0005528:Transport, NOS [Cell Function]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "involved in transhepatocellular transport of cholephilic compound"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0005528:Transport, NOS [Cell Function]
   748   C0205198:Compound [Qualitative Concept]
   748   C1314939:Involved [Functional Concept]
   748   C1317949:Transport [Manufactured Object]
   748   C1706082:Compound [Chemical]
   748   C3495449:transport [Medical Device]

Phrase: "may"

Phrase: "explain"

Phrase: ","

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "the cholestatic effect of this metal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.178: Indeed, Mrp2 mediates canalicular secretion of GSH (Paulusma et al., 1999), a key determinant of the so-called bile saltindependent fraction of the bile flow (Ballatori and Truong, 1992). 

Phrase: "Indeed,"

Phrase: "Mrp2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "canalicular secretion of GSH (Paulusma et al.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]

Phrase: "1999"

Phrase: ")"

Phrase: ","

Phrase: "a key determinant of the so-called bile saltindependent fraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1521761:Determinant [Functional Concept]

Phrase: "of the bile flow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "(Ballatori"

Phrase: "and"

Phrase: "Truong,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.179: In conclusion, our results show that chronic Al intoxication induces cholestasis and impairs hepatic transport of organic anions by decreasing both sinusoidal uptake and canalicular excretion. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that chronic Al intoxication"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0473223:Aluminium intoxication [Disease or Syndrome]
   827   C0728899:Intoxication [Finding]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "cholestasis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008370:Cholestasis [Disease or Syndrome]

Phrase: "and"

Phrase: "impairs"

Phrase: "hepatic transport of organic anions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1159606:organic anion transport [Cell Function]
   781   C1159585:anion transport [Cell Function]
   760   C0005528:Transport, NOS [Cell Function]
   760   C1317949:Transport [Manufactured Object]
   760   C3495449:transport [Medical Device]

Phrase: "by decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "both sinusoidal uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "canalicular excretion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0221102:Excretion [Physiologic Function]
   861   C0504085:Excretion [Body Substance]
   861   C2699704:EXCRETION [Regulation or Law]
Processing 00000000.tx.180: This latter event, which is the rate-limiting step in the overall transport from plasma to bile, is accounted for by a decreased expression of the main transporter involved in this process, Mrp2. 

Phrase: "This latter event,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]

Phrase: "which"

Phrase: "is"

Phrase: "the rate-limiting step in"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1261552:Step [Conceptual Entity]
   812   C1704379:Step [Functional Concept]
   812   C1705117:Step [Quantitative Concept]
   812   C2825408:Step [Manufactured Object]

Phrase: "the overall transport from plasma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0005528:Transport, NOS [Cell Function]
   760   C1317949:Transport [Manufactured Object]
   760   C3495449:transport [Medical Device]

Phrase: "to bile,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005388:Bile [Body Substance]

Phrase: "is"

Phrase: "accounted for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1551359:account [Idea or Concept]
   799   C2741673:Account # [Clinical Attribute]
   799   C2981730:Account [Classification]

Phrase: "by a decreased expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of the main transporter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "involved in this process,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1184743:Process [Body Part, Organ, or Organ Component]
   770   C1314939:Involved [Functional Concept]
   770   C1522240:Process [Phenomenon or Process]

Phrase: "Mrp2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.181: Clearly, additional studies are needed to clarify the exact mechanism(s) through which Al exerts these deleterious effects.  

Phrase: "Clearly,"

Phrase: "additional studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "the exact mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "("

Phrase: "s) through which Al"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   770   C2603362:S' [Clinical Attribute]

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "these deleterious effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.182: ACKNOWLEDGMENTS  This work was supported by a research grant from the Universidad Nacional del Litoral, Cursos de Accin para la Investigacin y Desarrollo (CAI+D 2002, Cdigo Proy, 17116), Secretara de Ciencia y Tcnica, UNL. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by a research grant"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0260206:research grant [Research Activity]
   797   C0035176:research supported [Quantitative Concept]
   760   C0018173:Grant [Quantitative Concept]
   760   C0035168:research [Research Activity]
   760   C0242481:Research [Research Activity]
   760   C1521721:Supported [Conceptual Entity]
   760   C1548284:Grant [Idea or Concept]
   726 E C0183683:Support [Medical Device]

Phrase: "from the Universidad Nacional del Litoral,"

Phrase: "Cursos de Accin para la Investigacin y Desarrollo"

Phrase: "(CAI+D 2002,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "Cdigo Proy,"

Phrase: "17116"

Phrase: ")"

Phrase: ","

Phrase: "Secretara de Ciencia y Tcnica,"

Phrase: "UNL."
Processing 00000000.tx.183: We thank Stella Mahieu, Mara del Crmen Contini, and researchers from IFISE (Instituto de Fisiologa Experimental) for their valuable collaboration in the use of technical methodologies.  

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Stella Mahieu,"

Phrase: "Mara del Crmen Contini,"

Phrase: "and"

Phrase: "researchers from IFISE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035173:Researchers [Professional or Occupational Group]

Phrase: "(Instituto de Fisiologa Experimental"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0011198:DE [Geographic Area]
   812   C0017480:DE [Geographic Area]
   812   C1517586:Experimental [Qualitative Concept]
   812   C3541240:DE [Idea or Concept]

Phrase: ")"

Phrase: "for their valuable collaboration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282116:Collaboration [Social Behavior]

Phrase: "in the use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of technical methodologies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0969625:methodology [Intellectual Product]
   827   C3266812:Methodology [Idea or Concept]
Processing 00000000.tx.184: NOTES  1 To whom correspondence should be addressed at Instituto de Fisiologa Experimental (IFISE)-CONICET, Facultad de Ciencias Bioqumicas y Farmacuticas, Universidad Nacional de Rosario, Suipacha 531, S2002LRL Rosario, Argentina. 

Phrase: "NOTES"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "1 To whom correspondence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0282413:Correspondence [Intellectual Product]
   770   C2827734:1+ [Quantitative Concept]
   770   C2981698:1+ [Classification]

Phrase: "should"

Phrase: "be"

Phrase: "addressed at Instituto de Fisiologa Experimental (IFISE)-CONICET,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0011198:DE [Geographic Area]
   748   C0017480:DE [Geographic Area]
   748   C1517586:Experimental [Qualitative Concept]
   748   C3541240:DE [Idea or Concept]
   714   C0376649:Address [Intellectual Product]
   714   C1442065:Address [Spatial Concept]

Phrase: "Facultad de Ciencias Bioqumicas y Farmacuticas,"

Phrase: "Universidad Nacional de Rosario,"

Phrase: "Suipacha 531,"

Phrase: "S2002LRL Rosario,"

Phrase: "Argentina."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003761:Argentina [Geographic Area]
  1000   C1504311:Argentina [Fish]
Processing 00000000.tx.185: Fax: +54 341-4399473. 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+54 341-4399473."
Processing 00000000.tx.186: E-mail: mcarill{at}fbioyf.unr.edu.ar  REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Abubakar, M. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "mcarill{at}fbioyf.unr.edu.ar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C2986463:AR+ [Finding]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Abubakar,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.187: G., Taylor, A., and Ferns, G. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Taylor,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Ferns,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331729:Fern [Plant]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.188: A. 

Phrase: "A."
Processing 00000000.tx.189: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.190: Aluminium administration is associated with enhanced hepatic oxidant stress that may be offset by dietary vitamin E in the rat. 

Phrase: "Aluminium administration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001554:Administration [Occupational Activity]
   861   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "associated with enhanced hepatic oxidant stress"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0038435:Stress [Finding]
   753   C0085403:oxidant [Chemical Viewed Functionally]
   753   C0205054:Hepatic [Body Location or Region]
   753   C2349975:Enhanced [Activity]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "that"

Phrase: "may"

Phrase: "be"

Phrase: "offset by dietary vitamin E"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0042874:Vitamin E [Lipid,Pharmacologic Substance,Vitamin]
   760   C0012155:Dietary [Food]
   760   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]
   760   C1711330:Offset [Quantitative Concept]
   760   C2699635:DIETARY [Functional Concept]
   751 E C0591450:Ephynal [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "in the rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]
Processing 00000000.tx.191: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.192: J. 

Phrase: "J."
Processing 00000000.tx.193: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.194: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.195: 84, 4954.[ISI][Medline] Alfrey, A. 

Phrase: "84,"

Phrase: "4954."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Alfrey,"

Phrase: "A."
Processing 00000000.tx.196: C., LeGendre, G. 

Phrase: "C., LeGendre,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.197: R., and Kaehny, W. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Kaehny,"

Phrase: "W."
Processing 00000000.tx.198: D. 

Phrase: "D."
Processing 00000000.tx.199: (1976). 

Phrase: "(1976"

Phrase: ")."
Processing 00000000.tx.200: The dialysis encephalopathy syndrome. 

Phrase: "The dialysis encephalopathy syndrome."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0221040:Dialysis encephalopathy syndrome [Disease or Syndrome]
           Dialysis encephalopathy
   827   C0011945:Dialysis [Natural Phenomenon or Process]
   827   C0011946:dialysis [Therapeutic or Preventive Procedure]
   827   C0039082:Syndrome [Disease or Syndrome]
   827   C0085584:Encephalopathy [Disease or Syndrome]
   827   C0917873:dialysis [Therapeutic or Preventive Procedure]
   827   C1059964:Dialysis [Eukaryote]
   827   C1963101:Encephalopathy [Finding]
Processing 00000000.tx.201: Possible aluminum intoxication. 

Phrase: "Possible aluminum intoxication."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0473223:Aluminium intoxication [Disease or Syndrome]
   827   C0728899:Intoxication [Finding]
Processing 00000000.tx.202: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.203: Engl. 

Phrase: "Engl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414400:ENGL [Gene or Genome]
Processing 00000000.tx.204: J. 

Phrase: "J."
Processing 00000000.tx.205: Med. 

Phrase: "Med."
Processing 00000000.tx.206: 294, 184188.[Abstract] Ballatori, N., and Truong, A. 

Phrase: "294,"

Phrase: "184188."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ballatori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Truong,"

Phrase: "A."
Processing 00000000.tx.207: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.208: (1992). 

Phrase: "(1992"

Phrase: ")."
Processing 00000000.tx.209: Glutathione as a primary osmotic driving force in hepatic bile formation. 

Phrase: "Glutathione as a primary osmotic driving force"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in hepatic bile formation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0232750:Bile formation [Organ or Tissue Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
Processing 00000000.tx.210: Am. 

Phrase: "Am."
Processing 00000000.tx.211: J. 

Phrase: "J."
Processing 00000000.tx.212: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.213: 263, G617G624.[ISI][Medline] Barnhart, J. 

Phrase: "263,"

Phrase: "G617G624."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Barnhart,"

Phrase: "J."
Processing 00000000.tx.214: L., and Combes, B. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Combes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331946:combes [Health Care Related Organization]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.215: (1976). 

Phrase: "(1976"

Phrase: ")."
Processing 00000000.tx.216: Biliary excretion of dye in dogs infused with BSP or its glutathione conjugate. 

Phrase: "Biliary excretion of dye"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0221102:Excretion [Physiologic Function]
   770   C0504085:Excretion [Body Substance]
   770   C2699704:EXCRETION [Regulation or Law]

Phrase: "in dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012984:Dogs [Mammal]
  1000   C1280551:Dogs [Mammal]

Phrase: "infused with BSP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0038753:Bromosulfophthalein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "its glutathione conjugate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0301869:Conjugate [Immunologic Factor]
Processing 00000000.tx.217: Am. 

Phrase: "Am."
Processing 00000000.tx.218: J. 

Phrase: "J."
Processing 00000000.tx.219: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.220: 231, 399407.[Abstract/Free FullText] Beers, R. 

Phrase: "231,"

Phrase: "399407."

Phrase: "[Abstract/Free FullText"

Phrase: "] Beers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004922:Beers [Food]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.221: F., and Sizer, I. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Sizer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221872:sizer [Medical Device]

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.222: W. 

Phrase: "W."
Processing 00000000.tx.223: (1952). 

Phrase: "(1952"

Phrase: ")."
Processing 00000000.tx.224: A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. 

Phrase: "A spectrophotometric method for measuring"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025663:Method [Intellectual Product]
   760   C0449851:Method [Functional Concept]
   760   C0871511:METHOD [Intellectual Product]

Phrase: "the breakdown of hydrogen peroxide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C1327325:hydrogen peroxide breakdown [Molecular Function]
   760   C0443161:break down [Qualitative Concept]
   760   C0699900:breakdown [Organism Function]
   760   C1265875:breakdown [Acquired Abnormality]

Phrase: "by catalase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]
Processing 00000000.tx.225: J. 

Phrase: "J."
Processing 00000000.tx.226: Biol. 

Phrase: "Biol."
Processing 00000000.tx.227: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.228: 195, 133140.[Free FullText] Berlyne, G. 

Phrase: "195,"

Phrase: "133140."

Phrase: "[Free FullText"

Phrase: "] Berlyne,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.229: M., Yagil, R., Ari, J. 

Phrase: "M."

Phrase: ","

Phrase: "Yagil,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ari,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412533:ARI [Gene or Genome]

Phrase: "J."
Processing 00000000.tx.230: B., Knopf, E., Weinberger, G., and Danovitch, G. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Knopf,"

Phrase: "E.,"

Phrase: "Weinberger,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Danovitch,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.231: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.232: (1972). 

Phrase: "(1972"

Phrase: ")."
Processing 00000000.tx.233: Aluminum toxicity in rats. 

Phrase: "Aluminum toxicity in rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040539:toxicity [Qualitative Concept]
   770   C0600688:Toxicity [Injury or Poisoning]
Processing 00000000.tx.234: Lancet 1, 564568.[CrossRef][Medline] Bertholf, R. 

Phrase: "Lancet 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: "564568."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bertholf,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.235: L., Herman, M. 

Phrase: "L., Herman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.236: M., Savory, J., Carpenter, R. 

Phrase: "M."

Phrase: ","

Phrase: "Savory,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1135885:Savory [Food]

Phrase: "J.,"

Phrase: "Carpenter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336362:Carpenter [Professional or Occupational Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.237: M., Sturgill, B. 

Phrase: "M."

Phrase: ","

Phrase: "Sturgill,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.238: C., Katsetos, C. 

Phrase: "C., Katsetos,"

Phrase: "C."
Processing 00000000.tx.239: D., Vandenberg, S. 

Phrase: "D."

Phrase: ","

Phrase: "Vandenberg,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.240: R., and Wills, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Wills,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042950:wills [Mental Process]
  1000   C0043177:Wills [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.241: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.242: (1989). 

Phrase: "(1989"

Phrase: ")."
Processing 00000000.tx.243: A long-term intravenous model of aluminum maltol toxicity in rabbits: Tissue distribution, hepatic, renal, and neuronal cytoskeletal changes associated with systemic exposure. 

Phrase: "A long-term intravenous model of aluminum maltol toxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C3161035:Model [Intellectual Product]

Phrase: "in rabbits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034493:Rabbit [Mammal]

Phrase: ":"

Phrase: "Tissue distribution,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0040287:Tissue Distribution [Quantitative Concept]
  1000   C0220927:tissue distribution [Functional Concept]
   861   C0040300:Tissue [Tissue]
   861   C0520511:distribution [Idea or Concept]
   861   C1547928:Tissue [Intellectual Product]
   861   C1704711:Distribution [Functional Concept]

Phrase: "hepatic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205054:Hepatic [Body Location or Region]

Phrase: "renal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022646:Renal [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "neuronal cytoskeletal changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]

Phrase: "associated with systemic exposure."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0205373:Systemic [Functional Concept]
   770   C0274281:Exposure, NOS [Injury or Poisoning]
   770   C0332157:Exposure [Clinical Attribute]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.244: Toxicol. 

Phrase: "Toxicol."
Processing 00000000.tx.245: Appl. 

Phrase: "Appl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1858559:APPL [Gene or Genome]
Processing 00000000.tx.246: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.247: 98, 5874.[ISI][Medline] Campbell, A. 

Phrase: "98,"

Phrase: "5874."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Campbell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331936:Campbell [Health Care Related Organization]

Phrase: "A."
Processing 00000000.tx.248: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.249: The potential role of aluminium in Alzheimer's disease. 

Phrase: "The potential role of aluminium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.250: Nephrol. 

Phrase: "Nephrol."
Processing 00000000.tx.251: Dial. 

Phrase: "Dial."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1707733:Dial [Manufactured Object]
   944 E C0002132:allobarbital [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.252: Transplant. 

Phrase: "Transplant."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040732:Transplant [Therapeutic or Preventive Procedure]
  1000   C0332835:Transplant [Tissue]
Processing 00000000.tx.253: 17(Suppl. 

Phrase: "17"

Phrase: "(Suppl."
Processing 00000000.tx.254: 2), 1720.[Medline] Degiorgis, N. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "1720."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Degiorgis,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.255: M., Itois, M. 

Phrase: "M."

Phrase: ","

Phrase: "Itois,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.256: E., and Cabrini, R. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Cabrini,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.257: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.258: (1987). 

Phrase: "(1987"

Phrase: ")."
Processing 00000000.tx.259: Model experimental para el studio de las alteraciones seas producidas por aluminio. 

Phrase: "Model experimental para el studio de las alteraciones seas producidas por aluminio."
Processing 00000000.tx.260: Actas del II Congreso de Osteologia y Metabolismo Mineral, Argentina. 

Phrase: "Actas del II Congreso de Osteologia y Metabolismo Mineral,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0026162:Mineral [Inorganic Chemical]

Phrase: "Argentina."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003761:Argentina [Geographic Area]
  1000   C1504311:Argentina [Fish]
Processing 00000000.tx.261: 19. 

Phrase: "19."
Processing 00000000.tx.262: Ellman, G. 

Phrase: "Ellman,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.263: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.264: (1959). 

Phrase: "(1959"

Phrase: ")."
Processing 00000000.tx.265: Tissue sulfhydryl groups. 

Phrase: "Tissue sulfhydryl groups."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0038734:sulfhydryl group [Organic Chemical]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
Processing 00000000.tx.266: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.267: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.268: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.269: 82, 7073.[ISI][Medline] El-Maraghy, S. 

Phrase: "82,"

Phrase: "7073."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] El-Maraghy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.270: A., Gad, M. 

Phrase: "A.,"

Phrase: "Gad,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0270549:GAD [Mental or Behavioral Dysfunction]
  1000   C1414925:GAD [Gene or Genome]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.271: Z., Fahim, A. 

Phrase: "Z.,"

Phrase: "Fahim,"

Phrase: "A."
Processing 00000000.tx.272: T., and Hamdy, M. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Hamdy,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.273: A. 

Phrase: "A."
Processing 00000000.tx.274: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.275: Effect of cadmium and aluminum intake on the antioxidant status and lipid peroxidation in rat tissues. 

Phrase: "Effect of cadmium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "aluminum intake on the antioxidant status"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1512806:Intake [Functional Concept]

Phrase: "and"

Phrase: "lipid peroxidation in rat tissues."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0023775:Lipid Peroxidation [Molecular Function]
   760   C0023779:Lipid [Lipid]
   760   C0178796:peroxidation [Phenomenon or Process]
Processing 00000000.tx.276: J. 

Phrase: "J."
Processing 00000000.tx.277: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.278: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.279: Toxicol. 

Phrase: "Toxicol."
Processing 00000000.tx.280: 15, 207214.[CrossRef][ISI][Medline] Fulton, B., Jaw, S., and Jeffery, E. 

Phrase: "15,"

Phrase: "207214."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fulton,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Jaw,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022359:Jaw [Body Part, Organ, or Organ Component]
  1000   C0024687:Jaw [Body Part, Organ, or Organ Component]
  1000   C1273020:Jaw [Body Location or Region]

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Jeffery,"

Phrase: "E."
Processing 00000000.tx.281: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.282: (1989). 

Phrase: "(1989"

Phrase: ")."
Processing 00000000.tx.283: Bioavailability of aluminum from drinking water. 

Phrase: "Bioavailability of aluminum"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0005508:Bioavailability [Quantitative Concept]
   790   C1706947:BIO-AVAILABILITY [Research Activity]
   718 E C0935763:Bioavailable [Qualitative Concept]

Phrase: "from drinking water."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0599638:Drinking Water [Substance]
           WATER
   861   C0001948:drinking [Individual Behavior]
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0684271:Drinking [Organism Function]
   861   C1550678:Water [Inorganic Chemical]
   827 E C0452428:Drink [Food]
   789 E C0443350:Watery [Qualitative Concept]
Processing 00000000.tx.284: Fundam. 

Phrase: "Fundam."
Processing 00000000.tx.285: Appl. 

Phrase: "Appl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1858559:APPL [Gene or Genome]
Processing 00000000.tx.286: Toxicol. 

Phrase: "Toxicol."
Processing 00000000.tx.287: 12, 144150.[ISI][Medline] Fulton, B., and Jeffery, E. 

Phrase: "12,"

Phrase: "144150."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fulton,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Jeffery,"

Phrase: "E."
Processing 00000000.tx.288: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.289: (1994). 

Phrase: "(1994"

Phrase: ")."
Processing 00000000.tx.290: The temporal relationship between hepatic GSH loss, heme oxygenase induction, and cytochrome P450 loss following intraperitoneal aluminium administration to mice. 

Phrase: "The temporal relationship between hepatic GSH loss,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0449235:Temporal relationship [Temporal Concept]
   748   C0439849:Relationship [Qualitative Concept]
   748   C1705630:Relationship [Idea or Concept]
   748   C1706279:Relationship [Idea or Concept]
   748   C3540605:Relationship [Intellectual Product]

Phrase: "heme oxygenase induction,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205263:Induction [Functional Concept]
   827   C0857127:induction [Therapeutic or Preventive Procedure]
   734   C0018969:Haem Oxygenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "cytochrome P450 loss"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1517945:Loss [Quantitative Concept]
   734   C0010762:Cytochrome P-450 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1149063:cytochrome P450 [Molecular Function]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "intraperitoneal aluminium administration to mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0021493:intraperitoneal administration [Therapeutic or Preventive Procedure]
   760   C0001554:Administration [Occupational Activity]
   760   C1533734:Administration [Therapeutic or Preventive Procedure]
Processing 00000000.tx.291: Toxicol. 

Phrase: "Toxicol."
Processing 00000000.tx.292: Appl. 

Phrase: "Appl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1858559:APPL [Gene or Genome]
Processing 00000000.tx.293: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.294: 127, 291297.[CrossRef][ISI][Medline] Goldstein, J., and Combes, B. 

Phrase: "127,"

Phrase: "291297."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Goldstein,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Combes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331946:combes [Health Care Related Organization]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.295: (1966). 

Phrase: "(1966"

Phrase: ")."
Processing 00000000.tx.296: Spectrophotometric assay of the liver enzyme that catalyzes sulfobromophthalein glutathione conjugation. 

Phrase: "Spectrophotometric assay of the liver enzyme"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C2717977:Enzyme Assay [Laboratory Procedure]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]

Phrase: "that"

Phrase: "catalyzes"

Phrase: "sulfobromophthalein glutathione conjugation."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1160466:conjugation [Cell Function]
   755 E C0522529:Conjugated [Spatial Concept]
Processing 00000000.tx.297: J. 

Phrase: "J."
Processing 00000000.tx.298: Lab. 

Phrase: "Lab."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022877:Lab [Manufactured Object,Organization]
   944 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   916 E C0587081:Labs [Finding]
Processing 00000000.tx.299: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.300: Med. 

Phrase: "Med."
Processing 00000000.tx.301: 67, 863872.[ISI][Medline] Gregus, Z., Fischer, E., and Varga, F. 

Phrase: "67,"

Phrase: "863872."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gregus,"

Phrase: "Z.,"

Phrase: "Fischer,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Varga,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.302: (1980). 

Phrase: "(1980"

Phrase: ")."
Processing 00000000.tx.303: Effect of cholestyramine-induced bile acid depletion on the hepatobiliary transport of cholephilic organic anions in rats. 

Phrase: "Effect of cholestyramine-induced bile acid depletion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on the hepatobiliary transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "of cholephilic organic anions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003075:Anions [Element, Ion, or Isotope]

Phrase: "in rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]
Processing 00000000.tx.304: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.305: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.306: Pharmacodyn. 

Phrase: "Pharmacodyn."
Processing 00000000.tx.307: Ther. 

Phrase: "Ther."
Processing 00000000.tx.308: 245, 311322.[ISI][Medline] Jansen, P. 

Phrase: "245,"

Phrase: "311322."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jansen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.309: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.310: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.311: Foreword: From classic bile physiology to cloned transporters. 

Phrase: "Foreword"

Phrase: ":"

Phrase: "From classic bile physiology"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0031842:Physiology [Biomedical Occupation or Discipline]
   827   C0031843:physiology [Physiologic Function]
   755 E C0205463:Physiologic [Functional Concept]

Phrase: "to cloned transporters."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596902:transporters [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.312: Semin. 

Phrase: "Semin."
Processing 00000000.tx.313: Liver Dis. 

Phrase: "Liver Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0451119:DIS [Intellectual Product]
   861   C1444662:DIS [Finding]
Processing 00000000.tx.314: 20, 245250.[ISI][Medline] Jeffery, E. 

Phrase: "20,"

Phrase: "245250."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jeffery,"

Phrase: "E."
Processing 00000000.tx.315: H., Jansen, H. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Jansen,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.316: T., and Dellinger, J. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Dellinger,"

Phrase: "J."
Processing 00000000.tx.317: A. 

Phrase: "A."
Processing 00000000.tx.318: (1987). 

Phrase: "(1987"

Phrase: ")."
Processing 00000000.tx.319: In vivo interactions of aluminum with hepatic cytochrome P-450 and metallothionein. 

Phrase: "In vivo interactions of aluminum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "with hepatic cytochrome P-450"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0010762:Cytochrome P-450 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1149063:cytochrome P450 [Molecular Function]
   812   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1325304:cytochrome [Molecular Function]

Phrase: "and"

Phrase: "metallothionein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025545:Metallothionein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.320: Fundam. 

Phrase: "Fundam."
Processing 00000000.tx.321: Appl. 

Phrase: "Appl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1858559:APPL [Gene or Genome]
Processing 00000000.tx.322: Toxicol. 

Phrase: "Toxicol."
Processing 00000000.tx.323: 8, 541548.[ISI][Medline] Klaassen, C. 

Phrase: "8,"

Phrase: "541548."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Klaassen,"

Phrase: "C."
Processing 00000000.tx.324: D. 

Phrase: "D."
Processing 00000000.tx.325: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.326: Xenobiotic transporters: Another protective mechanism for chemicals. 

Phrase: "Xenobiotic transporters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596902:transporters [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "Another protective mechanism for chemicals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.327: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.328: J. 

Phrase: "J."
Processing 00000000.tx.329: Toxicol. 

Phrase: "Toxicol."
Processing 00000000.tx.330: 21, 712.[CrossRef][ISI][Medline] Klein, G. 

Phrase: "21,"

Phrase: "712."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Klein,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.331: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.332: (1993). 

Phrase: "(1993"

Phrase: ")."
Processing 00000000.tx.333: Aluminum and hepatobiliary complications of total parenteral nutrition. 

Phrase: "Aluminum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "hepatobiliary complications of total parenteral nutrition."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0009566:Complications [Pathologic Function]
   753   C1171258:complications [Pathologic Function]
   719 E C2362589:Complication [Idea or Concept]
Processing 00000000.tx.334: Gastroenterology 10, 15831584. 

Phrase: "Gastroenterology 10,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017163:Gastroenterology [Biomedical Occupation or Discipline]

Phrase: "15831584."
Processing 00000000.tx.335: Klein, G. 

Phrase: "Klein,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.336: L., Heyman, M. 

Phrase: "L., Heyman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.337: B., Lee, T. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Lee,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.338: C., Miller, N. 

Phrase: "C., Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0402830:Miller [Professional or Occupational Group]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.339: L., Marathe, G., Gourley, W. 

Phrase: "L., Marathe,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Gourley,"

Phrase: "W."
Processing 00000000.tx.340: K., and Alfrey, A. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Alfrey,"

Phrase: "A."
Processing 00000000.tx.341: C. 

Phrase: "C."
Processing 00000000.tx.342: (1988). 

Phrase: "(1988"

Phrase: ")."
Processing 00000000.tx.343: Aluminum-associated hepatobiliary dysfunction in rats: Relationships to dosage and duration of exposure. 

Phrase: "Aluminum-associated hepatobiliary dysfunction in rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031847:dysfunction [Functional Concept]
   753   C0277785:Dysfunction, NOS [Qualitative Concept]

Phrase: ":"

Phrase: "Relationships to dosage"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0439849:Relationships [Qualitative Concept]
   756 E C1705630:Relationship [Idea or Concept]
   756 E C1706279:Relationship [Idea or Concept]
   756 E C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "duration of exposure."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C2826870:Exposure Duration [Temporal Concept]
   790   C0449238:Duration [Temporal Concept]
   790   C2926735:Duration [Pharmacologic Substance]
Processing 00000000.tx.344: Pediatr. 

Phrase: "Pediatr."
Processing 00000000.tx.345: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.346: 23, 275278.[Abstract] Klein, G. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "275278."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Klein,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.347: L., Lee, T. 

Phrase: "L., Lee,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.348: C., Heyman, M. 

Phrase: "C., Heyman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.349: B., and Rassin, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Rassin,"

Phrase: "D."
Processing 00000000.tx.350: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.351: (1989a). 

Phrase: "(1989a"

Phrase: ")."
Processing 00000000.tx.352: Altered glycine and taurine conjugation of bile acids following aluminum administration to rats. 

Phrase: "Altered glycine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0522461:Glycine [Plant]

Phrase: "and"

Phrase: "taurine conjugation of bile acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C2752608:bile acid conjugation [Molecular Function]
   808 E C0443599:Conjugated bile acids [Biologically Active Substance,Steroid]
   760   C1160466:conjugation [Cell Function]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "aluminum administration to rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001554:Administration [Occupational Activity]
   770   C1533734:Administration [Therapeutic or Preventive Procedure]
Processing 00000000.tx.353: J. 

Phrase: "J."
Processing 00000000.tx.354: Pediatr. 

Phrase: "Pediatr."
Processing 00000000.tx.355: Gastroenterol. 

Phrase: "Gastroenterol."
Processing 00000000.tx.356: Nutr. 

Phrase: "Nutr."
Processing 00000000.tx.357: 9, 361364.[ISI][Medline] Klein, G. 

Phrase: "9,"

Phrase: "361364."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Klein,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.358: L., Lee, T. 

Phrase: "L., Lee,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.359: C., Mann, P. 

Phrase: "C., Mann,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.360: A., Miller, N. 

Phrase: "A.,"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.361: L., and Alfrey, A. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Alfrey,"

Phrase: "A."
Processing 00000000.tx.362: C. 

Phrase: "C."
Processing 00000000.tx.363: (1989b). 

Phrase: "(1989b"

Phrase: ")."
Processing 00000000.tx.364: Effects of aluminum on the liver following high-dose enteral administration to rats. 

Phrase: "Effects of aluminum"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "on the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "high-dose enteral administration to rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0678814:enteral administration [Therapeutic or Preventive Procedure]
   753   C0001554:Administration [Occupational Activity]
   753   C1533734:Administration [Therapeutic or Preventive Procedure]
Processing 00000000.tx.365: J. 

Phrase: "J."
Processing 00000000.tx.366: Pediatr. 

Phrase: "Pediatr."
Processing 00000000.tx.367: Gastroenterol. 

Phrase: "Gastroenterol."
Processing 00000000.tx.368: Nutr. 

Phrase: "Nutr."
Processing 00000000.tx.369: 9, 105107.[ISI][Medline] Konig, J., Nies, A. 

Phrase: "9,"

Phrase: "105107."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Konig,"

Phrase: "J.,"

Phrase: "Nies,"

Phrase: "A."
Processing 00000000.tx.370: T., Wi, Y., Leier, I., Keppler, D. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Wi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: "Y.,"

Phrase: "Leier,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Keppler,"

Phrase: "D."
Processing 00000000.tx.371: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.372: Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. 

Phrase: "Conjugate export"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0699789:Export [Phenomenon or Process]

Phrase: "pumps of the multidrug resistance protein (MRP) family"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   814   C1817498:multidrug-resistance protein [Molecular Function]
   778   C0242640:Multi-Drug Resistance [Organism Attribute]
   778   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C2945682:protein pump [Amino Acid, Peptide, or Protein]
   748   C0015576:Family [Family Group]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0182537:Pump [Medical Device]
   748   C0237834:Resistance [Mental Process]
   748   C1514892:Resistance [Physiologic Function]
   748   C1704727:Family [Conceptual Entity]
   748   C1706421:Pump [Manufactured Object]

Phrase: ":"

Phrase: "localization,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0475264:Localisation [Functional Concept]
  1000   C1744691:localisation [Biologic Function]

Phrase: "substrate specificity,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0038592:Substrate Specificity [Quantitative Concept]
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   861   C1710236:Substrate [Manufactured Object]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "MRP2-mediated drug resistance."
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   861   C0013203:Drug resistance [Biologic Function]
   812   C0013227:Drug [Pharmacologic Substance]
   812   C0237834:Resistance [Mental Process]
   812   C1254351:Drug [Pharmacologic Substance]
   812   C1514892:Resistance [Physiologic Function]
   756 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   756 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   741 E C0332325:Resistant [Functional Concept]
   741 E C1550464:resistent [Idea or Concept]
   741 E C2827757:RESISTANT [Laboratory or Test Result]
   719 E C0456386:Medicament [Pharmacologic Substance]
Processing 00000000.tx.373: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.374: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.375: Acta. 

Phrase: "Acta."
Processing 00000000.tx.376: 1461, 377394.[ISI][Medline] Kubitz, R., Wettstein, M., Warskulat, U., and Hussinger, D. 

Phrase: "1461,"

Phrase: "377394."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kubitz,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wettstein,"

Phrase: "M."

Phrase: ","

Phrase: "Warskulat,"

Phrase: "U.,"

Phrase: "and"

Phrase: "Hussinger,"

Phrase: "D."
Processing 00000000.tx.377: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.378: Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone. 

Phrase: "Regulation of the multidrug resistance protein 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "in the rat liver"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "by lipopolysaccharide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023810:Lipopolysaccharide [Lipid]

Phrase: "and"

Phrase: "dexamethasone."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   944 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   944 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   944 E C0740057:Decadron [Pharmacologic Substance,Steroid]
Processing 00000000.tx.379: Gastroenterology 116, 401410.[ISI][Medline] LaRusso, N. 

Phrase: "Gastroenterology 116,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017163:Gastroenterology [Biomedical Occupation or Discipline]

Phrase: "401410."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] LaRusso,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.380: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.381: (1984). 

Phrase: "(1984"

Phrase: ")."
Processing 00000000.tx.382: Proteins in bile: how they get there and what they do. 

Phrase: "Proteins in bile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "how"

Phrase: "they"

Phrase: "get"

Phrase: "there"

Phrase: "and"

Phrase: "what they"

Phrase: "do."
Processing 00000000.tx.383: Am. 

Phrase: "Am."
Processing 00000000.tx.384: J. 

Phrase: "J."
Processing 00000000.tx.385: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.386: 274, 61996205. 

Phrase: "274,"

Phrase: "61996205."
Processing 00000000.tx.387: Lione, A. 

Phrase: "Lione,"

Phrase: "A."
Processing 00000000.tx.388: (1985). 

Phrase: "(1985"

Phrase: ")."
Processing 00000000.tx.389: Aluminum toxicology and the aluminum-containing medications. 

Phrase: "Aluminum toxicology"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0040541:Toxicology [Biomedical Occupation or Discipline]
   861   C1548006:Toxicology [Intellectual Product]
   789 E C0205472:Toxicologic [Functional Concept]

Phrase: "and"

Phrase: "the aluminum-containing medications."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0013227:Medications [Pharmacologic Substance]
   827   C0802604:Medications [Clinical Attribute]
   827   C2598133:Medications [Clinical Attribute]
   793 E C3244316:medication [Functional Concept]
Processing 00000000.tx.390: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.391: Ther. 

Phrase: "Ther."
Processing 00000000.tx.392: 29, 255285.[CrossRef][ISI][Medline] Lowry, O. 

Phrase: "29,"

Phrase: "255285."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lowry,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.393: H., Rosobrough, N. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rosobrough,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.394: J., Farr, A. 

Phrase: "J.,"

Phrase: "Farr,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441583:Farr [Laboratory Procedure]

Phrase: "A."
Processing 00000000.tx.395: L., and Randall, R. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Randall,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.396: J. 

Phrase: "J."
Processing 00000000.tx.397: (1951). 

Phrase: "(1951"

Phrase: ")."
Processing 00000000.tx.398: Protein measurement with the Folin phenol reagent. 

Phrase: "Protein measurement with the Folin phenol reagent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0202202:Protein measurement [Laboratory Procedure]
   774   C0202446:Phenol measurement [Laboratory Procedure]
   748   C0242485:Measurement [Functional Concept]
Processing 00000000.tx.399: Biol. 

Phrase: "Biol."
Processing 00000000.tx.400: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.401: 193, 265275. 

Phrase: "193,"

Phrase: "265275."
Processing 00000000.tx.402: Mari, M., and Cederbaum, A. 

Phrase: "Mari,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Cederbaum,"

Phrase: "A."
Processing 00000000.tx.403: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.404: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.405: Induction of catalase, , and microsomal glutathione S-transferase in CYP2E1 overexpressing HepG2 cells and protection against short-term oxidative stress. 

Phrase: "Induction of catalase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205263:Induction [Functional Concept]
   790   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "and"

Phrase: "microsomal glutathione S-transferase in CYP2E1 overexpressing HepG2 cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   742   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "protection against short-term oxidative stress."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1545588:Protection [Finding]
Processing 00000000.tx.406: Hepatology 33, 652661.[CrossRef][ISI][Medline] Marzolo, M. 

Phrase: "Hepatology 33,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0086403:Hepatology [Biomedical Occupation or Discipline]
   861   C1555763:Hepatology [Professional or Occupational Group]

Phrase: "652661."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Marzolo,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.407: P., Rigotti, A., and Nervi, F. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Rigotti,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Nervi,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027769:nervi [Sign or Symptom]
   966 E C0027740:Nervus [Tissue]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.408: (1990). 

Phrase: "(1990"

Phrase: ")."
Processing 00000000.tx.409: Secretion of biliary lipids from the hepatocyte. 

Phrase: "Secretion of biliary lipids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]

Phrase: "from the hepatocyte."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0227525:Hepatocyte [Cell]
  1000   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.410: Hepatology 12, 134S141S.[Medline] Meier, P. 

Phrase: "Hepatology 12,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0086403:Hepatology [Biomedical Occupation or Discipline]
   861   C1555763:Hepatology [Professional or Occupational Group]

Phrase: "134S141S."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Meier,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.411: J., Sztul, E. 

Phrase: "J.,"

Phrase: "Sztul,"

Phrase: "E."
Processing 00000000.tx.412: S., Reuben, A., and Boyer, J. 

Phrase: "S."

Phrase: ","

Phrase: "Reuben,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Boyer,"

Phrase: "J."
Processing 00000000.tx.413: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.414: (1984). 

Phrase: "(1984"

Phrase: ")."
Processing 00000000.tx.415: Structural and functional polarity of canalicular and basolateral plasma membrane vesicles isolated in high yield from rat liver. 

Phrase: "Structural"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structural [Spatial Concept]

Phrase: "and"

Phrase: "functional polarity of canalicular"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596963:Polarity [Quantitative Concept]

Phrase: "and"

Phrase: "basolateral plasma membrane vesicles"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0333262:VESICLES [Acquired Abnormality]
   779 E C1622418:vesicle [Cell Component]
   756   C1167208:Basolateral plasma membrane [Cell Component]
   729 E C0205378:Vesicular [Qualitative Concept]
   708   C0596156:basolateral membrane [Cell Component]

Phrase: "isolated in high yield"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0205250:High [Qualitative Concept]
   770   C0205409:Isolated [Functional Concept]
   770   C1299351:High [Qualitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C2700149:HIGH [Intellectual Product]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "from rat liver."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.416: J. 

Phrase: "J."
Processing 00000000.tx.417: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.418: 98, 9911000.[Abstract] Nieboer, E., Gibson, B. 

Phrase: "98,"

Phrase: "9911000."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Nieboer,"

Phrase: "E.,"

Phrase: "Gibson,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.419: L, Oxman, A. 

Phrase: "L,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Oxman,"

Phrase: "A."
Processing 00000000.tx.420: D., and Kramer, J. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Kramer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331847:Kramer [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.421: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.422: (1995). 

Phrase: "(1995"

Phrase: ")."
Processing 00000000.tx.423: Health effects of aluminum: A critical review with emphasis on aluminum in drinking water. 

Phrase: "Health effects of aluminum"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0018684:Health [Idea or Concept]
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: ":"

Phrase: "A critical review with emphasis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0282443:Review [Intellectual Product]
   760   C1552617:Review [Idea or Concept]

Phrase: "on aluminum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "in drinking water."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0599638:Drinking Water [Substance]
           WATER
   861   C0001948:drinking [Individual Behavior]
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0684271:Drinking [Organism Function]
   861   C1550678:Water [Inorganic Chemical]
   827 E C0452428:Drink [Food]
   789 E C0443350:Watery [Qualitative Concept]
Processing 00000000.tx.424: Environ. 

Phrase: "Environ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1568941:Environ [Organic Chemical]
Processing 00000000.tx.425: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.426: 3, 2981. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "2981."
Processing 00000000.tx.427: Ohkawa, H., Ohishi, N., and Yagi, K. 

Phrase: "Ohkawa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ohishi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Yagi,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.428: (1979). 

Phrase: "(1979"

Phrase: ")."
Processing 00000000.tx.429: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. 

Phrase: "Assay for lipid peroxides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C1510438:Assay [Laboratory Procedure]

Phrase: "in animal tissues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0229982:animal tissues [Tissue]
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "by thiobarbituric acid reaction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   734   C0076442:thiobarbituric acid [Organic Chemical]
Processing 00000000.tx.430: Anal. 

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.431: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.432: 95, 351358.[ISI][Medline] Paglia, D. 

Phrase: "95,"

Phrase: "351358."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Paglia,"

Phrase: "D."
Processing 00000000.tx.433: E., and Valentine, W. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Valentine,"

Phrase: "W."
Processing 00000000.tx.434: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.435: (1967). 

Phrase: "(1967"

Phrase: ")."
Processing 00000000.tx.436: Studies on the quantitative and qualitative characterization of erythrocyte glutathione-peroxidase. 

Phrase: "Studies on the quantitative"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "qualitative characterization of erythrocyte glutathione-peroxidase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]
Processing 00000000.tx.437: J. 

Phrase: "J."
Processing 00000000.tx.438: Lab. 

Phrase: "Lab."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022877:Lab [Manufactured Object,Organization]
   944 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   916 E C0587081:Labs [Finding]
Processing 00000000.tx.439: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.440: Med. 

Phrase: "Med."
Processing 00000000.tx.441: 70, 158169.[ISI][Medline] Paulusma, C. 

Phrase: "70,"

Phrase: "158169."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Paulusma,"

Phrase: "C."
Processing 00000000.tx.442: C., Van Geer, M. 

Phrase: "C., Van Geer,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.443: A., Evers, R., Heijn, M., Ottenhoff, R., Borst, P., and Oude Elferink, R. 

Phrase: "A.,"

Phrase: "Evers,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Heijn,"

Phrase: "M."

Phrase: ","

Phrase: "Ottenhoff,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Borst,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Oude Elferink,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.444: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.445: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.446: Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. 

Phrase: "Canalicular multispecific organic anion transporter/multidrug resistance protein 2"
Meta Candidates (Total=22; Excluded=3; Pruned=0; Remaining=19)
   924   C0757457:canalicular-multispecific organic anion transporter 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   924   C1412078:CANALICULAR MULTISPECIFIC ORGANIC ANION TRANSPORTER 2 [Gene or Genome]
   890   C3540577:Canalicular Multidrug Resistance Protein [Amino Acid, Peptide, or Protein]
   877   C1420131:ORGANIC ANION TRANSPORTER 2 [Gene or Genome]
   877   C1420142:ORGANIC ANION TRANSPORTER 2 [Gene or Genome]
   873   C0525410:canalicular multispecific organic anion transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   873   C1412077:MULTISPECIFIC ORGANIC ANION TRANSPORTER, CANALICULAR [Gene or Genome]
   873   C3538745:Canalicular Multispecific Organic Anion Transporter [Amino Acid, Peptide, or Protein]
   849   C0290741:Multispecific Organic Anion Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   849   C0763572:Multidrug resistance protein 2 [Amino Acid, Peptide, or Protein]
   829   C0007292:Transporter Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1817498:multidrug-resistance protein [Molecular Function]
   807   C0242640:Multi-Drug Resistance [Organism Attribute]
   791   C0003075:Anion [Element, Ion, or Isotope]
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0237834:Resistance [Mental Process]
   791   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0747055:Organic [Qualitative Concept]
   791   C1514892:Resistance [Physiologic Function]
   720 E C0332325:Resistant [Functional Concept]
   720 E C1550464:resistent [Idea or Concept]
   720 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "low-affinity transport of reduced glutathione."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C2612752:glutathione transport [Cell Function]
   753   C0005528:Transport, NOS [Cell Function]
   753   C1317949:Transport [Manufactured Object]
   753   C3495449:transport [Medical Device]
Processing 00000000.tx.447: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.448: J. 

Phrase: "J."
Processing 00000000.tx.449: 338, 393401.[CrossRef][ISI][Medline] Richards, T. 

Phrase: "338,"

Phrase: "393401."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Richards,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.450: G., Tindell, V. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Tindell,"

Phrase: "V."
Processing 00000000.tx.451: R., and Young, A. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Young,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "A."
Processing 00000000.tx.452: (1959). 

Phrase: "(1959"

Phrase: ")."
Processing 00000000.tx.453: A modification of the bromsulphthalein liver function test to predict the dye content of the liver and bile. 

Phrase: "A modification of the bromsulphthalein liver function test to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0392747:Modification [Functional Concept]
   742   C1554963:modification [Qualitative Concept]
   726   C0581601:Functional modification [Therapeutic or Preventive Procedure]

Phrase: "predict"

Phrase: "the dye content of the liver"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "bile."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005388:Bile [Body Substance]
Processing 00000000.tx.454: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.455: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.456: 18, 499511.[ISI] Schmitt, M., Kubitz, R., Wettstein, M., Vom, D. 

Phrase: "18,"

Phrase: "499511."

Phrase: "[ISI] Schmitt,"

Phrase: "M."

Phrase: ","

Phrase: "Kubitz,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wettstein,"

Phrase: "M."

Phrase: ","

Phrase: "Vom,"

Phrase: "D."
Processing 00000000.tx.457: S., and Hussinger, D. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Hussinger,"

Phrase: "D."
Processing 00000000.tx.458: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.459: Retrieval of the Mrp2 gene encoded conjugate export pump from the canalicular membrane contributes to cholestasis induced by tert-butyl hydroperoxide and chloro-dinitrobenzene. 

Phrase: "Retrieval of the Mrp2 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1514918:Retrieval [Health Care Activity]

Phrase: "encoded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0679058:encoded [Mental Process]
  1000   C2700640:Encoded [Activity]

Phrase: "conjugate export pump from the canalicular membrane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0182537:Pump [Medical Device]
   748   C1706421:Pump [Manufactured Object]

Phrase: "contributes to cholestasis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0008370:Cholestasis [Disease or Syndrome]
   790   C1880177:Contribute [Activity]

Phrase: "induced by tert-butyl hydroperoxide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0076150:tert-Butyl Hydroperoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0020281:Hydroperoxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0205263:Induced [Functional Concept]
   760   C0754515:TERT [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1367342:TERT [Gene or Genome]
   760   C1705316:TERT [Gene or Genome]

Phrase: "and"

Phrase: "chloro-dinitrobenzene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012459:Dinitrobenzene [Organic Chemical]
Processing 00000000.tx.460: Biol. 

Phrase: "Biol."
Processing 00000000.tx.461: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.462: 381, 487495.[ISI][Medline] Short, A. 

Phrase: "381,"

Phrase: "487495."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Short,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1282927:short [Qualitative Concept]
  1000   C1806781:Short [Quantitative Concept]
  1000   C2350002:Short [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.463: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.464: K., Winney, R. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Winney,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.465: J., and Robson, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Robson,"

Phrase: "J."
Processing 00000000.tx.466: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.467: (1980). 

Phrase: "(1980"

Phrase: ")."
Processing 00000000.tx.468: Reversible microcytic hypochromic anaemia in dialysis patients due to aluminium intoxication. 

Phrase: "Reversible microcytic hypochromic anaemia in dialysis patients"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0271901:Microcytic hypochromic anaemia [Disease or Syndrome]
   778   C0002884:Hypochromic anaemia [Disease or Syndrome]
   778   C0221018:ANEMIA, HYPOCHROMIC [Disease or Syndrome]
   778   C0271900:hypochromic anaemia [Disease or Syndrome]
   774   C0085576:Microcytic anaemia [Disease or Syndrome]
   748   C0002871:Anaemia [Disease or Syndrome]
   748   C0302870:MICROCYTIC [Finding]
   748   C1000483:Anemia [Plant]

Phrase: "due to aluminium intoxication."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0473223:Aluminium intoxication [Disease or Syndrome]
   861   C0728899:Intoxication [Finding]
Processing 00000000.tx.469: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.470: Eur. 

Phrase: "Eur."
Processing 00000000.tx.471: Dial. 

Phrase: "Dial."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1707733:Dial [Manufactured Object]
   944 E C0002132:allobarbital [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.472: Transplant. 

Phrase: "Transplant."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040732:Transplant [Therapeutic or Preventive Procedure]
  1000   C0332835:Transplant [Tissue]
Processing 00000000.tx.473: Assoc. 

Phrase: "Assoc."
Processing 00000000.tx.474: 17, 226233.[Medline] Snel, C. 

Phrase: "17,"

Phrase: "226233."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Snel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3149517:SNEL [Disease or Syndrome]

Phrase: "C."
Processing 00000000.tx.475: A., Zhao, Y., Mulder, G. 

Phrase: "A.,"

Phrase: "Zhao,"

Phrase: "Y.,"

Phrase: "Mulder,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.476: J., and Pang, K. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Pang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413561:PANG [Gene or Genome]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.477: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.478: (1993). 

Phrase: "(1993"

Phrase: ")."
Processing 00000000.tx.479: Methods for the quantitation of bromosulfophthalein and its glutathione conjugate in biological fluids. 

Phrase: "Methods for the quantitation of bromosulfophthalein"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0025663:Methods [Intellectual Product]
   753   C0025664:methods [Intellectual Product]
   753   C0449851:Methods [Functional Concept]
   719 E C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "its glutathione conjugate in biological fluids."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0301869:Conjugate [Immunologic Factor]
Processing 00000000.tx.480: Anal. 

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.481: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.482: 212, 2834.[CrossRef][ISI][Medline] Takikawa, H. 

Phrase: "212,"

Phrase: "2834."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Takikawa,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.483: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.484: Hepatobiliary transport of bile acids and organic anions. 

Phrase: "Hepatobiliary transport of bile acids"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1159620:bile acid transport [Cell Function]
   760   C0005528:Transport, NOS [Cell Function]
   760   C1317949:Transport [Manufactured Object]
   760   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "organic anions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003075:Anions [Element, Ion, or Isotope]
Processing 00000000.tx.485: J. 

Phrase: "J."
Processing 00000000.tx.486: Hepatobiliary Pancreat. 

Phrase: "Hepatobiliary Pancreat."
Processing 00000000.tx.487: Surg. 

Phrase: "Surg."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541227:Surg [Temporal Concept]
Processing 00000000.tx.488: 9, 443447.[CrossRef][Medline] Trauner, M., Arrese, M., Soroka, C. 

Phrase: "9,"

Phrase: "443447."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Trauner,"

Phrase: "M."

Phrase: ","

Phrase: "Arrese,"

Phrase: "M."

Phrase: ","

Phrase: "Soroka,"

Phrase: "C."
Processing 00000000.tx.489: J., Ananthanarayanan, M., Koeppel, T. 

Phrase: "J.,"

Phrase: "Ananthanarayanan,"

Phrase: "M."

Phrase: ","

Phrase: "Koeppel,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.490: A., Schlosser, S. 

Phrase: "A.,"

Phrase: "Schlosser,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.491: F., Suchy, F. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Suchy,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.492: J., Keppler, D., and Boyer, J. 

Phrase: "J.,"

Phrase: "Keppler,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Boyer,"

Phrase: "J."
Processing 00000000.tx.493: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.494: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.495: The canalicular conjugate export pump (Mrp2) is downregulated in intrahepatic and obstructive cholestasis. 

Phrase: "The canalicular conjugate export pump"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0182537:Pump [Medical Device]
   812   C1706421:Pump [Manufactured Object]

Phrase: "(Mrp2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "is"

Phrase: "downregulated in intrahepatic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1512948:intrahepatic [Spatial Concept]

Phrase: "and"

Phrase: "obstructive cholestasis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008370:Cholestasis [Disease or Syndrome]
Processing 00000000.tx.496: Gastroenterology 113, 255264.[ISI][Medline] Ward, M. 

Phrase: "Gastroenterology 113,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017163:Gastroenterology [Biomedical Occupation or Discipline]

Phrase: "255264."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ward,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1305702:Ward [Health Care Related Organization,Manufactured Object]
  1000   C1547134:Ward [Idea or Concept]
  1000   C2355574:Ward [Population Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.497: K., Feest, T. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Feest,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.498: G., Ellis, H. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ellis,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.499: A., Parkinson, I. 

Phrase: "A.,"

Phrase: "Parkinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   900   C1021144:Parkinsonia [Plant]

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.500: S., Kerr, D. 

Phrase: "S."

Phrase: ","

Phrase: "Kerr,"

Phrase: "D."
Processing 00000000.tx.501: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.502: S., Herrington, J., and Goode, G. 

Phrase: "S."

Phrase: ","

Phrase: "Herrington,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Goode,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.503: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.504: (1978). 

Phrase: "(1978"

Phrase: ")."
Processing 00000000.tx.505: Osteomalacic dialysis osteodystrophy: Evidence for a water-borne aetiological agent, probably aluminium. 

Phrase: "Osteomalacic dialysis osteodystrophy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0264009:Osteodystrophy [Congenital Abnormality,Disease or Syndrome]

Phrase: ":"

Phrase: "Evidence for a water-borne aetiological agent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332120:Evidence [Functional Concept]

Phrase: "probably aluminium."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]
Processing 00000000.tx.506: Lancet 1, 841845.[Medline] Yokel, R., and McNamara, P. 

Phrase: "Lancet 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: "841845."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yokel,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "McNamara,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.507: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.508: Aluminum toxicokinetics: An update. 

Phrase: "Aluminum toxicokinetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282299:Toxicokinetics [Biomedical Occupation or Discipline]
   861   C0282690:toxicokinetics [Functional Concept]

Phrase: ":"

Phrase: "An update."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519814:Update [Temporal Concept]
Processing 00000000.tx.509: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.510: Toxicol. 

Phrase: "Toxicol."
Processing 00000000.tx.511: 88, 159167.[CrossRef][ISI][Medline] Zatta, P., Taylor, A., Zambenedetti, P., Milacic, R., and Dell'Antone, P. 

Phrase: "88,"

Phrase: "159167."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zatta,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Taylor,"

Phrase: "A.,"

Phrase: "Zambenedetti,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Milacic,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Dell'Antone,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.512: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.513: Aluminum inhibits the lysosomal proton pump from rat liver. 

Phrase: "Aluminum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the lysosomal proton pump from rat liver."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0018440:Proton Pump [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1527253:Lysosome Proton Pump [Cell Component]
           Lysosome Proton
   778   C1621561:proton pump [Molecular Function]
   774   C0695733:liver pump [Therapeutic or Preventive Procedure]
   774   C1563226:Liver pump [Therapeutic or Preventive Procedure]
   748   C0033727:Proton [Element, Ion, or Isotope]
   748   C0182537:Pump [Medical Device]
   748   C1706421:Pump [Manufactured Object]
Processing 00000000.tx.514: Life Sci. 

Phrase: "Life Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.515: 66, 22612266.[CrossRef][ISI][Medline] This Article Abstract FREE Full Text (PDF) All Versions of this Article: 79/1/189 most recent kfh085v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Search for citing articles in: ISI Web of Science (2) Disclaimer Request Permissions Google Scholar Articles by Gonzalez, M. 

Phrase: "66,"

Phrase: "22612266."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "This Article Abstract FREE Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1527021:Text [Intellectual Product]
   804   C1554111:Text [Idea or Concept]
   804   C1705606:Text [Intellectual Product]
   804   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "79/1/189 most recent kfh085v1"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0557854:Services [Occupational Activity]
   966 E C2825316:Service [Manufactured Object]
   966 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in ISI Web"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282111:Web [Manufactured Object]

Phrase: "of Science Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0162443:Journal [Intellectual Product,Manufactured Object]
   748   C0205314:New [Temporal Concept]
   714   C0033213:Issue [Finding]
   714   C1706387:Issue [Intellectual Product]

Phrase: "Add to My Personal Archive Download"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0003738:archive [Manufactured Object]
   753   C0024552:MY [Geographic Area]
   753   C1519021:Personal [Organism Attribute]
   753   C1554162:Archive [Idea or Concept]
   753   C1883712:Add [Functional Concept]

Phrase: "to citation manager Search"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552603:search [Intellectual Product]
   827   C1706202:Search [Activity]

Phrase: "for citing articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706852:Article [Intellectual Product]

Phrase: "in"

Phrase: ":"

Phrase: "ISI Web of Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0282111:Web [Manufactured Object]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "Disclaimer Request Permissions Google Scholar Articles by Gonzalez,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1706852:Article [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.516: A. 

Phrase: "A."
Processing 00000000.tx.517: Articles by Carrillo, M. 

Phrase: "Articles by Carrillo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.518: C. 

Phrase: "C."
Processing 00000000.tx.519: PubMed PubMed Citation Articles by Gonzalez, M. 

Phrase: "PubMed PubMed Citation Articles by Gonzalez,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1706852:Article [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.520: A. 

Phrase: "A."
Processing 00000000.tx.521: Articles by Carrillo, M. 

Phrase: "Articles by Carrillo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.522: C. 

Phrase: "C."
Processing 00000000.tx.523: Online ISSN 1096-0929 - Print ISSN 1096-6080 Copyright  2005 Society of Toxicology Oxford Journals Oxford University Press Site Map Privacy Policy Frequently Asked Questions Other Oxford University Press sites: Oxford University Press American National Biography Booksellers' Information Service Children's Fiction and Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights and Permissions Science School Books Social Sciences Very Short Introductions World's Classics

Phrase: "Online ISSN 1096-0929 - Print ISSN 1096-6080 Copyright  2005 Society of Toxicology Oxford Journals Oxford University Press Site Map Privacy Policy Frequently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   788   C2735290:Privacy policy [Intellectual Product]
   782   C0242456:Policy [Intellectual Product]

Phrase: "Asked"

Phrase: "Questions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "Other Oxford University Press sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: ":"

Phrase: "Oxford University Press American National Biography Booksellers' Information Service Children's Fiction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0887933:fiction [Intellectual Product]

Phrase: "and"

Phrase: "Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary"

Phrase: "of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   852   C0947619:Finger.right [Body Part, Organ, or Organ Component]
   782   C0035621:Rights [Qualitative Concept]
   782   C0205090:Right [Spatial Concept]

Phrase: "and"

Phrase: "Permissions Science School Books Social Sciences Very Short Introductions World's Classics"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   788   C0439658:classics [Qualitative Concept]
   755 E C0439858:Classic [Qualitative Concept]

